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SUMMARY
The effects o f seven different xenobiotics on the induction o f cytochromes P450 and 
cytochrome P450-mediated arachidonic acid (AA) metabolism have been examined in the present 
study. Results from this study have demonstrated that arachidonic acid oxidation catalysed by 
cytochrome P450 enzymes is highly regioselective. Whereas cytochrome P450 lA , IIB and IVA 
sub-families catalyse A A oxidation in a regioselective manner, cytochrome P450 IIEl and 
in A  1(2) isoenzymes do not support any identifiable AA metabohsm.
Three novel hydroxylated arachidonic acid metabolites (18-, 17- and 16-HETEs) have been 
successfully generated, purified and structurally characterized from PENCB and 3-MC induced rat 
liver microsome incubations. Similar metabolite peaks have also been observed from the PENCB- 
induced guinea pig liver microsome incubations.
Species differences in the induction o f cytochrome P-450 have been observed between the 
rat and guinea pig in PENCB treatment, which mainly reside in the induction of cytochrome P-450 
lA  and IVA sub-families. Whereas PENCB-induced rat hepatic cytochromes P-450 significantly 
induced the formation of 19-HETE and suppressed 20-HETE formation, PENCB treatment did 
not affect the 19-HETE formation but induced the 20-HETE formation in the guinea pig, indicative 
of induction o f P-450 lA l and suppression of P-450 IVAl in the rat, but no induction o f P-450 
LAI and induction o f P-450 IVA l in the guinea pig by PENCB treatment.
The present study also demonstrated that the induction of cytochrome P-450 IVA l by PCB 
is both congener-specific and species-dependent. Whereas PENCB (MC-type) suppressed the 
induction o f P-450 IV A l in the rat but induced it in the guinea pig, TCB (PB-type) induced the 
induction of IVAl in the rat, but had no effect on the induction of this isoenzyme in the guinea pig 
at a dose of 300 pmoles/kg.
Finally, PENCB exposure resulted in substantial inhibition o f fatty acid metabolism in the 
rat, whereas no such effects o f PENCB were observed in the guinea pig. This result casts strong 
doubt on the possible roles of lipid metabolism disorders in the toxicity o f PCBs and related PAH 
compounds.
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************ CHAPTER 1************
INTRODUCTION
Polychlorinated biphenyls (PCBs) and other structurally-related polyhalogenated aromatic 
hydrocarbons (PAHs), such as polybrominated biphenyls (PBBs), polychlorinated naphthalenes 
(PCNs), polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), 
polychlorinated azo(xy)benzenes, and polychlorinated terphenyls are notorious, ubiquitous 
environmental contaminants (Poland and Knutson, 1982 and Safe, 1984). These groups of 
chemicals share a number of chemical and biological similarities including 1) their chemical 
structures are remarkably similar, i.e. they are approximate isostereomers (see Figure 1.1), 2) 
they produce a similar and characteristic pattern of toxic responses, although they vary greatly in 
potency (Table 1.1) (Kimbrough, 1987; Poland and Knutson, 1982 and Safe, 1984), 3) while 
some were manufactured as commercial products (such as PCBs, PBBs and PCNs), and others 
occur only as contaminants in the commercial products (such as PCDDs, PCDFs and the 
azoxybenzenes), they have all become widely distributed in the environment; 4) they possess 
remarkable chemical stability and lipophilicity, which result in their persistence in the environment 
and accumulation in the food chain and 5) they are believed to act by a common toxicity 
mechanism.
PCBs have been used in a form of mixture of congeners in commercial products. The 
commercial polychlorinated biphenyls were widely used as industrial compounds with such 
diverse applications as plasticizers, heat transfer fluids, organic diluents, cutting oils, wax 
extenders, adhesives, flame retardants and dielectric fluids for capacitors and transformers 
(Hutzinger et al., 1974; Pomerantz et al., 1978). Since the first detection o f PCBs in the 
environment in late 1960s (Risebrough et al., 1968), these compounds were reported as 
contaminants in almost every component o f the global ecosystem including air, water, fish, 
wildlife and human blood, adipose tissue and milk (Bush et al., 1985, 1986; Buckley, 1982; 
Ballschmiter et al., 1981; Wasserman et al., 1979; Safe, 1982; Holdrinet et al., 1977; Kannan et 
al., 1988; Tanable, 1988). The very properties that made PCBs attractive to industry, the physico­
chemical stability, such as resistance to fire and persistence in the environment, are the same 
properties that have resulted in their perceived toxicological problems and therefore have caused 
increasing concerns about their potential threat to human health.
FIG U R E  1.1 ST R U C T U R E  SIM IL A R IT Y  B E T W E E N  P C B s A N D  O TH ER  
PO LYH ALO G EN ATED ARO M ATIC HYDRO CARBONS
2 '  3. .Cl
1 I'y
\  /
3 6 6 ' ------------------5"
Cl Cl
3,4,5,3',4',5' - Hexachlorobiphenyl 2,3,7,8-Tetrachlorodibenzo-p-dioxin
2,3,7,8-Tetrachlorodibenzofuran 2,3,6,7-Tetrachloronaphthalene
TABLE 1.1 RELATIVE TOXICITY OF THE MOST TOXIC 
CONGENERS OF RELATED HALOGENATED 
HYDROCARBONS IN THE GUINEA PIG
LD5o(pmol/kg) RELATIVE POTENCY
2,3,7,8-TCDD 0.006 1883
2,3,7,8-TCDF 0.023 507
3,4,5,3’,4’,5’-HCB 1.39 8
2,3,6,7-TCN >11.3 1
(Derived from McConnell, 1980)
Commercial production o f PCBs is via the chlorination procedure o f the biphenyl ring. The 
chlorine content of the products is directly dependent on the amount o f chlorine (CI2) used in the 
reaction schemes. This nonspecific-orientated chemical reaction results in the random chlorination 
of the biphenyl ring and the formation of a mixture o f congeners. Theoretically speaking, there are 
209 possible PCB congeners and isomers available ranging from m onochloro- to 
decachlorobiphenyl in commercial products. Since the mid 1970s, the production and industrial 
use o f PCBs have been discontinued based on chronic animal toxicity data and concern about the 
environmental persistence o f these highly lipophilic compounds, which tend to bioaccumulate in 
ecosystem s via the food chain. Nevertheless, the huge amounts o f  PCBs leaked into the 
environment will remain for years before they can be totally biotransformed, which is the reason 
for continuing scientific research on the toxicology o f these chemicals.
The toxicities of PCBs as well as other related polyhalogenated aromatic hydrocarbons 
(PAHs) have well been documented in both laboratory animals and humans (Chen et ah, 1981). 
According to the available toxicological data from scientific literature, the toxicities o f these 
compounds are congener-specific, dependent on not only the degree o f chlorination but also the 
pattern of chlorine substitution. The toxicities are also species, strain, sex, age and tissue organ 
specific. Among the 209 PCBs congeners, the toxic potency ranges from non-toxic to highly toxic 
from congener to congener.
The mechanisms by which PCBs and related PAHs cause toxicity have been extensively 
studied in laboratory animals over the past two decades. However, little is known concerning their 
precise molecular mechanisms o f toxicity. Several hypotheses have been proposed, but neither of 
them can provide an explanation for these diverse and nonspecific toxic responses, particularly the 
large species differences in the acute lethality caused by treatment with PCBs and their related 
PAH counterparts.
1.1 GENERAL CHEM ISTRY AND PROPERTIES OF PCBS
1.1 .1  IN D U STR IA L PR O D U C T IO N  AN D  PR O PE R TIE S OF PC B S
Industrial mass production o f PCBs are prepared by the chlorination o f biphenyl ring with 
anhydrous chlorine and iron filings or ferric chloride as catalyst (Hubbard, 1964; Jenkins, 1932)
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This reaction occurs at high temperatures. The amount o f anhydrous chlorine used in the reaction 
schemes directly determines the content o f chlorine in the products. The crude product is generally 
purified to remove the impurities, such as colour, trace hydrogen chloride and the catalyst, by 
treatment with alkali or sometimes, distillation. The final commercial product is a colourless 
complicated mixture o f polychlorinated biphenyls with different degree o f chlorination per 
molecule and their corresponding isomers. Two hundred and nine different PCB congeners do 
theoretically exist (Cook, 1972), however, it is unlikely on the basis o f both mechanistic and 
statistical grounds that all of them could be formed in the technical chlorination process. Usually, 
there are more than 80 congeners available in the technical mixtures (Jensen et al., 1974; 
Ballschmitter and Zell, 1980). In addition, trace quantities o f polychlorinated naphthalenes and 
polychlorinated dibenzofurans are also formed in the chlorination process of the biphenyl and are 
present in some mixtures (Vos eta l., 1970; Coulston eta l., 1983). The presence o f the latter type 
of compound may be o f considerable toxicological significance.
The pure PCBs are solids at room temperature (25°C) and melting points range from 54°C 
for 2-chlorobiphenyl to 310°C for 2,3,4,5,6,2',3',4',5',6'-decachlorobiphenyl (George et al., 
1988). Generally, PCB melting points increase with the complexity o f the compound. The 
technical mixtures o f PCB > contain congeners with different numbers o f  chlorine atom per 
molecule. This is the fact that is responsible for the physical state o f PCB preparations. The 
commercial mixtures of PCBs are mobile oils (e.g. Aroclor 1221,1232, 1242 and 1248), viscous 
liquids (e.g. Aroclor 1254) or sticky resins (e.g. Aroclor 1260 and 1262) due to the mutual 
depression of melting points of their components. They are highly lipophilic and chemically very 
stable. They are very resistant to degradation, oxidation and other chemical reagents such as acids 
and bases. They can withstand extreme temperatures up to 1600°F (87CPC) and are fire resistant.
1.1.2 SYN TH ESIS OF IN D IVID U AL PCB ISO M ERS
Industrial preparation of technical PCBs always results in the formation o f a mixture o f
many PCBs isomers and congeners, from which it is very difficult to purify a particular PCB
isomer. Instead, individual PCB isomers are synthesized via particular chemical reactions which
have previously been reviewed by Hutzinger et al (1974a). The reaction products can be finally
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purified by column chromatography. For space limitations, I have no intention to give detailed 
descriptions Of these chemical reactions, and interested readers are advised to consult the original 
reference (Hutzinger et a l ,  1974a).
1.2 M ETA BO LISM , D ISTR IBU TIO N  AND ELIM INA TIO N OF PCBS.
1 .2 .1  M E TA B O LISM  OF PCBS
Administration o f commercial PCB mixtures to animals has demonstrated that many of the 
lower chlorinated isomers or congeners are preferentially ehminated from body tissues and organs 
(Burse et al., 1974, 1976; Defreitas et al., 1974; Safe er al., 1975), indicating the in vivo 
metabolism o f the PCB. It has been confirmed that phenolic products are the major PCB 
metabolites, which are subsequently conjugated with glucuronic acid and/or glutathione 
(Matthews et al., 1975a; Berlin et a l ,  1975; Mamoru et al., 1983). The rates o f metabolism and 
excretion o f several PCB congeners have been shown to decrease sharply as the number of 
chlorines increases in the following order: 4-chloro- > 4,4'-dichloro- > 2,5,2',5'-tetrachloro- > 
2,4,5,2',5'-pentachloro-biphenyls (Van Miller et al., 1915', Matthews et al., 1975b). The 
formation o f arene oxide intermediates in PCB metabolism was first reported by Gardner et al 
(1973) and then confirmed by Safe et al (1975). The availability o f two adjacent unchlorinated 
carbon atoms has been demonstrated to be critically important for PCB metabolism, which is 
considered to be favourable for the formation of an arene oxide intermediate during the metabolism 
of these compounds by the mixed function oxidase systems (cytochrome P450). Metabolism of 
those PCBs which do not possess two adjacent unsubstituted carbon atoms can go either via direct 
hydroxylation o f the biphenyl molecule or via the formation o f an arene oxide between a 
chlorinated and an unchlorinated carbon atoms. However, each of these metabolic routes has been 
shown to be much slower than the route of an arene oxide formation via two unchlorinated carbon 
atoms (Daly et al., 1972; Jerina et al., 1974). The latter mechanism usually results in 
dechlorination and/or shifting o f the chlorine atom (Daly et al., 1974; Jensen et al., 1974; 
Hutzinger et al., 1974b). Thus, it would be expected that those PCBs which are more readily 
metabolized and excreted may also more readily form an arene oxide intermediate. Arene oxide 
intermediates have been shown to be highly electrophilic (Daly et al., 1972; Jerina et al., 1974),
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and can covalently combine with cellular macromolecules such DNA, RNA and proteins, thus 
resulting in carcinogenesis and toxicity. However, it has not been proven that those PCBs which 
are more easily metabolized are more toxic than those which are more resistant to metabolism. On 
the contrary, highly toxic PCBs or dioxins are very resistant to biodégradation (Poiger et al., 
1979; Safe 1984). Based on structure-activity relationships for PCBs (Safe, 1984; Shimada , 
1987), it is unlikely that the more toxic compounds such as 3,4,3',4'-tetra-, 3,4,5,3',4'-penta- 
and 3,4,5,3',4',5'-hexachlorobiphenyls would form covalent adducts with DNA or proteins and 
result in cellular toxicity. In addition, arene oxide intermediates are the primary precursors in the 
formation o f sulphur-containing metabolites (Mamoru and Mio, 1983; Mamoru 1983; Preston et 
al., 1984). It was recognized from urinary analysis that glutathione-conjugates could be further 
metabolized to an acetic acid derivative via pyruvate and that mercapturic acid derivatives were not 
the only end metabolites (Mamoru and Mio, 1983). Sulphur-containing metabolites were also 
detected in Yusho patients (Haraguchi et al., 1984), rats (Bakke et al., 1982), mice (Mio et al., 
1976) and seals (Jensen and Jasson, 1976).
1 .2 .2  D ISTR IB U TIO N  OF PCBS IN  VIVO
Polychlorinated biphenyls are highly lipophilic compounds which are readily absorbed in the 
gastrointestinal tract and rapidly distributed throughout the whole body. Matthews and co-workers 
have shown that the initial distribution and subsequent disposition o f a series o f chlorinated 
biphenyl congeners o f increasing numbers of chlorine atoms exhibited remarkable similarity 
(Matthews et a l ,  1975b; Sugiura e ta l., 1975; Peterson et al., 1976; Tuey and Matthews, 1977a; 
1977b; Morales et al., 1979; Bungay et al., 1979). The initial concentrations o f all the tested 
com pounds (4 -ch loro , 4 ,4 '-d ich loro , 2 ,2 ',4 ,5 ,5 '-p en tach loro  and 2 ,2 ',4 ,4 ’,5 ,5'- 
hexachlorobiphenyls) were highest in the liver, followed by the muscle and blood after a single 
z.v. dose o f each compound, and this decreased rapidly with time. Long-term distribution o f all of 
the PCBs in tissues follows the order: adipose tissue > skin > liver > muscle. The tissue 
distribution and excretion of PCBs depends on the rate of metabolism, which in turn depends on 
not only the degree of chlorination but also the chlorination patterns. The availability o f two 
adjacent unchlorinated carbon atoms markly facilitates mammalian PCB metabolism and excretion.
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Comparative studies on the distribution and metabolism o f 2,5,2',5'-tetra- and 2,4,5,2',4',5'- 
hexachlorobiphenyls in the rat (Bungay et al., 1979) and several tetra- to hexachlorobiphenyl 
isomers in the mouse (Gage and Holm, 1976; Brandt, 1977) has confirmed this finding.
Experiments in mice have shown that the administration o f certain PCBs results in the 
specific accumulation o f methylsulphone metabolites in the lung (Brandt, 1977; Brandt et al., 
1982a; Brandt et al., 1982b). The formation o f  methylthio, methylsulphinyl, and/or 
methylsulphonyl metabolites o f PCBs involved the action o f intestinal microflora (Brandt et a l ,  
1982b). The selective accumulation of 4,4'-bis(methylsulphonyl)-2,2',5,5'-tetrachlorobiphenyl 
((MeS0 2 )2-TCB) in the lung was later found to be due to the presence o f a secreted (M eS02)2- 
TCB-binding protein in the respiratory tracts of rats, mice and man (Lund et al., 1986).
1.2.3 E LIM IN A TIO N  OF PCBS IN  VIVO
Highly lipophilic PCBs can persist in the animal body indefinitely unless they have been 
metabolized (hydroxylation), but once hydroxylated, they are very easily removed from the 
animal. The elimination o f PCBs is mainly via three routes: bile, urine and intestine. However, no 
parent compounds have ever been found in the urine or bile (Burse e t al., 1976). In rats, both 
2,4,3',4'-, and 3,4,3',4'-tetrachlorobiphenyls were metabolized to monohydroxy-derivatives, 5- 
and 3-hydroxy-2,4,3',4'-tetrachorobiphenyls (Yoshimura e ta l . ,  1973; Yamamoto and 
Yoshimura, 1973) and 5-, or 2-hydrxy-3,4,3',4'-tetrachlorobiphenyl (Yoshimura and Yamamoto, 
1973) respectively and excreted into the faeces through the biliary system, but the bile did not 
contain the unchanged compounds in either case. Thus, the unchanged PCB found in the faeces 
must have been excreted through the wall o f  the gastro-intestinal tract as demonstrated by 
Yoshimura and Yamamoto (1975). They found 2,4,3',4'-tetrachlorobiphenyl in the faeces o f rats 
with bile duct ligation after an initial i.v. injection of the compounds.
For many years, attempts on the characterization o f metabolism, disposition and clearance of 
PCBs and related polyhalogenated aromatic hydrocarbons turned up with no clues which could 
account for the toxicity and the species difference in the toxicity of PCBs. The ability to store these 
chemicals in adipose tissue may be o f protective value, but there is no evidence that the difference 
in the amounts o f constitutive adipose tissue between different species could explain this species
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difference in the toxicity. Abdel-Hamid (1981) reported that the distribution and clearance of  
3,4,3',4’-tetrachlorobiphenyl (one o f the highly toxic congeners) were similar in both male and 
female rats and the toxicity of this congener could not be attributed to inability of the animals to 
metabolize and excrete it or to its persistence in any tissues, with the exception o f the blood. This 
congener and its metabolites appear to be more persistent in the blood than any other PCB 
congeners studied to date. A  recent comparative study o f the pharmacokinetics o f 2,5,2',5'- 
tetrachlorobiphenyl and 3,4,3’,4'-tetrachlorobiphenyl revealed that the half-life, systemic 
clearance and distribution for these two isomers were all similar, whereas only 3,4,3',4'- 
tetrachlorobiphenyl caused obvious thymic atrophy and hepatotoxicity even at much lower tissue 
concentrations (Clevenger et a l ,  1989). The latter results demonstrated that the in vivo difference 
in the toxic potency of these two TCB isomers did not result from the significant differences in 
their tissue disposition, ehmination, or ultimate bioaccumulation.
Briefly, information from the literature concerning the metabolism o f PCBs can be 
summarized as following:
1 ) metabolism is more likely to be a detoxification process rather than an activation one, and 
the rate o f elimination o f PCBs is dependent on the rate at which they are metabolized;
2) the rate o f  metabolism o f PCBs is dependent on both the number o f  chlorine atoms and 
the patterns o f  chlorination; once the number o f chlorine atoms reaches four, chlorination 
patterns play a critical role in the metabolism;
3) the availability o f two adjacent unchlorinated carbon atoms (particularly a pair in the meta ­
para positions) is favourable fo r  metabolism;
4) the metabolism o f PCBs can go via an arene oxide formation, direct hydroxylation and 
m icrobial breakdown o f  the phenyl ring. In any case, the route via an arene oxide 
intermediate formed from two adjacent unchlorinated carbon atoms goes much quickly than 
any other route.
1.3 TO X ICITY  OF PCBS TO ANIM ALS AND HUM ANS
Polychlorinated biphenyls and other related polyhalogenated aromatic hydrocarbons have 
been shown to be highly toxic to laboratory animals and humans. One of the most distinctive 
aspects o f their toxicity is that they vary so much from congener to congener between different 
species and different tissues that it is very difficult to explain the toxicology by one simple
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biochemical alteration or particular organ histopathological changes. It is not the case that every 
congener is o f equal toxic potency, instead, the toxic potency ranges from non-toxic to highly 
toxic from congener to congener. Studies with relatively pure chlorinated biphenyl isomers have 
shown that toxicity tended to increase with degree of chlorination (Johnstone et al., 1974), but the 
chlorination patterns seemed also important (Ecobichon and Comeau, 1975; Goldstein et al., 
1976).
1 .3 .1  C LA SSIF IC A TIO N  OF PC B  C O N G EN ERS: cytochrom e P 450 inducib ility
Hepatic cytochrome P450-dependent drug-metabolism enzymes have been demonstrated to 
consist of multiple forms o f isoenzymes, genetically expressed by a gene superfamily (Nebert et 
al., 1987). In the early years of studies on the induction of drug-metabolizing enzymes, inducers 
of cytochrome P450-dependent enzyme systems have been divided into two types (Conney, 
1967). One type, o f which phénobarbital is a prototype, enhances the metabolism o f a large 
variety of substrates, such as aminopyrine, pentoxyresorufin, and increases the concentration of 
cytochrome P450 IIB sub-family (IIBl and IIB2). Another type o f inducer includes the 
carcinogenic polycyclic aromatic hydrocarbons, of which 3-methylcholanthrene (3-MC) is a 
prototype. These compounds induce the expression o f cytochrome P450 LA sub-family (P448) 
(mainly lA l) , a cytochrome which is different from cytochrome P450 present in untreated or 
phénobarbital pretreated rats, as indicated by a 2 nm shift o f the Soret peak in the CO-difference 
spectrum; an increase in the ratio o f 455 nm to 430 nm peaks of the ethyl isocyanide difference 
spectrum; a shift in the peak of 455 nm to 453 nm; and an alteration in the substrate specificity 
(Sladekand Mannering, 1966; Lu and Levin, 1974).
Studies with commercial mixtures o f PCBs have shown that PCBs are a new type of 
inducer, possessing the inducing potencies of both PB and 3-MC prototypes, increasing both 
cytochrome P450 IIB and lA  subfamilies, increasing the substrate metabolism catalysed by both 
IIB and LA isoenzymes (Alvares et al., 1973) and their corresponding cytochrome P450 protein 
expression (Alvares and Sickovitz, 1973). Further studies with pure PCB isomers have shown 
that PCBs were not a new type of inducer but rather contained the two distinctive groups of 
congeners or isomers (Goldstein et al., 1977). Accordingly, individual PCB isomers could be
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categorized on the basis o f  their chemical structure into PB-type or MC-type inducers o f 
microsomal enzyme activity (Goldstein et al., 1977; Poland and Glover, 1977; Yoshimura et 
a /.,1978). It was found that chlorination at both para- (4 and 4') positions were important for 
activity (Goldstein et al., 1977). Further studies indicated that certain PCB congeners could be 
mixed inducers, i.e. a single PCB isomer induced both 3-MC- and PB-type microsomal enzyme 
activity (Parkinson er al, 1980a). Based on these structure-activity relationships and their chemical 
structure, PCBs can be categorized into four types o f inducers:
(1 ) MC-type inducers: PCBs which induce MC-type activity must be chlorinated at 
both para positions, at least two meta positions but not necessarily on the same 
phenyl ring (Goldstein et al., 1977; Yoshimura et al., 1977; Parkinson et
(2) PB-type inducers; due to considerable variability, the precise structural 
requirements fo r  PCBs as PB-type inducers o f microsomal enzyme activities 
cannot be readily defined (Parkinson et al., 1980c);
(3) mixed-type inducers: PCBs with an additional substituent at one ortho position  
do not necessarily abolish the M C-type activity o f these PCB congeners but result 
in the increase o f PB-type activity, thus possessing both 3-MC- and PB-type 
activity (Parkinson et a l, 1980a and 1980c);
(4) non- or weak inducers; PCB isomers which are chlorinated in only one ring, or 
are chlorinated in both rings but not in the para positions, have very little activity as 
inducers o f liver drug-metabolizing enzymes.
The strict structural requirements for 3-MC-type inducers have been considered to be due to 
the favourable formation o f a coplanar PCB structure ( Goldstein et al., 1977; Yoshimura et al., 
1978; Parkinson et al., 1980c) which favours the binding o f PCB moiety with the cytosolic Ah 
receptor protein involved in the initiation of microsomal monooxygenase enzyme induction of 
this family (Poland et a /.,1976). One additional ortho chloro substituent of the coplan ar 3-MC- 
type inducers have been considered not sufficient to hinder the formation o f coplanar structure, but 
two or more additional ortho chloro substituents result in the breakdown of the balance between 
the coplanar and non-coplanar stereoisomers and result in the complete abolition o f MC-type
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inductive properties (Poland and Glover 1977; Goldstein et al., 1977; Parkinson et al., 1980c). 
Initial reports suggested that chlorination at both p a ra  positions (4, & 4') and additional 
chlorination at ortho positions were a prerequisite for PB-type activity (Goldstein et al., 1977). 
Further experiments generated contradictory evidence and therefore ruled out that para  chloro 
substitution o f biphenyl is the structural requirements for PB-type activity, for instance, 
2,2',3,3',5,5'-hexachlorobiphenyl which has no para  chloro substituents but has been shown to 
be a PB-type inducer (Kohli et al., 1979a, 1979b). The explanations for the inactivity o f some 
lower chlorinated PCB isomers have been suggested to be partially due to their rapid rate of 
metabolism (Goldstein et al., 1977) except 3,5,3',5'-tetrachlorobiphenyl, which is poorly 
metabolized and accumulated more extensively than 3,4,3',4'-tetrachlorobiphenyl (Sugiura et al., 
1976), but relatively inactive as an inducer.
It has been demonstrated that the toxicity o f several classes o f halogenated aromatic 
hydrocarbons including PCBs is sometimes associated with their MC-type inducibility (Poland 
and Glover, 1977; Poland et a l ,  1979). It therefore seems very important to categorize PCBs 
according to their inducibility and identify those PCB congeners with properties o f MC-type 
inducers for the study of PCB-related biological effects.
1.3.2 TO XICITY OF PC B S A N D  OTH ER R E LA TE D  PAH S
The toxic effects o f PCBs and other related PAH compounds show remarkable similarities 
even though there exist qualitative and quantitative differences between different groups of  
chemicals and different species. In summary, the characteristic toxic effects are:
(1) Diverse and nonspecific toxic responses;
(2) Following administration o f  an acute dose o f the toxins, the animals experience 
continuous anorexia (i.e. decreased food  intake) and progressive loss o f body weight until 
death ensues;
(3) Delayed onset o f lethality usually ranges from  1 to 3 weeks in small laboratory animals 
and probably 1 to 2 months in large animals after an initial acute exposure. Increased  
dosage does not significantly shorten the latency from exposure to death;
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(4) The toxicities o f PCBs and related PAHs are sex, strain, species, age and tissue (?) 
dependent.
1 .3 .2 .1  Skin  d isorders
PCBs and other related PAHs have been found to be rather typical chloracnogenic agents. 
They have been demonstrated to cause skin lesions in the rabbit (Vos and Beems, 1971; Vos and 
Noteboom-Ram, 1972), the nude mouse (Pupvel et al., 1982), non-human primate (Allen et al., 
1978; McConnell and Moore, 1979), cattle (Jackson and Halbert, 1974) horse and humans 
(Kimbrogh, 1980; Peterson et al., 1981; Needham et al., 1982). This kind o f skin eruption is 
called chloracne in humans. The rabbit ear is particularly susceptible to this toxic insult. Topical 
application o f these chemicals to the rabbit ear first produced hyperplasia and hyperkeratosis and 
later developed grossly visible folliculitis (Vos and Beems, 1971; Vos and Noteboom-Ram, 1972; 
Hass et al., 1978). The inner surface o f the rabbit ear is so sensitive that it has been used as a tool 
to test for the presence and the toxic potential o f these compounds (Jones and Krizek, 1962). 
Monkeys exhibit highly characteristic skin (and occular) lesions after dietary exposure to PCBs 
and PBBs (Lambrecht et al., 1978; Allen er al., 1978, 1979; McConnell and Moore, 1979; 
McConnell et ah, 1979). The skin lesions of the monkeys exposed to PCBs are highly diagnostic 
and in many ways similar to those changes observed in man, i.e. chloracne. The lesions consist of 
oedema, alopecia and folliculitis, particularly on the face, the eyelids and later on the chest. 
Concomitantly, the skin on the remainder o f the body, especially in the extremities, becomes dry 
and scaly and the finger and toe nails are often lost (McConnell and Moore, 1979; Aulerich et al., 
1987).
Rodents are usually more resistant to the skin lesions caused by PCBs and PAHs. Rats,
guinea pigs and mice have not been found to develop acne, except the hairless mice. In nude mice,
histopathological examination shown numerous intra-dermal, keratinous cysts and atrophy of
sebaceous glands in the damaged skin area (Pupvel et al., 1982).
Mink developed thickened, elongated and deformed nails, but no chloracne was found in
this species (Aulerich et al., 1987) even though mink are highly susceptible to PCB toxicosis.
Ferrets, an animal species closely related to mink, developed hyperkeratosis and excessive nail
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growth after exposure to a diet containing 20 ppm o f Aroclor 1242 for several months (Bleavins et 
a/., 1982).
The rationale for the difference in animal susceptibilities to the development of skin lesions 
is not clear. The mechanisms by which these compounds cause skin damage is still unknown.
1.3.2.2 H e p a to to x ic ity
Liver has always been considered as the target organ in the investigations o f toxicology of
halogenated aromatic hydrocarbon compounds. The severity o f PCBs and related PAH-mediated
hepatotoxicity varies considerably according to age, sex, species, route o f administration and
duration of exposure. Moderate to severe hepatic damage was often observed in chickens, rabbits,
rats and mice whereas minimal liver damage appeared in guinea pigs, monkeys and mink
(McConnell, 1980; Aulerich et a l ,  1987; Gillette et al., 1987). This is an interesting observation
since the latter three animal species are much more susceptible to the toxicity o f PCBs and related
PAH compounds than the former (Parkinson and Safe, 1981; Poland and Knutson, 1982). The
most consistent evidence of the effects of PCBs and PAHs on the liver is hepatomegaly in all ages
and species of animal studied (Kimbrough eta l., 1978; McConnell eta l., 1978a, 1978b; Aulerich
et al., 1987; Gillette et al., 1987) and may be observed at doses below those where significant
organ weight loss effects are found in the thymus, the most susceptible organ (Kociba et al.,
1976). Concomitantly, hepatic fatty infiltration is usually observed in the enlarged liver (Jones and
Greig, 1975; Allen et a l ,  1976; McKinney et al., 1976; Kohli et al., 1979). In rats, dietary PCB
increased the levels of total lipids, triglyceride, phospholipids, cholesterol and free fatty acids in
the liver (Kato et al., 1982). The mechanism underlying the effects o f PCBs and related PAHs
on disturbances o f lipid metabolism is not clear at present. No difference was found in lipid
synthesis between control and TCCD-treated rats (Cunningham and Williams, 1972). Reduced
levels o f ester hydrolase may indicate decreased lipid utilization (Albro er al., 1978). The
morphological changes of liver vary considerably from hypertrophy to necrosis. The most severe
liver lesions have been reported in rabbits (Vos and Beems, 1971) and chickens (Vos and
Koeman, 1970) with large areas o f necrosis. In acute lethal exposures, large areas o f necrosis
with haemorrhage and fatty change, were found randomly throughout the chicken hepatic
parenchyma (Vos and Koeman, 1970). Proliferation o f endoplasmic reticulum, especially the
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smooth endoplasmic reticulum (SER) was observed (Adamson and Weeks, 1973), which usually 
occurs in the case o f hepatomegaly. Hepatic glutathione (GSH) contents were not significantly 
altered by 3,4,3’,4’-TCB or 3,4,5,3',4’,5’-HCB (Rifkind et a l ,  1984), indicating that GSH 
depletion does not have a significant role in the production o f hepatotoxicity by PCBs. The 
hepatocytes were swollen and contained a higher water content, indicating cell oedema (Rifkind et 
a l ,  1984). No precise mechanism has been proposed by which PCBs and PAHs cause these 
hepatic lesions.
1 .3 .2 .3  Im m u n otox icity
Immunotoxicity is one o f the most distinctive and consistent toxic effects o f PCBs and other 
related PAHs. Marked thymic atrophy (McNutty e ta l ,  1980; Silkworth and Grabstein, 1982) and 
involution o f other lymphoid tissues, e.g. spleen, bursa in chickens (Flick et a l ,  1965; Vos and 
Koeman, 1970) have been observed. A  wide spectrum o f immunotoxic effects o f PCBs and 
PBBs on rodents have been reported, such as atrophy o f thymus and spleen, suppression of 
antibody response (Vos and Dried-Grootenhuts, 1972; Wilson e ta l., 1978), depression o f T-cell 
responsiveness to mitogens (Vos and Dried-Grootenhuts, 1972; Bonnyns and Bastomsky, 1976), 
alterations in B and T cell functions (Spencer, 1982) and delayed hypersensitivity (Franker,
1986). A number of studies suggested that the immunotoxic effects caused by PAHs were not 
secondary to thymic involution (Vecchi et a l ,  1980,1983; Clark et a l ,  1981,1983; Silkworth et 
a l ,  1984), but rather can be observed prior to any thymic involution. A  recent publication has 
shown that perinatal TCDD exposure resulted in severe damage of lymphocyte stem cells (Fine et 
a l ,  1988), as evidenced by a significant reduction in the lymphocyte stem cell-specific enzyme 
terminal deoxynucleotidyl transferase (TdT) activity and its corresponding mRNA level. Tucker et 
al (1986) have shown that the same dose ranges o f TCDD suppress both the T-cell dependent 
and independent responsiveness in the murine in vivo and in vitro model without loss o f cell 
viability, indicating that one target cell for PAHs may be the B cell. Krammer et a l (1987) 
reported an alteration in the quantitative and qualitative protein phosphorylation pattern associated 
with TCDD treatment o f stimulated B cells, implying that TCDD affected early activation o f the B 
cell. This change in the pattern of protein phosphorylation by TCDD treatment may result from the 
induction o f protein kinase C, particularly the protein tyrosine kinase activity (Bombick and
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Matsumura, 1987; Madhukar et al., 1988). TCDD treatment alters the development and 
differentiation of thymic epithelial cells (Greenlee et al., 1985), thereby reducing the ability o f the 
thymus to support the proper maturation o f T cells and leading to a fundamental loss in mature 
active T cells.
The immunotoxicity o f PCBs and PAHs is dependent on the isomer planarity and Ah 
receptor complex formation (Clark et al., 1981,1983; Silkworth and Grabstein, 1982; Silkworth 
et al., 1984, 1986; Tucker et a l ,  1986) and the suppression o f immune responses by 3,4,3',4'- 
tetrachlorobiphenyl (Silkworth et al., 1986) or TCDD (Luster et al., 1985) is determined by the 
Ah phenotype expressed by lymphoid tissues (e.g. bone marrow) rather than nonlymphoid tissues 
(e.g. liver). In addition, recent studies (Luster et a l ,  1986; Bannister et al., 1987, Blank et al., 
1987; Davis and Safe, 1989) have demonstrated that Ah receptor antagonists are able to reduce or 
eliminate the immunosuppressive effects o f TCDD both in the in vivo and in vitro murine model. 
Although the precise molecular mechanism(s) o f immunotoxicity caused by toxic PAHs is not 
known, existing evidence suggests that some immunotoxic effects o f PAHs can be the result of 
altered cell differentiation and maturation pattern in lymphoid tissues, which is derived from an 
early activation of Ah gene locus (Davis and Safe, 1988), and suggest that this toxic effect can be 
initiated by any Ah receptor agonist (Silkworth et al., 1984) and antagonized by any Ah receptor 
antagonists (Davis and Safe, 1989).
1.3.2.4 G astro in testina l dam age
Gastric enteritis caused by PCBs has been shown in monkeys (Allen and Norback, 1983), 
mink (Aulerich et a l ., 1985, 1987; Gillette et al., 1987) and cattle (PBBs) (McConnell, 1980). 
This effect has not been observed in rats, mice or guinea pigs (McConnell e t al., 1978b). 
3,4,3'4'-TCB-treated mink developed diarrhoea and melena throughout the experimental period 
(Gillette et a l ,  1987) and bloody stool (Aulerich et al., 1987). The most significant histological 
changes occurred in the small intestines o f all 3,4,3',4'-TCB-treated mink. The entire length o f  
the small intestine was affected. There was necrosis o f villous epithelium, with blunting and 
fusion o f villi (Gillette gf al., 1987). Guinea pigs treated orally with Aroclor 1254 (1400 mg/kg in 
olive oil for two consecutive days) developed diarrhoea on the third day. Diarrhoea, melena and 
mucosal faeces could be observed throughout the whole experimental period (unpublished
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results). Hyperplasia of the epithelium of the intestines has been noted in monkeys (McConnell, 
1980) and hamsters (Olson et a l ,  1980). In monkeys, large multiple papillary neoplastic like 
growths, almost fungoid in shape, developed in the glandular portion o f the stomach, usually 
with ulcers within and between these growths, and sometimes with variable amounts of 
submucosal oedema and inflammation (McConnell, 1980). Moderate to severe ileitis and 
peritonitis were found in many o f the hamsters which died following TCDD treatment (Olson et 
al., 1980). Gastric ulcers were present in mink which died after exposure to 3,4,5,3',4',5'-HCB 
(Aulerich et al., 1987). The epithelial necrosis generally spared the basal one-third o f the mucosa, 
and the deep crypt epithelium was often moderately hyperplastic, however 2,4,2',4'-TCB did not 
cause this lesion (Gillette et al., 1987). No precise mechanisms have been proposed for the 
gastrointestinal damage caused by PCBs and PAHs.
1.3.2.5 O edem a
As compared with mammals, chickens, when exposed to PAHs, do not show marked 
weight loss but rather show an increase in body weight as a result o f an excessive accumulation of 
extracellular body fluids. Chickens exposed to “toxic fat” which was contaminated with high 
levels of chlorinated dibenzo-p- dioxins demonstrated subcutaneous oedema, ascites, hydrothorax 
and hydropericardium (Allen, 1964; Firestone, 1973). Experimental PCB and PBB poisonings in 
chicks have produced similar oedema effects (Platonow et al., 1973; Ringer and Polin, 1977). 
Subcutaneous oedema is also observed in monkeys exposed to TCDD, especially on the face 
(McConnell et al., 1978a; McConnell et al., 1978b; McConnell and Moore, 1979). Mink 
developed ascites following a toxic dose of 3,4,5,3',4',5'-hexachlorobiphenyl (Aulerich et al., 
1987). Subcutaneous oedema and ascites are also observed occasionally in mice exposed to these 
chemicals (McConnell, 1980). Hepatocytes of chicken embryo exposed to PCB results in 
increased water content and clinical signs of oedema ( Rifkind and Muschick, 1983; Rifkind et a l ,  
1984a).
1 .3 .2 .6  R eprodu ctive  lesions
Reproductive disorders have been demonstrated in a variety o f animal species after exposure
to PCBs and other PAH compounds. The exposed animals exhibited such evidence o f impaired
reproductive ability as increased frequency o f resorption and abortion and low birth weight o f their
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offspring (Barsotti et al., 1976; Allen and Lambrecht, 1978; Spencer, 1982). Higher doses of 
TCDD cause decreased spermatogenesis and structural damage to testes and spermatogonia, 
however, no morphological changes in sperm have been found (Kociba and Schwartz, 1982). 
Silbergeld and Mattison (1987) have reported that TCDD has a range o f toxic effects on the 
reproductive system in both males and females, on hormone biochemistry and on embryo-foetus 
development. These effects may partly involve an identified cytosolic Ah receptor and its 
association with the induction o f microsomal cytochrome P-450-dependent monooxygenases in 
many organs. TCDD treatment increases the activity o f monooxygenase enzymes in the liver and 
gonads o f the treated animals, but unlike polycyclic aromatic hydrocarbons which also possess 
the MC-type activity, TCDD is not cytotoxic to any population o f oocytes in the mature female 
mouse (Silbergeld and Mattison, 1987). The precise mechanisms involved in the reproductive 
toxicity o f PCBs and other PAHs is not known, but it is suggested that such an outcome may 
result from the comprehensive toxic effects o f these groups o f chemicals such as alterations o f  
hormone and vitamin status.
1 .3 .2 .7  C arcinogenicity an d  m utagenicity
Carcinogenic and mutagenic effects o f PCBs and PAHs have been demonstrated in a number 
o f animal species (Poland and Knutson, 1982; Safe, 1984). Chronic treatment o f rats with low  
levels of TCDD resulted in an increased incidence of neoplasms (Van Miller et al., 1977). Data 
from the literature show that these toxic effects are only observed after long-term exposure to 
relatively high doses of the chemicals. Rao et al (1988) reported that long-term (12-13 months) 
treatment o f TCDD {via s.c. or i.p. administration) results in a 21% incidence o f squamous cell 
carcinomas in Syrian golden hamsters. There is no evidence that they are cancer initiators, for 
example, they cannot be metabolized at an appreciable rate to electrophilic intermediates which 
could subsequently bind to DNA in vivo (Poland and Glover, 1979; Safe, 1989) to initiate 
tumours. However, the literature abounds with references that PCBs or dioxins are very effective 
cancer promotors (Van Miller et al., 1977; Poland and Glover, 1979; Pilot et al., 1980; Preston et 
al., 1981; Dixon et a l ,  1988). It is expected that the promotional effects o f these chemicals on the 
induction o f cancer may result from their effects on MFO enzyme induction, the increased MFO
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enzyme activity in turn activating the tumour initiators. A  recent publication (Safe, 1989) gave a 
detailed review on the carcinogenicity and mutagenicity of PCBs and related PAH compounds.
1.3 .2 .8  P o r p h y r ia
PCBs have been demonstrated to cause porphyria in humans, adult rats , mice and some bird 
species, whereas young rats, mink and guinea pigs are less susceptible or do not develop this 
toxic lesion at all (Strik etaL , 1980). The lesion is characterized by significant increases in hepatic 
and urinary porphyrins (mainly uroporphyrin and heptaocarboxyporphyrin) (Goldstein et a l ,  
1973; Grote et al., 1975). The mechanism by which PCBs and related PAHs cause disturbances 
in the metabolism of haem is not exactly clear. It has been reported that 6-aminolaevulinic acid 
synthetase (ALAS), the rate-limiting enzyme in the biosynthesis of heam is induced (Goldstein et 
al., 1973; Grote et al., 1975; Poland and Kende, 1976; Woods, 1977; Poland and Glover, 1977) 
and the activity o f uroporphyrinogen decarboxylase (UROD) is inhibited by the treatment of 
PCBs and related PAHs (Elder, 1978; Smith et al., 1981; Smith and Francis, 1981; DeVemeuil et 
al., 1983; G rtïg  et al., 1984; Sassa et a l ,  1984). It has been suggested that the inhibition of 
UROD coupled with the induction o f ALAS are both important factors in determining the 
development of hepatic porphyria in mice (DeVemeuil et al., 1983; Sassa et al., 1984; Seki et al.,
1987). There is also evidence that the halogenated aromatic hydrocarbon-mediated induction of 
cytochrome P450-dependent monooxygenases is important in the development o f hepatic 
porphyria. It has been suggested that these enzymes may lead to formation o f a metabolically 
activated toxic intermediate which inactivates UROD (DeVemeuil et al., 1983; Sassa et al., 1984; 
Sinclair et a l ,  1984,1986; Lambrecht et al., 1988) or altematively, the induced monooxygenases 
initially cause the oxidation o f uroporphyrinogen to uroporphyrin which may accumulate in some 
systems without a decrease in UROD activity (Lambrecht et al., 1988). A recent article (Yao and 
Safe, 1989) reported that 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) can partially antagonize 
TCDD-induced porphyria in female mice but has no effect on hepatic AHH, EROD and UROD  
activities, indicating that other factors, in addition to induction o f cytochrome P450-dependent 
monooxygenases and depressed UROD activity, are involved in TCDD-induced porphyria in 
C57BL/6 female mice. The time required for the expression of uroporphyrinogen decarboxylase
inhibition of chick liver in ova is longer than that in chick embryo liver culture (Rifkind et al.,
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1985). Further studies on dose-response relationships between MFO induction and 
uroporphyrinogen decarboxylase inhibition in chick embryo by Rifkind et al (1985) revealed that 
a dissociation o f these dose-response relationships is possible. The authors suggested that 
uroporphyrinogen decarboxylase inhibition cannot be a direct consequence o f either ALAS or 
MFO induction, and induction per se does not lead directly to toxicity and that other factors must 
contribute.
1.3 .2 .9  C a rd io to x ic ity
Cardiotoxicity is a newly identified toxic response to PCBs and dioxins. The contractile 
response o f ventricular muscle from hearts o f chick embryo to norepinephrine was remarkably 
reduced when they were pretreated with 3,4,5,3',4',5'-hexachlorobiphenyl and 3,4,3',4'- 
tetrachlorobiphenyl as compared to controls (Rifkind et a l ,  1984b). The cardiotoxic effects of 
3,4,5,3',4',5'-hexachlorobiphenyl are dose-related and associated with its MC-type inducibility. 
TCDD produced significant alterations in cardiac function after prolonged exposure. Basal force of 
contraction was significantly reduced 20 days after TCDD administration and the exposure of atrial 
muscle to the positive inotropic effect o f isoproterenol had much less effect than in pair-fed 
controls (Brewster et al., 1987). Both o f these two groups suggested that this effect may be 
attributed to alteration o f the P-adrenergic system, which is associated with changes in cAMP- 
related enzyme systems. TCDD also influences cellular cAMP concentrations (Brewster, 1985). In 
female rats, six days after treatment with TCDD, the blood pressure and resting heart rates were 
significantly less than in control animals. Treated rats were also less responsive to the stimulatory 
effects o f the p i  receptor agonist, (-)isoproterenol (Hermansky et al., 1988), however, no 
histopathologic changes were found in the heart under those conditions. A recent publication 
(Canga et al., 1988) has confirmed that TCDD treatment significantly decreased P-adrenergic 
responsiveness o f guinea pig right ventricular papillary to isoproterenol. In addition, TCDD 
treatment increased the intracellular Ca^+ concentration in papillary muscle o f guinea pig heart 
(Canga et al., 1988). TCDD-induced disturbance o f calcium homeostasis in rat liver has also been 
reported by Al-Bayati et al. ( 1988). They demonstrated a significant increase in calcium levels in 
liver cytosol, mitochondria, microsomes and homogenates after TCDD exposure. It is not clear
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whether the decreased force o f heart contraction, caused by TCDD in the guinea pig and by 
3,4,5,3',4',5'-hexachlorobiphenyl in the chick embryo, is a direct effect or a secondary effect.
1 .3 .2 .1 0  U rinary system  lesions
It has been observed that the transitional epithelial lining o f the urinary tract (renal pelvis, 
ureter and urinary bladder) o f guinea pigs, monkeys and cows exposed to PCBs proliferated to 
two or three times its normal thickness (McConnell gf a/., 1978a, 1978b; 1980). Kidney 
malfunctions were also observed in mice (Neubert et al., 1973). The earliest change in kidney is 
the disruption and distortion of mitochondria followed by necrosis, however, in most studies, 
kidney lesions are not apparent, at least under light microscopy (McConnell, 1980).
1 .3 .2 .11 Im balance o f  vitam in m etabolism
Polyhalogenated aromatic hydrocarbon (PAHs) treatments have been demonstrated to
cause a decrease in the hepatic levels o f vitamins A, B and E and an increase in vitamin C
(Parkinson and Safe, 1981), of which the decrease in the hepatic vitamin A level arouse particular
attention because of the established similarities of certain toxic symptoms o f PAH poisoning and
the effects o f vitamin A deficiency. TCDD (Thunberg et al., 1979, 1980), 3,4,5,3',4',5'-
hexachlorobiphenyl (Cullum and Z ile, 1985; Jensen et al., 1987) and 3,4,3',4'-
tetrachlorobiphenyl (Brouwer and van den Berg, 1984; Brouwer et al., 1985) treatment caused
significant reduction o f hepatic retinoid content. Exposure to 3,4,3',4'-tetrachlorobiphenyl
resulted in a significant reduction of retinoid concentration in the liver as well as in the lung and
heart o f the Sprague-Dawley rat, but no reduction of retinoid content was observed in skin and
kidney. Whereas 3,4,3',4'-tetrachlorobiphenyl, a toxic 3-MC-type inducer, significantly
decreased hepatic vitamin A content, 2,5,2',5'-tetrachlorobiphenyl, a weak or non-inducer,
2,4,5,2',4',5'-hexachlorobiphenyl and DDT, PB-type inducers, had no effects on hepatic vitamin
A content (Azais et al., 1987). On the contrary, the kidney total vitamin A content increased about
3-fold by 3,4,3',4'-tetrachlorobiphenyl treatment, which was only equal to 1/40 o f the total
vitamin A which disappeared from the liver (Azias et a l ,  1987). The reduction o f hepatic vitamin
A concentration was demonstrated to be independent o f drug-metabolizing enzyme activities and
cytochrome P450 content in the liver (Brouwer et al., 1985; Azais et al., 1987). An earlier study
by Thunberg et al (1980) suggested that TCDD effects on retinol reduction was mediated through
2 1
UDP-glucuronosyltransferase (UDPGT) induction and subsequent increase in glucuronidation 
and enhanced excretion of retinol; but they did not find any correlation between the induction of 
UDPGT and retinol reduction in a following up study (Thunberg et al., 1984). The reduction o f  
serum retinol caused by 3,4,3',4'-tetrachlorobiphenyl treatment was found to be due to the 
interference o f vitamin A transport system by a 3,4,3',4'-tetrachlorobiphenyl metabolite (Brouwer 
and van den Berg, 1986). This 3,4,3',4'-tetrachlorobiphenyl metabolite has a preferential affinity 
for serum transthyretin (TTR) protein (Shimada and Sawabe, 1983; Brouwer and van den Berg,
1986), and it was proposed that binding o f the metabolite with the TTR protein results in some 
conformational change of TTR or blockage o f the TTR binding site for retinol binding protein, 
thus eventually leading to a reduced serum concentration o f RBP-TTR protein complex. As 
compared with 3,4,3',4'-tetrachlorobiphenyl, TCDD treatment did not decrease but rather 
increased plasma retinol concentrations (Thunberg et al., 1979; Hakansson and Ahlborg, 1985; 
Hakansson et al., 1986; Brouwer et al., 1989). It was recently reported (Brouwer et al., 1989) 
that the reduction in the retinoid status in rats caused by both TCDD and 3,4,3',4'- 
tetrachlorobiphenyl was most likely through a combined enhancement o f mobilization o f retinoids 
from their storage sites and an increased glomerular filtration of retinoids, and the different effects 
of TCDD and 3,4,3',4'-tetrachlorobiphenyl on serum retinol and RBP concentrations might result 
from the differences in magnitude of stimulation of hepatic mobilization and glomerular filtration 
of retinol-bound RBP by TCDD and 3,4,3',4'-tetrachlorobiphenyl, however the exact mechanism 
is still unclear.
1 .3 .2 .1 2  E ndocrine disorders
It has been demonstrated that PCBs and other hepatic cytochrome P450 inducers have the 
ability to alter the hormone status in several mammalian species (Bastomsky and Murphy, 1976; 
Derr and Dekker, 1979; Yoshihara et al., 1982) by increasing the in vivo  hormone 
biotransformation. Treatments o f rats with TCDD or polychlorinated biphenyls resulted in a 
significant decrease in serum free thyroxine (FT4) concentration (Bastomsky, 1974, 1977), with a 
concomitant increase of the total biliary excretion o f thyroxine and its glucuronide conjugate 
metabolites. Gorski and Rozman (1987) reported that in rats exposed to TCDD, serum levels of  
thyroid stimulating hormone (TSH) and total triiodothyronine (TT3) were not affected by any
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dose at any time point o f measurement, whereas total thyroxine (TT4) and free thyroxine (FT4) 
were decreased in a dose-dependent manner by days 2 and 4 after dosing, and returned to normal 
levels after 32 days if  the animals survived. In mink exposed to diets supplemented with 
3,4,5,3',4',5'-hexachlorobiphenyl (345-HCB), both total and free triiodothyronine concentrations 
were decreased in both 0.01 and 0.05 ppm (mg/kg) diet groups, and total thyroxine level was 
decreased in the 0.05 ppm diet group (Aulerich et a l ,  1987). Serum levels o f  thyroxine in rats 
exposed to TCDD were 66% less than in control animals (Hermansky e ta l ,  1988). Serum insulin 
levels were also decreased in a dose-dependent manner, but interestingly, blood glucose level was 
also suppressed (Gorski and Rozman, 1987). The effects o f TCDD on serum glucocorticoid 
levels seems controversial, as it was reported to be decreased by Balk and Piper (1984) and 
increased by other studies (Neal et al., 1979; Van Logton et al., 1980; Gorski er al., 1988a). 
Corticosterone therapy could decrease the toxicity o f TCDD in rats (Gorski e ta l., 1988b, 1988c). 
Incubation o f mouse Ley ding cells with 2,2',4,4',5,5'-hexachlorobiphenyl but not a more toxic 
PCB mixture (Clophen A 50) resulted in increased testosterone production (Johansson, 1989). 
Some PCB and related PAH congeners have been shown to be able to bind to oestrogen receptors 
and to have oestrogenic effects (Bitman and Cecil, 1970; Korach et al., 1988).
An in-depth study of the effects o f PCB on the metabolism of steroids has been reported by 
Nagata e ta l  (1985). The authors demonstrated that 3,4,5,3',4'-PenCB treatment selectively  
increased 7 a - but strongly repressed 2(3, 6(3 and 16a-hydroxylations o f testosterone in liver 
microsomes. The unique change o f steroid metabolism caused by highly toxic PCB isomers may 
be responsible, at least in part, for the endocrine disorder symptoms via disturbance o f steroid 
homeostasis (Yoshiharaera/., 1982; Nagata era/., 1985b).
1 .3 .2 .1 3  B iochem ica l m anifesta tions o f  p lasm a m em brane d isorders
Matsumura and co-workers (Matsumura et al., 1984a, 1984b) have demonstrated that a 
number o f physiological important components o f hepatic plasma membrane are affected by 
TCDD. The activities o f Na+/K+-ATPase, Ca^+-ATPase and Mg^+-ATPase were significantly 
reduced as compared to controls, whereas activities o f protein kinase C were significantly 
increased, particularly prote'.n tyrosine kinase (Bombick et al., 1985; Bombick and Matsumura,
1987) . As for the receptor activities, epidermal growth factor (EGF) binding was severely
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decreased at a dose o f  25 jig/kg, and the effects of TCDD on glucagon receptor binding were 
significant only at a high dose (115 |ig/kg). TCDD-decreased binding o f EGF was also observed 
in a dose-dependent manner in a human keratinocyte cell line Scc-12F (Hudson et al., 1979). 
Comparisons of the kinetics for the decrease of EGF binding by TCDD and benzo[a]pyrene (BP) 
showed that maximal inhibition of EGF binding by BP. was achieved by 24 hr with 90% recovery 
of EGF binding by 48 hr, whereas maximal inhibition o f EGF binding by TCDD was achieved by 
72 hr with no recovery up to 10 days after removal o f TCDD from the growth medium. The 
down-regulation o f EGF receptor binding has been demonstrated to be associated with increased 
protein kinase C activity, which catalyses the phosphorylation o f the EGF receptor protein 
(Bombick er <3/., 1985; Madhukar er fl/., 1988).
The mechanisms by which TCDD caused this battery o f biochemical effects are unknown, 
but the possibility that TCDD directly interacts with plasma membrane components to produce 
these effects has been ruled out (Peterson et al., 1979).
1 .3 .2 .14 E ffects on lip id  m etabolism
Polychlorinated biphenyls (PCBs) and other related PAHs have been demonstrated to be 
able to influence in vivo lipid metabolism. Clinical examination o f PCB poisoning cases (Yusho) 
revealed increases in serum triglyceride, cholesterol and phospholipid levels (Nakagawa et a l ,  
1986). Hepatic fatty infiltration is usually observed in enlarged liver o f  rodents (Allen et al., 
1976; Kohli et al., 1979; Jones and Greig, 1975) or chicks (McKinney et al., 1976). The levels of 
total lipids, triglycerides, phospholipids, cholesterol and free fatty acid have been elevated by 
dietary PCB treatment (Kato et al., 1982). Albro et al (1978) reported that a sub-lethal dose of 
TCDD caused a temporary increase in triglyceride and free fatty acid levels, with persistent 
decrease in levels of sterol esters, but a lethal dose o f TCDD caused a large increase in cholesterol 
esters and free fatty acid, with little change in triglyceride levels. The mechanisms by which 
PCBs and related PAHs caused disturbances o f lipid metabolism are not clear. No difference-was 
found in lipid synthesis between control and TCDD-treated rats (Cunningham and Williams, 
1972). Rogers er al (1983) showed that PCB mixtures could influence the lipid profile o f Chinese 
hamster ovary (CHO-KI) cells by increasing the phosphatidylcholine levels and decreasing the 
phosphatidylethanolamine levels. Albro et a l (1978) reported that the levels o f ester hydrolase
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(lysosomal acid lipase) was decreased by TCDD treatment, indicating decreased lipid utilization in 
TCDD treated rats. However, a recent report by Rozman and Greim (1986) revealed that TCDD 
treatment actually increased [l-l'^C]-palmitic acid p-oxidation by 30%. There exists contradictory 
evidence in the literature concerning the effects o f TCDD on de novo fatty acid biosynthesis. Low 
doses o f TCDD (Ijig/kg) inhibited fatty acid synthesis in the liver and adipose tissue by 44% and 
41% respectively (Lakshman et a l ,  1988), but another report (Gorski gf a l ,  1988d) revealed that 
a high dose o f TCDD (125 fig/kg) increased de novo fatty acid biosynthesis in liver , but 
decreased in the brown adipose tissue. The reason for this discrepancy is still unknown.
In addition, Stohs and co-workers (Hasson et al., 1983, 1985; Stohs et al., 1983, 1984a,
1984b; Shara and Stohs, 1987; Al-Bayati et al., 1987, 1988; Mohammadpour et al., 1988) have
consistently demonstrated that treatments of rats with TCDD or toxic MC-type PCB isomers
induce lipid peroxidation, increasing both the content o f conjugated dienes in the lipids of hepatic
microsomes, the content of thiobarbituric acid reactive substances in hepatic and extrahepatic
tissues and the rate of NADPH-dependent lipid peroxidation in hepatic microsomes subsequently
tested in vitro. This effect was thought to be associated with the induction of aryl hydrocarbon
hydroxylase (AHH) activity. Neither PB-type congeners (Shara and Stohs, 1987), MC-type
congeners given to hamsters even at much higher dose (200 times higher than in guinea pigs, 5
times higher than in rats) (Hassan et al., 1983) nor lower doses o f TCDD in genetically non-
responsive mice (Mohamadpour et al., 1988) can produce this effect. Moreover, glutathione
peroxidase and superoxide dismutase activities were decreased and a variety of antioxidants, given
in the diet, could offset TCDD-induced lipid peroxidation and glutathione peroxidase inhibition
(Hassan et al., 1983,1985; Hermansky et al., 1988) but had no effects on TCDD lethality (Stohs
et al., 1984a). Another in vitro study (Albro et al., 1986) shown that TCDD, when added to rat
hepatic microsomal suspensions in the presence o f NADPH, can induce peroxidation of
microsomal lipids when complexed ferric ion was also included in the system, but not in hamster
liver microsomal preparation as determined by production o f thiobarbiturate-reactive substances
(malondialdehyde and dienal), conjugated dienes and disappearance o f polyunsaturated fatty acid.
Previous in vivo studies failed to detect any significant loss o f polyunsaturated fatty acids in liver
total lipids or phospholipids o f rats (Albro gf al., 1978) or guinea pigs (Neal et at., 1979) given a
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lethal dose o f TCDD. It was demonstrated that the hepatotoxic effects of TCDD in mice were 
greatly reduced in vivo if  the animals were made iron-deficient (Sweeney et a i ,  1979). Although 
data from the literature has demonstrated that TCDD and toxic PCB congeners can induce lipid 
peroxidation in one way or another, it is still premature to define the relationship between enzyme 
induction, lipid peroxidation and the lethality of these chemicals.
An early report by Kohli and Goldstein (1980) revealed no evidence that TCDD could 
increase prostaglandin synthetase activity of rabbit liver or kidney medulla microsomes, whereas 
Hughes (1985) demonstrated that chick embryo lung microsomes treated with MC-type PCBs 
could produce PGF2a> PGE2  and TxB2 from exogenous [l-l4C]-arachidonic acid (AA). More
recently, Quilley and Rifkind (1986) showed that the dose-response relationships were biphasic, 
with prostaglandin (PG) release increasing at low doses and returning to basal levels at higher 
doses from cardiac muscle pretreated with toxic PCBs. The fall in PG release coincided with the 
induction o f cardiac cytochrome P448 (7-EROD induction as an indicator), thus the authors 
attributed the decrease o f PGs release to their increased metabolism by the increased mono­
oxygenase activities. Phénobarbital or PB-type PCBs have no such effects (Quilley and Rifkind, 
1986). Pregnant guinea pigs treated with Clophan A 50 showed a significant increase in the level 
of the 11-ketotetranorprostaglandin F metabolite in the urine (Lundkvist et al., 1987). The fact 
that low doses of toxic PCB and dioxin have effects on the release o f prostaglandins from tissues 
indicates that these chemicals may have effects on the release o f their precursor, AA, from 
phospholipids, which is the rate-limiting step in the biosynthesis o f prostaglandins. Under normal 
conditions, AA exists mainly in the form of phospholipids, the level o f free AA being delicately 
controlled by cells. Once liberated from the membrane lipids by diverse stimuli, the free 
arachidonic acid is rapidly metabolized.
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1.4 M ECH ANISM  OF A CTIO N OF THE PCBS
The mechanisms by which PCBs and other related polyhalogenated aromatic hydrocarbons 
(PAHs) cause toxic effects have been extensively studied in experimental animals over the past 
two decades. However, because o f the diverse effects and considerable variation o f toxicity 
caused by PCBs and other related PAHs between different species, the precise mechanism of 
toxicity is far from clear. Although several hypotheses have ever been proposed (e.g. Ah receptor 
model; Vitamin A deficiency model; and thyroid hormone agonist model), they have all failed to 
provide an explanation for the enormous species differences in the acute lethality caused by these 
classes of chemicals. In this section, I would like to give a detailed account on the validity and 
limits o f these hypotheses.
l A . l  A h  R E C E P TO R  TO X IC ITY M O D E L
It has been demonstrated that the toxicities of individual polyhalogenated aromatic 
hydrocarbons are structure-dependent and are associated with their potencies as 3-MC-type 
inducers which induce cytochrome P450 lA l dependent monooxygenase activities (AHH/EROD) 
and their binding affinities for the hepatic cytosolic receptor protein (Ah receptor ) in several 
species (Poland and Glover, 1977; Poland et a l ,  1979; Poland and Knutson, 1982; Sawyer and 
Safe, 1982; Bandiera et al., 1982; 1983; Andres et al., 1983). The Ah receptor is a cytosolic 
protein genetically expressed by a gene called the Ah locus (Nebert and Jensen, 1979), which can 
bind with a variety o f carcinogenic polycyclic aromatic hydrocarbons and initiate the expression of 
cytochrome P450 lA l and the associated AHH and EROD activities and coordinate expression of 
a number o f other enzymes activities including UDP-glucuronosyltransferase (Owens, 1977), DT- 
diaphorase (Beatty and Neal, 1976), ornithine decarboxylase (Nebert e t al., 1980), Ô - 
aminolaevulinic acid synthetase (Poland and Glover, 1973), glutathione-S-transferase B (Kirsch et 
al., 1975), aldehyde dehydrogenase (Dietrich et al., 1978; Hempel et al., 1989) and choline 
kinase (Ishidate et a l ,  1980) activities and repression of other enzymes, e.g. uroporphyrinogen 
decarboxylase activity (Jones and Sweeney, 1980).
The proposed model o f Ah receptor mediated toxicity is shown in Figure 1.2. Xenobiotic
ligands bind with the cytosolic receptor, and the ligand-receptor complex is translocated into the
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nucleus to initiate the expression o f Ah locus, resulting in the induction o f cytochrome P450 
LA 1/2 (AHH/EROD activities) and coordinate induction or suppression o f a number of other 
enzyme activities, eventually lead to a pleiotropic toxic response.
In the proposed Ah receptor model, two lines of evidence are usually employed to support 
an association between a given response and binding to the Ah receptor (Poland and Knutson, 
1982):
1 ) correlation o f structure-activity relationship fo r receptor binding and that for toxic 
potency;
2) segregation o f sensitivity o f the effect with the Ah locus in responsive and non- 
responsive mice.
In studies o f Ah receptor binding, TCDD has been the most widely used ligand because of 
its established high binding affinity for the receptor as compared with other polyhalogenated 
aromatic hydrocarbons (Bandiera et al., 1982; Poland and Knutson, 1982).
ligand
FIGURE 1.2 AH RECEPTOR M ODEL
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(Derived from Poland and Knutson, 1982)
In certain strains of mice and rats, the Ah receptor mediated mechanism seems to be able to
explain the toxicology of TCDD and related PAH compounds. However, there co-exists a number
28
of factors either in favour of or against the role o f the Ah receptor in mediating toxicity. For
instance, there are several reports confirming the role o f Ah receptor in the induction o f AHH
activity in genetically responsive and non-responsive mice (Poland and Glover, 1973; Nebert and
Gielen, 1972; Jones and Sweeney, 1980) in rat hepatoma H-4-IIE cells (Safe, 1986; Zacharewski
e t al., 1989), rats (Bandiera et al., 1984; Mason et al., 1986) and Hartley guinea pigs (Holcomb
et al., 1988). However, there are also a number o f reports which demonstrate the dissociation of
toxicity from the induction o f AHH activity, thus casting strong doubt o f the role o f Ah receptor in
mediating toxicity. Rifkind and Muschick (1983) reported that Benoxaprofen can decrease the
toxicity of 3,4,3',4'-tetrachlorobiphenyl without alteration o f EROD activity in the chick embryo.
Similarly, thyroid hormone and corticosterone treatment can modulate the toxicities o f TCDD
without any effects on the AHH activity in male Sprague-Dawley rats (Rozman et al., 1985,
1988). Jones and Sweeney (1980) demonstrated that the induction o f hepatic porphyria segregated
with the Ah locus in C57BL/6 and DBA/2 mice. Yao and Safe (1989) demonstrated that 6 -
methyl-1,3,8-trichlorodibenzofuran (MCDF) can partially suppress TCDD-induced porphyria in
female C57BL/6 mice, without any effects on hepatic AHH, EROD or UROD activities, which
also support a role for the Ah receptor in the induction o f hepatic porphyria. In addition, Greig et
al (1984) reported that development of hepatic porphyria did not correlate with the Ah phenotype
in mice. Structure-activity relationship analysis in several species and genetic studies in mice
support the correlation o f increased porphyrin level with increased AHH induction and decreased
UROD activity (Jones and Sweeney, 1980; Poland and Knutson, 1982). Rifkind e ta l  (1985)
demonstrated that the dose-response relationships for hepatic induction (AHH, EROD, UROD)
and lethality are dissociated with 3,4,3',4'-TCB, 3,4 ,5 ,3’,4',5'-HCB and TCDD in chick
embryo, suggesting that induction p er se does not lead directly to toxcity and that other factors
must be involved. TCDD, 3,4,3',4'-TCB and Aroclor 1254 can only induce suppression of
cytotoxic T cell generation in Ah locus positive (C57BL/6) mice but not in negative (DBA/2) mice,
whereas 2,2',4,4’,6,6'-HCB which lacks affinity for the Ah receptor cannot produce this effect
in either strain o f mice (Clark et al., 1983; Nagarkatti et al., 1984). Lubet et al. (1984) also
confirmed the role of Ah receptor in mediating polycyclic hydrocarbon-induced immunotoxicity in
mice using the plague forming cell (PEC) response as a toxic index. Vecchi et al (1980) have
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shown a profound reduction o f humoral antibody production in TCDD-treated Ah positive 
phenotype mice, but Pazdemik and Rozman (1985) have shown that thyroidectomy prevents the 
suppressive effects o f TCDD on humoral antibody response without affecting the AHH activity.
Quantitative analysis o f Ah receptor levels show that there exists a good correlation between 
the Ah receptor levels, AHH induction and lethality in C57BL/6 and DBA/2 mice (Poland and 
Knutson, 1982), but no correlation has been found in two clones o f  mouse hepatoma cells 
(Forster-Gibson et ah, 1988) and two strains o f rats (Pohjanvirta et ah, 1988) as shown in Table
1.2 and 1.3. In addition, Gasiewicz and Rucci (1984) demonstrated that, despite species and 
tissue specific differences in the biochemical and toxicological responses to TCDD and related 
compounds, no differences have been found in both the Ah receptor concentration and the Ah 
receptor function in various species and various tissues. As shown in Table 1.3, despite 250 
times different LD50 values, the Ah receptor concentration is similar in Han/Wistar and 
Long/Evans rats.
TABLE 1.2
Cells
AHH Activity 
(U/mg protein)
 ^ Specific Binding 
fmol[ HjTCDD bound/mg protein
Cytosol + nuclear extracts
H epa-lC l 50.1±2.0 124146
HS-1 15.7±0.5 103136
TABLE 1.3
(Derived from Forster-Gibson et ah, 1988)
MICE
a
RATS
C57BL/6J DBA/2J Han/Wistar Long-Evans
132 620 >3,000 12
Specific binding
(fmoles/mg cytosolicprotein) 85 ND 23 20
(Derived from a: Poland and Knutson, 1982; b: Pohjanvirta et al., 1987.)
3 0
Taken collectively, data from the literature suggest that binding o f PAH ligands to the 
cytosolic Ah receptor correlates with certain toxic responses in certain species but the overall 
hypothesis is still insufficient to provide a satisfactory explanation for the toxicity o f TCDD and 
related PAH compounds, particularly the large species difference in the acute lethality o f these 
compounds; therefore other factors must be involved.
1.4.2 V ITA M IN  A D E F IC IE N C Y  TO X IC ITY M O D E L
As reviewed under section 1.3.2.11, toxic MC-type PCB congeners and related compounds 
have been demonstrated to cause a decrease in the levels o f vitamin A in hepatic and several 
extrahepatic tissues. It has also been observed that skin disorders and other epithelial toxic effects 
of PCBs and related compounds share remarkable similarities with that o f vitamin A deficiency. 
Based on these observations, several authors (Thunberg, 1984,; Thunberg et a l ,  1984; Brouwer 
and van den Berg, 1986) put forward another alternative mechanistic model to try to explain the 
toxicology of PCBs and related PAH compounds.
Figure 1.3 shows the mechanistic pathway o f the influence o f 3,4,3',4'-tetrachlorobiphenyl 
and related compounds upon vitamin A  transport. The interruption o f RBPh binding with TTR by 
a 3,4,3',4'-TCB metabolite results in decreased plasma concentration o f both retinol and its 
primary binding protein (RBP), and eventually transportation o f retinol from its storage site to 
peripheral target tissues (Brouwer et al., 1985; Brouwer and van den Berg, 1986). The 3,4,3',4'- 
TCB metabolite has preferential affinity for TTR protein (Shimada and Sawyer, 1983; Brouwer 
and van den Berg, 1986), however there is no evidence that other PCB isomers and TCDD  
metabolites can act in the same way as the 3,4,3',4'-TCB metabolite does. Instead, TCDD can 
only cause decreased plasma levels of retinol when the liver had been almost depleted o f its 
vitamin A stores (Brouwer et al., 1989). More recently, Brouwer et a l (1989) suggested that 
3,4,3',4’-TCB and TCDD seem to enhance the mobilization o f vitamin A  from its store sites and 
the glomerular filtration o f retinol-bound RBP and the difference in the effects o f TCDD and 
3,4,3’,4'-TCB on plasma retinol concentration may result from the net difference in magnitude o f  
mobilization and glomerular filtration. The exact mechanism o f vitamin A depletion caused by 
TCDD, 3,4,3',4'-TCB and other related PAH compounds is still unestablished.
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FIGURE 1.3 MODEL PROPOSED FOR THE MECHANISM OF 
TOXICITY OF PCBS AND RELATED COMPOUNDS
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Thin lines represent the normal physiological pathway of vitamin A and thyroid 
hormone transport through the serum. The solid boldfaced lines and arrows 
represent the abnormal situations. The interrupted boldfaced lines and arrows 
indicate possible ways of interference or predicted effects.
RBP: Retinol binding protein; RBPa: apo or ligand (retinol)-free RBP;
RBPh: holo or ligand-bound RBP; TTR: Transthyretin;
T4: Thyroxine; MFO: Mixed-function oxidase;
TCB: 3,4,3',4'-Tetrachlorobiphenyl; TCB-X: Metabolite of TCB.
(Derivedfrom Brouwer and van den Berg, 1986)
There is evidence that high dietary levels of vitamin A can reduce the toxicity o f TCDD but 
can not prevent the lethality in rats (Thunberg, 1984; Stohs et al., 1984), however a more recent 
publication revealed no evidence of an antagonistic effect of vitamin A  in TCDD-induced cleft 
palate. On the contrary, vitamin A and TCDD shown synergistic effects on inducing cleft palate 
(Bimbaum gf a/., 1989).
1 .4 3  TH YRO ID  H O RM O N E A G O N IST  TO X IC ITY M O D EL
McKinney et a/ (1985) suggested that some or perhaps all o f the toxic effects o f TCDD and 
related PAH compounds are due to these compounds being potent and persistent thyroxine
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agonists. Based on computer simulation study o f experimental structure-activity ligand receptor 
interaction analysis, they proposed that TCDD binds to a cytosolic thyroid hormone receptor, 
upon translocation to the nucleus, the receptor-TCDD complex undergoes a conformational change 
which release the lateral halogens o f TCDD to interact with the active site o f a second nuclear 
receptor activating events that lead to a biological response.
There exists indeed great structural similarities between TCDD, coplanar PCBs and the 
thyroid hormones (Figure 1.4). However, if  TCDD and PAHs were indeed the potent and 
persistent agonists o f the thyroid hormone receptor, one would anticipate that co-treatments of 
TCDD and thyroid hormones would result in synergistic effects, but results from Rozman et al 
(1984, 1985) disagreed with this anticipation. They demonstrated that thyroidectomy greatly 
reduced the effects of TCDD on body weight loss in rats and thyroid hormone replacement 
restored body weight loss to “normal” in thyroidectomized TCDD-treated rat (Rozman et ah, 
1985). Moreover, as summarized in Table 1,4, some o f the facets o f TCDD toxicity resemble 
hyperthyroid and some hypothyroid status, which is incompatible with the thyroid hormone 
agonist theory.
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FIGURE 1.4 STRUCTURE SIMILARITY BETWEEN TCDD AND 
THYROID HORMONES
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2,3,7,8-Tetrachlorodibenzo-p-dioxin
TABLE 1.4 SYM PTOM S OF AROM ATIC HYDRO CARBON  
TO X ICITY AND THYROID DYSFUCTIO N
SYMPTOMS THYROID DYSFUCTION
Loss o f body weight/reduced growth 1
Constipation/diarrhoea 1,2
Osteoporosis 2
Loss o f nails 2
Scaliness of skin 2
Hyperkeratosis 2
Alopecia/hirsutism 2
Weakness 1,2
Bradycardia/tachycardia 1,2
Oedema 1,2
Sweating 2
Deafness 1
Thyromegaly 2
Increased/decreased body temperature 1,2
Uncoupling of oxidative phosphorylation 1
Sensitization of the myocardium to catecholamines 1
Increased/decreased serum glucose, cholesterol,
triglyceride, free fatty acid 1,2
1, Hyperthyroid; 2, Hypothyroid. {Derived from  Greim and Rozman, 1987)
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1.5 C YTO CH RO M E P450 AND CYTOCHROM E P450 M ED IATED SUBSTRATE
M ETABOLISM
1.5 .1  G E N E R A L C H A R A C TE R ISTIC S OF CYTO C H R O M E  P 450S
Cytochrome P450 (P450) is a haem-containing protein with unusual spectral properties, 
which show a characteristic optical absorption peak at a wavelength o f approximately 450 nm for 
the CO-bound, dithionite-reduced haemoprotein, and hence its name. The P450 protein is the 
terminal component o f the mixed-function oxidase system. Its ability to activate molecular oxygen
(0 %-------------+ Q2-) and subsequently to introduce one oxygen atom into substrate has created
many biological functions for organisms under different circumstances. It has been demonstrated 
that cytochrome P450 exists in multiple forms o f isoenzymes genetically expressed from a gene 
superfamily (Nelson and Strobel, 1987; Nebert et al., 1987). So far, nearly a hundred forms of 
P450 proteins and their sequences have been identified (Gonzalez, 1990).
Cytochrome P450 is a remarkable protein, which is engaged in both biosynthesis and 
catabolism of endogenous substrates such as vitamin D (Hansson et al., 1981), testosterone (Ryan 
et a l ,  1982; Cheng and Schenkman, 1983; Harada and Negishi, 1984), progesterone (Johnson et 
a l ,  1983; Cheng and Schenkman, 1984), estradiol (Johnson e ta l., 1983; Cheng and Schenkman,
1984), prostaglandins (Okita et al., 1981; Vatsis e ta l.,  1982), fatty acids (Gibson et al., 1980; 
Tamburini et a l ,  1984; Baddupalli et al., 1990), and cholesterol (Waxman et al., 1986) and in the 
elimination, detoxification or metabolic activation o f exogenous substrates, such as drugs, 
pesticides, insecticides, and environmental pollutants. The main role o f P450s in the metabolism 
o f xenobiotics is to introduce a polar hydroxyl group into the usual xenobiotic molecule, the 
metabolite subsequently acting as a substrate for conjugation enzymes to introduce additional polar 
groups. This allows excretion of the molecule from the animal, otherwise these highly lipophilic 
xenobiotics could remain in the body indefinitely. In general, different cytochrome P450 
isoenzymes have different substrate specificities, but unlike other enzymes, the substrate 
specificity of a single cytochrome P450 protein may be quite broad. Because o f  the presence o f  
multiple forms in a single organism, P450s can actually afford the body strong physiological and 
defensive ability to metabolize literally thousands o f lipophilic substrates. Thus, they have
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received considerable attention in fields such as biochemistiy, pharmacology, toxicology and 
physiology.
Cytochromes P450 are ubiquitous proteins which have been found in bacteria,yeast, plants
and animals. Their main intracellular locations are the endoplasmic reticulum (microsomes) and
mitochondria, but they are also found in the nucleus and cytosol (Bresnik, 1984). The bacterial
P450s are usually soluble proteins, whereas mammalian P450s are all integral, membrane bound
proteins (Nelson and Strobel, 1987). Mammalian cytochromes P450 can be roughly divided into
two major groups based on their intracellular location and the enzyme from which they receive
electrons (Gonzalez, 1990). The mitochondrial P450s , such as the side-chain cleavage enzyme
(P450 see) and steroid llp-hydroxylase (P450 l ip )  are found in the mitochondria o f the adrenal
cortex and are involved in steroid hormone biosynthesis. These proteins are synthesized by
membrane-free polyribosomes (Nabi et a l ,  1983) and have a leader extrapeptide sequence at the
N-terminal which is removed upon import into mitochondria (Morohashi et al., 1984). They
receive electrons from the iron-sulfur protein adrenodoxin via NADPH-adrenodoxin reductase.
The great majority o f P450s are of the second group, found primarily in the endoplasmic reticulum
membrane (microsomes). They are synthesized by membrane-bound polyribosomes (Gonzalez
S*and Kasper, 1980) and do not have processed leader sequence. They have a highly hydrophobic 
N-terminal segment which helps to anchor the P450 protein into the membrane phospholipid 
bilayer. This group o f P450s receive electrons from a flavoprotein via NADPH-cytochrome P450 
reductase and in some case, cytochrome bg. These two electron transport systems are shown in 
Figure 1.5.
In recent years, a number of extensive literature review articles have been published on 
various aspects o f cytochrome P450s, such as purification (Black and Coon, 1986; Guengerich, 
1987; Ryan and Levin, 1990); gene superfamily nomenclature (Nebert et al., 1987), evolutionary 
relationships (Nelson and Strobel, 1987); their roles in steroid metabolism (Hall, 1985, 1986; 
Jefcoate, 1986), drug metabolism (Guengerich, 1987), carcinogen activation (Kadlubar and 
Hammons, 1987) and the molecular biology o f P450s (Nebert and Gonzalez, 1987; Gonzalez, 
1989, 1990).
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FIGURE 1.5 M ICRO SO M AL AND M ITOCHO NDRIAL C YTO CH RO M E P450  
M EDIATING ELECTRON TRANSPORT CYCLES
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Under the new P450 gene superfamily nomenclature (Nebert et al., 1987), a single P450 
protein is given a name consisting of P450, followed by three components: a roman numeral (I,
II, III, IV, ), a capital letter (A, B, C ,  ) and an Arabic number (1, 2, 3 , ...... ) which
indicates its family name, subfamily name and the specific name respectively (in order o f  
discovery). For example, P450 lA l represent a P450 protein from family I, sub-family A and 
gene number 1. According to this new P450 gene superfamily nomenclature:
1) if  any protein has less than 36% similarity in the amino acid sequence to the 
P450 in any other gene family, it belongs to a new separate gene family; 2) within a 
gene fam ily in a given species, any protein  in one subfamily has 40-65%
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similarities of the amino acid sequence to a protein in any of the Other subfamilies ;
3) within a gene subfamily, any two protein have approximately 70% or more 
similar amino acid sequences.
It has been well established that cytochromes P450 exist in multiple forms o f isoenzymes. 
Their distribution patterns and relative proportions strongly depend on the species, sex, tissue, 
organ and physiological status. For instance, some are expressed only in particular tissues (e.g. 
liver, gonads), while others are expressed more widely; some are sex specific, while others are 
only induced by exposure o f the cells to a particular drug or other xenobiotic chemical. The 
relative proportion of a particular form of P450 and its associated enzyme activities are determined 
by multiple steps from gene transcription to protein stabilization. For example, P450 lA l is 
primarily regulated by transcriptional control, whereas P450IA 2 is mainly regulated by mRNA 
stabilization (Kimura et al., 1986). Induction o f cytochrome P450 lEEl by ethanol, acetone, 
pyrazole etc. is via specific protein stabilization effects o f these small molecules (Eliasson et al.,
1988) as well as by gene regulation events. A recent review article has highlighted the regulatory 
aspects of the cytochromes P450 (Gonzalez, 1989).
The treatment o f animals by xenobiotic inducers usually result in the induction o f particular 
forms of cytochromes P450 with concomitant suppression o f the others. For example, treatment 
of rats with 3,4,5,3',4',5'-hexachlorobiphenyl results in a large induction o f P450 lA l ,  while 
other constitutive forms o f cytchromes P450 are concomitantly suppressed, such as P450 E C U , 
IIIA2 (Yeowell et a l ,  1987, 1989). Thus exposure o f animals to drugs or xenobiotics may 
eventually result in complete alteration of cytochrome P450 distribution patterns and therefore the 
associated synthesis or catabolism of both endogenous and exogenous substrates.
1.5.2 CYTO CH RO M E P 450 AN D  M E TA B O LISM  OF A R A C H ID O N IC  A C ID
The microsomal cytochromes P450 can be divided into two groups on the basis o f their 
substrate specificity. The majority o f the microsomal P450s act primarily on compounds which are 
foreign to the host cells (i.e. xenobiotics), such as drugs, leading to the elimination, 
detoxification, or occasionally activation o f xenobiotics, and are therefore referred to as drug- 
metabolizing P450s. Other P450s are mainly involved in the metabolism o f endogenous
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substrates, such as steroid-hormone biosynthesis and metabolism, and the metabolism of fatty 
acids, prostaglandins and vitamin D, and are referred to as endogenous P450s. However, it must 
be noted that the substrate specificity o f cytochrome P450 isoenzymes is usually quite broad, i.e. 
drug-metabolizing P450s can also use endogenous substrates and endogenous P450s can also act 
on xenobiotics.
1 ,S ,2.1  A rach idon ic  A c id  M etabolism  C ascade
Arachidonic acid is an important polyunsaturated fatty acid, preferentially esterified into 
the 2 position of various cellular membrane phospholipids. It helps to maintain the integrity, 
fluidity, mobility and biological functions o f various plasma membranes. In addition, once 
released from the membrane phospholipids by the action o f phospholipase A 2 (PLA 2 ), free 
arachidonic acid (AA) can undergo a comprehensive metabolism cascade to generate a variety of 
biological active substances, such as prostaglandins (PGs), thromboxane A 2 (TXA2), leukotrienes 
and a number of hydroxy or epoxy metabolites. This large and still growing family o f oxygenated 
C20 fatty acid derivatives are collectively known as eicosanoids. Figure 1.6 shows the general 
cascade of arachidonic acid metabolism.
The cellular free arachidonic acid content is usually quite low, and the majority o f this fatty 
acid is stored in membrane phospholipids. Metabolism of arachidonic acid involves three 
pathways: (1) cyclooxygenases, leading to the formation o f prostaglandins (PGs), thromboxane 
A 2 (TxA2), and prostacycHn (PGI2); (2 ) lipoxygenases, leading to the formation of hydroxy- and 
dihydroxyeicosatetraenoic acids (HETEs and diHETEs) and leukotrienes; (3) cytochrome P450- 
dependent monooxgenase system, which metabolizes arachidonic acid to a variety o f oxygenated 
products such as HETEs, epoxyeicosatrienoic acids (EETs) and co- and co-l hydroxylated acids by 
an NAPDH-dependent mechanism ( Capdevila et al., 1981; Morrison and Pascoe, 1981; Oliw et 
al., 1982; Bains et al., 1985).
In recent years, the cytochrome P450 pathway o f arachidonic acid metabolism has received 
considerable attention because of the recognition o f the potential biological activity o f many of the 
metabolites derived from this pathway. In the presence o f NADPH and molecular oxygen, the 
cytochrome P450 system catalyses the metabolism of arachidonic acid via three type o f reactions
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FIGURE 1.6 ARACHIDONIC ACID METABOLISM CASCADE
PHOSPHOLIPIDS
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Abbreviations used are: PLA2 , phospholipase A% EET, epoxyeicosatrienoic acid; HETE, 
hydroxyeicosatetraenoic acid; DiHETE, Dihydroxyeicosatrienoic acid.
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as shown in Figure 1.6: 1) allylic oxidation leading to the formation o f various 
monohydroxyeicosatetraenoic acids (HETEs), but unlike the lipoxygenase action, P450 catalyses 
the insertion o f only one oxygen atom at a time into the fatty acid molecule in the first step, 
without the hydroepoxyeicosatetraenoic acids (HPETEs) as intermediates; 2) olefin  
epoxygenation, leading to the formation o f the four regioisomeric epoxyeicosatrienoic acids 
(EETs), which can undergo further hydrolysis by epoxide hydrolase to form the corresponding 
diol metabolites; 3) oxidation at the co and co-l positions to form the 20-and 19-HETEs, 
respectively (Capdevila er a/., 1981; Morrison and Pascoe, 1981; Oliw 1982; Bains e t a l ,
1985).
It is well known that different cytœhrome P450 isoenzymes catalyse the oxygenation o f the 
arachidonic acid at the different positions in the carbon backbone, thus resulting in the formation 
of different metabolite profiles. For example, the hypolipidemic drug induced cytochrome P450 
IV A l is specifically responsible for the co-hydroxylation o f arachidonic acid (Bains et a l ,  1985; 
Capdevila et a l ,  1985; Sharma et a l ,  1989); polycyclic hydrocarbon induced cytochrome P450 
lA l specifically catalyses the co-l-hydroxyaltion (Oliw et al., 1982); human liver cytochrome 
P450aa catalyses the epoxygenation o f the four double bonds (Schwartzman et a l ,  1988). 
However, some P450s do not use arachidonic acid as substrate at all (R. W. Estabrook, personal 
communication). For example, the diabetes-induced rat liver microsomal isoenzyme (IIEl) and 
clotrimazole-induced rat liver microsomal isoenzymes (IIIAl, and IILÂ2) have no effect on the 
arachidonic acid metabolite profile (unpublished observations). The reason for the 
stereoselectivities in arachidonic acid oxygenation may reside in the difference in the spatial 
relationship o f active sites o f different P450 isoenzymes. Computer-aided molecular modeling 
study indicates that arachidonic acid has a compact "hairpin-like" (U-type) conformation (Sharma 
et al., 1989). The geometric orientation o f the substrate molecule residing at the hemoprotein 
active site may reflect those stereo-structural differences, or the arachidonic acid molecule cannot 
insert into the active sites of some P450 proteins and thus result in the failure o f these isoenzymes 
to use arachidonic acid as substrate.
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1 .5 .2 .2  B io log ica l A ctiv ity  o f  Cytochrom e P 450 D epen den t A rach idon ic A c id
M etabolites
Arachidonic acid-derived eicosanoids including prostaglandins (PGs), thromboxane A2 
(TxA2) and leukotrienes have been considered as local hormones (Smith, 1989). Their plasma 
concentrations are very low, usually less than 10-9 M (Christ-Hazelhof and Nugteren, 1981; 
Fitzgerald et al., 1981) and their biosynthesis is not restricted to a central endocrine organ, but 
rather occurs in most organs (Smith, 1986, 1987). Eicosanoids are not stored hormones but are 
rather synthesized in nearby cells in response to various stimuli and participate in the regulation of 
various subcellular events.
Recently, numerous biological activities of different arachidonic acid metabolites derived 
from the cytochrome P450 monooxygenases have been described. It has been demonstrated that 
these cytochrome P450-dependent arachidonic acid metabolites share the common characteristics 
o f other eicosanoids, i.e. they act as local modulators o f circulating hormones and their activity is 
usually localized in the micro-environment of the cell o f origin (Capdevila et al., 1983; Falck et 
al., 1983; Kutsky et al., 1983; Snyder et al., 1986; Fitzpatrick and Murphy, 1989; M cGiff and 
Carroll, 1989 ). Table 1.5 summarizes the biological activities of cytochrome P450-dependent 
arachidonic acid metabolites.
It is difficult to assess the influence o f changes in cytochrome P450 caused by xenobiotic 
exposure on the in vivo metabolism of arachidonic acid and subsequent physiological effects of 
arachidonic acid metabolites on the systemic biological activities. However, the biological potency 
of a particular metabolite could be easily assessed by using a particular biological system.
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TABLE 1.5 BIO LO G ICAL ACTIONS OF CYTO CH RO M E P450-D EPEN DENT  
ARACHIDONIC ACID M ETABOLITES
Compound* Concentration Action Reference
19(s)-HETE 0.001-1 \iM Na'^/K^ATPase stimulator Escalante, 1988
20-HETE 0.1-2.5 pM Vasoconstrictor Escalante., 1989
12(R)-HETE 0.01-1 pM Inhibits Na-h/K+ATPase 
(Comeal epithelium) in vitro
Schwartzman, 1987
11,12-DiHETE < 1 pM Inhibits Na'^ /K"*" ATPase 
in v itro
Schwartzman, 1985
12(R)-DiHETE Vasodilator, Angiogenesis Needleman ,1986
14,15-cw-EET 1-10 pM Inhibits platelet aggregation 
in vitro
Fitzpatrick, 1986
14,15-EET
8,9-EET
0.01-1 pM Induces glucagon release in 
vitro from pancreatic islets
Falck, 1983
14,15-EET
11,12-EET
5,6-EET
>10 pM Inhibits vasopressin- 
stimulated water flow in 
toad bladder in vitro
Schlondorff, 1987
14,15-EET
11,12-EET
5,6-EET
>1 pM Increases loss from 
anine aortic smooth muscle 
microsomes in vitro
Kutsky, 1983
5,6,-EET 1 pM Increases ^^Ca^^ efflux from 
anterior pituitary; Increases 
cytosolic free Ca^ "^
Snyder, 1986
11,12-EET
8,9-EET
5,6-EET
25 pg/ml 
36 p g/m l 
32 p g /m l
Vasodilation of intestinal 
arteriolar blood flow in vitro
Proctor, 1987
5,6-EET 
& 5,6-DiHETE
0.001-1 pM Induces somatostatin release 
in vitro  from hypothalamic 
media eminence
Capdevila, 1983
5,6-EET 0.01-1 pM Induces insulin release in vitro  
from pancreatic islets
Falck, 1983
* Abbreviations used are as described in the footnote to Figure 1.6.
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1.6 AIM S OF THE PRESENT STUDY
The physiological importance o f cytochrome P450 in the maintenance o f homeostasis has 
received much attention, such as in the area o f cytochrome P450 mediated fatty acid metabolism, 
particularly cytochrome P450 dependent arachidonic acid metabolism. It has been demonstrated 
that cytochrome P450 catalysed arachidonic acid metabolism is highly regioselective (Capdevila et 
aL, 1985; Sharma et a i ,  1989); however, the precise molecular mechanisms underlying this 
regioselectivity is at present unclear. It is therefore one o f the primary aims o f this study to 
investigate and compare the effects o f treatments with different xenobiotics (including PCB 
isomers) on the induction of cytochrome P-450-mediated arachidonic acid metabolism.
The present study also aims to characterise the metabolism o f arachidonic acid by PCB- 
induced cytochrome P450, and to determine if  there is any substantial alteration in the metabolite 
profiles, because of the important biological effects o f many o f the P450-dependent arachidonic 
acid metabolites.
Lipid metabolism disorders are one o f the most consistent toxic effects o f PCBs, however 
the reason(s) for such biochemical alteration is still largely unknown. The present study is also 
designed to investigate the effects o f PCB treatment on various fatty acid metabolizing enzyme 
activities and these effects are compared in the rat and guinea pig, in order to provide an estimation 
of the effects o f PCB treatment on fatty acid metabolism, and the possible relevance o f this effect 
to the toxicity o f this class o f compounds.
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************ CHAPTER 2 ************
EFFECTS OF DIFFERENT XENOBIOTIC 
PRETREATMENTS ON THE IN  VITRO  
METABOLISM OF ARACHIDONIC ACID 
BY RAT LIVER MICROSOMES
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2.1 INTRODUCTION
One o f the best described endogenous substrates for the cytochrome P450 isoenzymes is 
arachidonic acid, an important constituent o f many plasma membrane phospholipids. In recent 
years, it has been well documented that arachidonic acid can serve as a substrate for several 
cytochrome P450 isoenzymes and the biological importance o f  this metabolic pathway for 
arachidonic acid has been fully recognized, mainly due to the demonstration o f the wide range of 
biological effects o f many o f the arachidonic acid metabolites which are cytochrome P450 
dependent (Fitzpatrick and Murphy, 1989). Cytochrome P450 preparations from different 
microsomal sources show distinct enzyme activities toward arachidonic acid as a substrate, as 
evidenced from the profoundly different profiles o f the oxygenated metabolites. For example, the 
microsomal preparation from rabbit kidney medullary portion o f the thick ascending limb o f the 
loop o f Henle (mTALH) catalyses the formation o f two major arachidonic acid metabolites, 
namely 5,6-epoxyeicosatrienoic acid (5,6-EET) and 11,12-dihydroxyeicosatrienoic acid (11,12- 
diHETE) (Schwartzman etaL , 1985); kidney microsomal preparations actively catalyse the 19- 
hydroxylation o f arachidonic acid (19-HETE) (Schwartzman et al., 1986); and monkey seminal 
v esic le  m icrosom al preparations specifica lly  catalyse the form ation o f  18(R)- 
hydroxyeicosatetraenoic acid (Oliw, 1989). In addition, xenobiotic pretreatment also results in 
substantial alterations o f the cytochrome P450 isoenzyme composition o f hepatic microsomal 
preparations and thus result in distinct arachidonic acid metabolite profiles which are related to 
P450 activities (Capdevila gf a/., 1985).
In the present study, rats were pretreated with various xenobiotics, which preferentially switch 
on the expression o f particular forms o f P450 with concomitant suppression o f others. 
Accordingly, the metabolism of arachidonic acid by these different hepatic microsomal cytochrome 
P450s were studied and compared.
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2.2 MATERIALS AND METHODS
2.2.1 M ATERIALS
2.2.1 .1  C H E M IC A L S
2,2'4,4’-Tetrachlorobiphenyl (TCB) (99% pure) and 3,4,5,3’,4'-pentachlorobiphenyl 
(PENCB) (99% pure) were purchased from the Greyhound Chromatography and Allied Chemical 
Co. (Birkenhead, Merseyside, U. K.). Phenobarbitone (PB) was bought from BDH Chemicals 
Ltd. (Poole, England). Clotrimazole (CLOT), streptozotocin (STZ), clofibrate (CLOF), 3- 
methylcholanthrene (3-MC), arachidonic acid and NADPH were obtained from Sigma Company 
(Poole, U. K.). [ 1 - ^^C]- Arachidonic acid was purchased from the Radiochemical Centre 
(Amersham, U. K.). The purity of arachidonic acid was determined every time HPLC analysis 
was run. No contamination of radioactive impurities were ever noticed in the metabolite elution 
times. A ll other chemicals were obtained from commercial sources and were o f highest purity 
available.
2.2.1.2 A N IM A L S  A N D  A N IM A L  P R E T R E A T M E N T  P R O T O C O L S
Male Wistar albino rats (100-120 g starting body weight. University o f Surrey Breeders, U. K.) 
were treated with various xenobiotics by using the treatment protocols summarized in Table 2.1. 
TABLE 2.1 ANIM AL TREATM ENT PROTOCOLS
XENOBIOTIC NO. OF 
ANIMALS
CONCENTRATION OF DOSAGE/ROUTES 
STOCK DOSING SOLUTIONS (NUMBERS OF DOSES)
DURATION 
OF EXPOSURE
PENCB 3 5 mg/ml(Corn oil)^ 5mg/kg//.p. (1)^ 5 days
TCB 3 43.8mg/mI(Com oil) 87.6mg/kg//.p. (1) 5 days
3-MC 3 25mg/ml(Com oil) 25mg/kg //.p.(3) 3 days
PB 3 80mg/ml(Salihe) 80mg/kg H.p. (3) 3 days
STZ 3 65mg/ml(50 mM Na citrate, pH4.5) 65mg/kg /fp .( l) 14 days
CLOT 3 50mg/ml(Com oil) lOOmg/kg //.p.(3) 3 days
CLOF 3 125mg/ml(Saline) 250mg/kg H.p. (3) 3 days
CONTROL 6 Corn oil 2ml/kg U.p. 5 days
a: Materials in brackets were vehicles used to dissolve chemicals; b: The numbers in brackets 
are the numbers o f doses. If the number is 1, it means a single dose; if  the number is 3, it means 
single daily dose for 3 consecutive days. The animals were killed on the last day o f the exposure 
duration. The doses and routes o f administration were derived from previously published 
experiments and based on their ability to induce P450 isoenzymes.
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2.2.2 M ETH ODS
2 .2 .2 .1  P R E P A R A T IO N  OF R A T  LIVER M IC RO SO M ES
The rats were all killed by decapitation on the last day o f experimental exposure as outlined 
in Table 2.1. The livers were quickly removed and washed in 0.9% (w/v) ice-cold NaCl solution, 
blotted dry and weighed. The livers were scissor-minced into ice-cold 0.25 M sucrose and 25% 
(w/v) homogenates prepared. All other operations were carried out at 4°C. After centrifugation at 
10,000xg for 20 minutes, the subsequent supernatant was further centrifuged at 100,000xg for 
60 minutes, the resulting microsomal pellets resuspended in the original volume o f 50 mM Tris 
HCl buffer, pH 7.5, containing 20% (v/v) glycerol and stored at -70°C before use without 
significant loss of enzyme activity.
2.2.2.2 D E T E R M IN A T IO N  OF TO TAL CYT O C H R O M E  P 450  C O N T E N T
Cytochrome P-450 content was routinely determined spectrophotometrically by the method
o f Omura and Sato (Omura and Sato, 1964). Microsomes were suspended in 50 mM Tris-HCl 
buffer, pH 7.5, containing 20% (v/v) glycerol at a concentration o f 2-3 mg protein/ml. Upon 
reduction o f the ferric to ferrous form of the haemoprotein by the addition o f a few  grains of  
sodium dithionite, the microsomal preparation was equally split into two quartz cuvettes (sample 
and reference) and a baseline recorded between 400 nm and 5(X) nm. The sample cuvette was 
bubbled with carbon monoxide (approximately 20 bubbles/second) for half a minute and re­
scanned. In the case o f substantial hemoglobin contamination, a modified procedure can be 
adopted to minimize the interference of the hemoglobin peak at 420 nm. Diluted microsomes were 
first bubbled with carbon monoxide, and then a baseline was run. After baseline correction, the 
sample cuvette was reduced with a few grains o f sodium dithionite and then rescanned. The 
specific content of total cytochrome P-450 was calculated using the following formula:
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Q  P.450 = AA X D / (8  X C) =AA x D x 10.989 / C
= nm oles/m g
Q P-450---- The specific content of cytochrome P-450 (nmoles/mg protein);
A A  ------ — Absorption difference (A*45q - A490);
8 ------—-  Extinction coefficient for AA450-490 (91 mM'^cm’ )^;
C ----------- protein concentration (mg/ml);
D ----------- Dilution factor o f the microsomes.
* In the case of peak shift, e.g. from 450 to 452 or 448, the value o f peak maximum 
was used.
2 .2 .2 .3  PR O TE IN  D ETERM IN ATIO N
Protein concentrations o f various microsomal preparations were determined by the method 
of Lowry et al (1951) using bovine serum albumin (BSA) as standard.
2 2.2.4 A R A C H ID O N IC  A C ID  M ETABO LISM
2 .2 .2 .4 .1  Incubation o f  arachidonic acid  metabolism
Arachidonic acid metabolism was carried out essentially as described by Capdevila et al 
(1985) in a final volume o f 2 ml incubation medium (50 mM Tris HCl, pH 7.5), containing 150 
mM KCl, 10 mM MgCl2, 0.5 mM arachidonic acid (at a specific activity o f 2.5 mCi/mmole) and 
the epoxide hydrolase inhibitor l,2-epoxy-3,3,3-trichloropropane (1 mM), to minimize the further 
metabolism of epoxides to diols. The reaction was initiated by the addition o f 1 mM NADPH  
(final concentration) in 1% (w/v) NaHCOg. The incubation was then carried out at 37°C in a 
shaking water bath for 15 minutes and stopped by the addition o f 100 fil IM  HCl. The linearity o f  
the enzyme reactions was established up to 25 minutes o f incubation (data not shown). The 
arachidonic acid metabolites were extracted from the incubation medium with 4 ml of ethyl acetate 
(containing 0.01% (w/v) of BHT), the aqueous phase re-extracted twice with 4 ml ethyl acetate 
and the combined extracts dried under a stream of nitrogen (N%). The extracts were finally 
dissolved in 250 |il o f HPLC starting solvent (see below) and stored at -20°C before HPLC 
separation.
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To check the involvement o f cytochrome P450 in arachidonic acid metabolism, some 
incubations were carried out in the presence o f incubation media saturated with carbon monoxide. 
These experiment demonstrated approximately 70% inhibition (data not shown).
2.2.2.4.2 R everse-phase high perform ance  liqu id  chrom atography (HPLC)
The arachidonic acid metabolites were separated by reverse-phase HPLC on an Ultrasphere 
CDS C l8 column (4.6 mm x 250 mm) using a linear elution gradient ranging from 30% 
acetonitrile (in water, containing 0.1% (v/v) acetic acid) to 100 % acetonitrile (containing 0.1% 
acetic acid) in 50 minutes at a flow rate o f 1 ml/min. The elution profile o f the radioactive 
metabolites was monitored using a Berthold LB503 HPLC radioactivity detector (Lab-Impex, 
Twickenham, U. K.) interfaced with a Commodore PET (Series 4000) data processing station. 
The rates o f metabolite formation were determined by collecting the relevant fractions and counting 
by scintillation spectrometry. The results were corrected for recovery rates from both the solvent 
extraction procedure and HPLC column. Radioactive recoveries after solvent extraction were 
estimated to be 87-95% and the data were corrected accordingly. The aqueous phases remaining 
after solvent extractions were not counted for radioactivity.
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2.3. RESULTS
2.3.1 XENO BIO TIC INDUCTIO N OF RAT H EPATIC CYTO CH RO M E P450
Table 2.2 summarizes the induction of hepatic cytochromes P450 by various xenobiotic 
treatments by using the treatment protocol outlined in Table 2.1. Hepatic total cytochrome P450 
contents were all significantly induced as compared with control, from 180% to 310% o f  the 
control value, as shown in column 2, Table 2.2. The inducibility o f these xenobiotics have been 
previously characterized as outlined in column 4 o f Table 2.2.
Table 2.2 XENO BIOTIC INDUCTIO N OF CYTO CH RO M E P450
XENOBIOTIC P450CONTENT(a) SORETPEAK 
MAXIMUM(b)
ISOENZYME(S) INDUCED 
/REFERENCE
CONTROL 0.61±0.15 450 nm
PENCB 1.62+0.05 448 nm IA1,2/Nagata et aU 1985
TCB 1.27+0.05 450 nm IIBl,2/Yoshimura et al, 1977
3-MC 1.36±0.03 448 nm IA1,2/Yabusaki et al., 1984
PB 1.78+0.21 450 nm IIBl, 2 /Wolf era/., 1986
STZ 1.14±0.12 450 nm IIE 1/Thomas et al., 1984
CLOT 1.93±0.21 450 nm IIIA 1,2/Rodrigues et al., 1988
CLOF 1.26±0.05 452 nm Sharma gf oL 1989
(a) The total hepatic cytochrome P450 contents were determined spectrophotometrically as 
described in section 2.2.2.2. The results o f P450 contents (mean ±  sd) are all expressed as 
nmol/mg protein.
(b)The Soret peak absorption maximum was determined using the peak detection mode.
2.3.2 ARACHIDO NIC ACID M ETABOLISM : COM PARISO N OF THE  
REVERSE PHASE HPLC M ETABOLITE PROFILES
Incubation o f [l-l^C]-arachidonic acid with rat liver microsomal preparations in the 
presence o f NADPH and molecular oxygen under conditions favourable for primary metabolism, 
resulted in the formation o f a variety o f metabolites as shown in Figure 2.1 (A-H). The metabolite 
profiles were obtained by reverse phase HPLC analysis o f the ethyl acetate extractable radiolabeled
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oxygenated products and unreacted substrate from the incubation media as outlined in section
Pretreatment of rats with various P450 inducers results in both qualitative and quantitative 
alteration of arachidonic acid metabolism. The formations o f  these metabolites appear to be 
cytochrome P450 dependent, as separate experiments have shown that 1) omission o f NADPH 
from the incubation media results in no metabolite formation and 2) pretreatment o f incubation 
media with carbon monoxide (CO) resulted in significant inhibition o f metabolite formation (up to 
70% on average, results not shown).
Figure 2.1 A shows the metabolite profile o f arachidonic acid catalysed by control rat liver 
microsomal preparations and three major groups of metabolites were identified according to their 
polarity. The arachidonic acid substrate is eluted at approximately 47.2 minutes. The metabolites 
o f lowest polarity are eluted from fractions 180 (36.0 minute) to 197 (39.4 minute), containing 
two major metabolite peaks, by comparison with the reported AA metabolite profile (Capdevila et 
al., 1985), which shows substantial similarity to the epoxyeicosatrienoic acids (EFT). The second 
group eluting between fractions 166 (32.0 minute) to 175 (35.0 minute), consisted o f several 
small peaks, with a similar polarity to the reported monohydroxyeicosatetraenoic acids (HETE), 
and thus they are collectively labeled as HETE. The third group of metabolites eluting between 
fractions 141 (28.1 minute) to 156 (31.2 minute), consisted o f three metabolite peaks, are 
separately named as peak I, peak II,and peak III,, exhibiting retention times o f 28.6, 29.4 and 
31.0 minutes respectively.
Pretreatment o f rats with phenobarbitone (PB) resulted in significant induction o f  
metabolites eluting from 36 to 39.4 minutes (Fig.2.1 B), which have been termed as EET as 
above. In addition, peak II was also significantly induced by phenobarbitone treatment. In 
contrast, other metabolites eluting within the HETE range (from 32 to 35 minutes) appeared to be 
unaffected by PB treatment (Figure 2 .IB).
2,4,2'4'-Tetrachlorobiphenyl (TCB) is a pure PB-type cytochrome P450 inducer 
(Parkinson et al., 1980b), and also significantly induces the formation o f the lowest polarity EET
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FIG U R E 2.1 R EV ER SE-PH ASE HPLC SEPARA TIO N  OF A RAC H IDO NIC ACID  
M ETABOLITES CATALYSED BY XENOBIOTIC INDUCED RAT  
LIVER M ICROSOM AL PREPARATIONS
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Footnotes fo r  Figure 2.1:
Arachidonic acid (0.25 |iCi/|imol) (0.5 mM) was incubated with 2 mg o f microsomal 
protein for 15 minutes in the presence of NADPH and O2 . The reaction was terminated 
with 100 jil HCl and the metabolites extracted three times with 4 ml ethyl acetate. The 
combined extracts were dried under N2 and finally dissolved in 250 jil o f ethanol and 
100 p,l injected onto the ODS Gig HPLC column and separated as described under 
section 2.2.2.4. The same amount o f radioactivity was injected onto the reverse phase 
HPLC column thus made these chromatograms to be comparable.
Abbreviations used are AA: arachidonic acid; EET: epoxyeicosatrienoic acid; HETE: 
hydroxyeicosatetraenoic acid. CONT/RAT: control rat liver microsome incubation; 
PB/RAT: phenobabitone induced rat liver microsome incubation; TCB/RAT: TCB 
induced rat liver microsome incubation; STZ/RAT: streptozotocin induced rat liver 
microsome incubation; CLOF/RAT: clofibrate induced rat liver microsome incubation; 
MC/RAT: 3-methylcholanthrene induced rat liver microsome incubation; PENCB/RAT: 
PENCB induced rat hver microsome incubation.
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metabolites and metabolite Peak II as demonstrated in Figure 2.1C. Results presented in Figures
2.1 B and 2.1C clearly indicate that PB and PB-type inducers induce cytochrome P450 
isoenzymes mainly responsible for the epoxygenation o f arachidonic acid.
Cytochrome P450 HEl is a diabetes-inducible isoenzyme. In the present study, STZ induced 
diabetes in the rats has been confirmed by clinical examination (excessive consumption o f water 
and significantly elevated blood glucose level, data not shown here). The induction o f cytochrome 
P450 IIEl has also been confirmed by a semi-quantitative western blot technique in the present 
study (results not shown). However, results presented in Figure 2.1 D and Table 2.2 clearly 
indicated that, in spite o f significant induction o f total cytochrome P450 content and the 
cytochrome P450 IIEl isoenzyme, the metabolism of arachidonic acid appeared to be suppressed 
by the STZ-induced rat liver microsomes. As compared with the control metabolite profile (Figure
2.1 A), no significant difference has been observed in the metabolite patterns between control and 
STZ-induced rat liver microsomal preparations. Results presented herein therefore indicate that 
cytochrome P450 BEI may not be able to use arachidonic acid as substrate.
Clofibrate is a hypolipidaemic agent, which has been demonstrated to be a potent inducer of 
the cytochrome P450 IVA sub-family (Sharma et al., 1989). Incubation o f [1-^^C]-arachidonic 
acid with clofibrate induced rat liver microsomes results in dramatic alteration in the arachidonic 
acid metabolite profile. Whereas the formation o f a metabolite peak with a retention time o f 29.4 
minute (peak II) was considerably induced, other metabolites were barely identifiable (Figure 
2. IE). The metabolism o f arachidonic acid by hypolipidaemic-induced cytochrome P450 
isoenzymes has been previously characterized (Capdevila et el., 1985; Sharma et al., 1989), 
where was demonstrated that co-hydroxylation o f arachidonic acid represents the exclusive reaction 
pathway catalysed by cytochrome P450 IVAl (Sharma et al., 1989).
Clotrimazole is an antibiotic and its effects as an inducer of cytochrome P450 isoenzymes 
have previously been described (Rodrigues et al., 1988), and these latter authors have 
demonstrated that clotrimazole is a potent inducer o f cytochrome P450 IDA 1(2) (PCN-inducible) 
isoenzymes. In the present study, after 100 mg/kg single daily treatment o f rats with clotrimazole
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for three days, the total liver cytochrome P450 content was induced for more than three fold. 
However, no detectable arachidonic acid metabolism was observed by this microsomal 
cytochrome P450 preparation (Fig.2.1 F). This result strongly suggests that cytochrome P450 
n iA l (2) may not be able to oxidize arachidonic acid.
Figures 2.1 G and 2.1H portray the arachidonic acid metabolite profiles catalysed by 3-MC 
and PENCB -induced rat liver microsomes respectively. 3-MC and PENCB induced arachidonic 
acid metabolite profiles show remarkable similarity to each other, but are considerably different 
from control and other xenobiotic-induced arachidonic acid metabolite profiles. Both o f these 
pretreatments significantly induced the formation o f metabolite peak I and peak III and 
substantially inhibited the formation o f other metabolites. In particular, PENCB pretreatment 
greatly suppressed the formation o f EETs and HETEs (Fig.2.1 H). In addition, peak II was 
barely discernible after PENCB treatment. In the case o f 3-MC pretreatment, while peak I and 
peak III were both significantly induced, peak II is still distinguishable. The formation of 
epoxides was markedly inhibited by 3-MC treatment, but the HETEs were still comparable to that 
of the control preparation.
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2.3.3 QUANTITATIO N OF THE RATES OF ARACHIDO NIC ACID M ETABOLISM  
CATALYSED BY XENO BIOTIC-INDUCED RAT LIVER M ICRO SO M ES
Table 2.3 shows the formation rates o f arachidonic acid metabolites catalysed by different 
xenobiotic-induced rat liver microsomal preparations. Phenobarbitone and TCB (PB-type inducer) 
pretreatments significantly increased the formation o f epoxides and peak II whereas 3-MC and 
PENCB (3-MC-type inducer) significantly suppressed epoxide formation and significantly 
induced the formation of peak I and another unidentified metabolite peak IB. PB and TCB have 
no such effect on the formation o f peak I or Peak BI. In addition, in spite o f remarkable similarity 
between 3-MC and PENCB on the formation o f arachidonic acid metabolite profiles, differences 
were still observed in the formation o f the co-hydroxylated product. W hile PENCB treatment 
significantly suppressed peak II formation, 3-MC induces the formation o f peak I and peak III 
without any suppressive effects on the peak II, possibly indicative o f different molecular events in 
the induction of the cytochrome P450 lA  sub-family between 3-MC and PENCB. Clofibrate 
pretreatment resulted in a large induction o f peak II, the formation o f peak I was unaffected, but 
other metabolites were all undetectable. STZ pretreatment results in general suppression o f all 
metabolite formations, in spite of significant induction o f total P450 content. Clotrimazole induced 
rat liver microsomal preparation did not support any identifiable arachidonic acid metabolism.
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2.4 DISCUSSION
As reviewed in chapter 1, cytochrome P450 is a gene superfamily, consisting o f multiple 
forms of haemoprotein isoenzymes, but unlike the situation with the majority o f other enzymes, 
the substrate specificity o f the cytochrome P450 isoenzym es is usually quite broad and 
overlapping. One particular isoenzyme can act on a number o f structurally unrelated substrates, or 
the metabolism o f a particular substrate may result from the contribution o f more than one 
isoenzyme. In addition, many cytochrome P450 isoenzymes are characterized by their substrate 
regio- and stereoselectivities.
It should be noted that all microsomal incubations with arachidonic acid contained 1 mM 
l,2-epoxy-3,3,3-trichloropropane as an epoxide hydrolase inhibitor to maximise yields o f epoxide 
metabolites. In separate experiments this inhibitor only minimally (approximately 5%) inhibited 
cyctochrome P450-dependent metabolism o f arachidonic acid and did not alter the metabolite 
profile (data not shown).
In the present study, the metabolism o f arachidonic acid by various xenobiotic induced rat 
liver microsomes was studied and compared. Incubation o f [ 1 - -arachidonic acid with control 
microsomal preparations in the presence o f NADPH and O2 results in the formations o f several 
oxygenated metabolites as shown in Figure 2.1 A. This may be derived from the contribution o f a 
combined action o f various forms o f constitutive P450 isoenzymes. Figure 2 .IB to 2.1H  
demonstrated the metabolite profiles o f arachidonic acid catalysed by different microsomal 
preparations. Pretreatments of rats with various xenobiotics result in substantially different 
metabohte profiles, particularly in the cases o f pretreatment with lA and IVA sub-family inducers. 
As demonstrated in Fig. 2 .IE and Table 2.3, clofibrate pretreatment gives rise to the induction of 
a predominant AA metabolite peak whereas other metabolite peaks are hardly discernible. 
Previous studies on the characterization of AA metabolism by clofibrate induced cytochrome P450 
IV A l revealed that co-hydroxylation of arachidonic acid was the predominant reaction (Capdevila 
et a l ,  1985; Sharma et a l ,  1989), which has also been shown to be exclusively catalysed by the 
cytochrome P450 IVAl isoenzyme (Kupfer, 1982) and further confirmed in my studies.
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Pretreaments of rats with PENCB and 3-MC result in the formations o f two major metabolite 
peaks which are located just before and behind the P450 IVA l dependent metabolite peak in terms 
o f HPLC elution order. Obviously, these two metabolite peaks are distinct from the clofibrate- 
inducible peak n . Previous studies of arachidonic acid metabolism with (L-naphthoflavone ((3-NF) 
induced rat liver microsomes revealed that co-l-hydroxylation was the predominant reaction 
yielding to 19-hydroxy metabolite (Oliw ef a/., 1982). p-NF and PENCB are both 3-MC-type 
inducers, however previous reports have not found the additional peak III identified by me. 
Whereas it has generally been recognised that both PENCB and 3-MC induce similar P450 
isoenzyme profiles, only PENCB significantly suppressed the formation o f 20-HETE, indicating 
that PENCB but not 3-MC has the ability to switch off the gene expression o f cytochrome P450 
IV A l. Cytochrome P450 IV A l is induced by hypolipidaemic drugs, its induction may be 
responsible for the lipid-lowering effects o f these drugs (Sharma er fl/., 1989). The ability of 
PENCB to switch off P450 IV A l gene expression may be partially responsible for the effects of 
this toxic PCB isomer in causing increased serum lipid levels.
The STZ-induced microsomal preparations resulted in a general suppression o f all 
metabolites identified. In the present study, the total cytochrome P450 content was slightly but 
significantly induced by STZ treatment. It is conceivable that the general suppressive effect o f this 
latter pretreatment on arachidonic acid metabolism might be due to the suppression o f those 
constitutive P450 isoenzymes that are responsible for arachidonic acid oxidation, concomitant with 
STZ-inducible cytochrome P450 BEI isoenzyme induction which is unable to use arachidonic acid 
as a substrate.
This inability of certain cytochrome P450 isoenzymes to sustain oxidation o f arachidonic acid 
is particularly obvious in the case o f cytochrome P450 IBA1(2). In spite o f the 3 fold induction of 
the total P450 content, no arachidonic acid metabolism was detected by the clotrimazole-induced 
microsomal preparations, indicating that arachidonic acid is not a good substrate for cytochrome 
P450 IBA1(2) either. Alternatively, residual clotrimazole still remained in the liver and complexed
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and therefore inactivated cytochrome P450, in a similar fashion to ketoconazole (Morita et al., 
1988).
Molecular modeling studies have demonstrated that arachidonic acid possesses a compact 
“hairpin-like” (U-type) conformation, which can be accommodated at the active site o f the P450 
haemoprotein. The geometrical orientation of the AA substrate molecule residing within the active 
site o f the isoenzyme may determine the stereoselective hydroxylation o f arachidonic acid 
(Capdevila et at., 1985). Thus the relative differences of the spatial three-dimensional structure of 
the active sites between different isoenzymes may result in metabolite regioselective specificity of 
different isoenzymes toward the AA molecule and the formation of different metabolite profiles.
In recent years, rapid progress has been made in the study o f cytochrome P450 dependent 
arachidonic acid metabolism, which is mainly due to the recognition o f the important biological 
effects o f many of the P450 dependent arachidonic acid metabolites, as outlined in Table 1.5. As 
shown in Table 1.5, these metabolites participate in the regulation o f various subcellular events. 
Cytochrome P450 is a widely distributed protein enzyme, which can be modulated by treatment of 
various xenobiotics, and alteration of the relative proportions o f particular P450 isoenzymes could 
result in dramatic changes o f the in vivo metabolism o f arachidonic acid and the subsequent 
subcellular regulation of important physiological pathways.
It must be emphasised that my studies do not answer the question whether PENCB itself 
or PENCB-dependent restriction of food intake changes the P450 profiles noted by me, and 
remains to be further clarified.
In conclusion, studies presented in the present chapter indicate that xenobiotic pretreatment 
result in a dramatic alteration of cytochrome P450 dependent arachidonic acid metabolism, and 
substantiate the continued use o f arachidonic acid as a means to assess the cytochrome P450 
isoenzyme profile in tissue homogenates.
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CHARACTERIZATION OF ARACHIDONIC ACID 
METABOLITES FORMED BY XENOBIOTIC INDUCED 
RAT LIVER MICROSOMAL CYTOCHROMES P450
65
3.1 INTRODUCTION
It has well been established that the metabolism of arachidonic acid by cytochrome P450 
dependent monooxygenase systems is highly regioselective, and different cytochrome P450 
isoenzymes catalyse the oxygenation at different positions of the fatty acid carbon backbone, thus 
resulting in the formation of different arachidonic acid metabolite profiles. This positional 
selectivity o f arachidonic acid hydroxylation is probably due to the relative differences in the 
spatial structures o f the active sites of various cytochrome P450 isoenzymes. Studies presented in 
Chapter 2 clearly further indicate that pretreatment o f rats with various xenobiotic inducers of 
cytochrome P450 results in the formations o f significantly different metabolite profiles of 
arachidonic acid. The formations of these metabolites have been demonstrated to be NADPH- 
dependent and carbon monoxide sensitive, indicating the involvement o f cytochrome P450 
monooxygenase systems. O f particular interest is the metabolite profile catalysed by PENCB- 
induçed rat liver microsomal preparations, which shows distinct profiles from both TCB and 
other xenobiotic pretreated rat liver microsomes.
The present chapter is intended to described the purification of these major P450-dependent 
arachidonic acid metabolites by means of combined reverse phase and normal phase HPLC 
techniques, and the structural identification of the purified metabolites by GC-mass spectrometry.
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3.2 MATERIALS AND METHODS
3.2.1 M ATERIALS
3 .2 .1 .1  CH EM ICALS
The chemicals used in the present Chapter are basically the same as those described in 
Chapter 2. The extra chemicals are from the following commercial sources.
N-Methyl-N-nitroso-p-toluenesulfonamide (Diazald) was obtained from Sigma Chemical 
Company (Poole, Dorset, England). 'H,0-bis (Trimethylsilyl) trifluoroacetamide (BSFTA) and 
Trimethylchlorosilane (TMCS) were bought from Pierce & Warriner (U.K.) Ltd. (Cheshire, 
England).
3.2.2 M ETHODS
The incubation o f arachidonic acid and the reverse phase HPLC separation o f the 
arachidonic acid metabolites were performed as described under section 2.2.2.4. Additional 
methodologies used are described below.
3 . 2 . 2 1  A R A C H ID O N IC  ACID  M E TA B O LISM
3.2 .2 .1 .1  N orm al-phase H P L C  separation o f  arachidonic ac id  m etabolites
The ethyl acetate extracts o f the radiolabeled arachidonic acid metabolites were separated by 
reverse-phase HPLC as described in section 2.2.2.4.2. Fractions from No. 143 (28.6 minute) to 
149 (29.8 minute) which contain peak I and peak II from the PENCB/RAT, MC/RAT, 
CONTROL/RAT and CLOF/RAT were collected and pooled respectively. The combined eluents 
were dried under nitrogen at room temperature and then reconstituted in hexane (containing 
0.01% (w/v) BHT as antioxidant) before being analysed by normal-phase HPLC. The normal- 
phase HPLC separation was carried out on a Spherisorb silica column (particle size: 5 p,m; 
column dimensions: 300 mm x 3.9 mm) by utilizing a linear gradient (gradient I) from 100% 
isopropanol : acetic acid : hexane (1 : 0.1 : 98.9, v/v/v) to 100% isopropanol : acetic acid : hexane 
(3 : 0.1 : 96.9, v/v/v) in 30 minutes at a flow rate o f 3 ml/min on a Varian 5000 HPLC system,
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which was connected to a Berthold LB503 HPLC radioactivity monitor (Lab-Impex, 
Twickenham, U. K.) and a Commodore PET (Series 4(XX)) data station.
Fractions from No. 150 (30.0 minute) to 159 (31.8 minute) from the same incubations as 
above, which contain peak III, were collected, pooled and dried under nitrogen at room  
temperature respectively and reconstituted in small volume o f hexane (containing 0.01% BHT) 
and separated on the same silica column, but using a solvent gradient system o f reduced polarity 
(gradient II), consisting o f 100% isopropanol : acetic acid : hexane (0.5 : 0.1 : 99.4, v/v/v) for 3 
minutes and then linearly increasing to 100% isopropanol : acetic acid : hexane (1.5 : 0.1 : 98.40, 
v/v/v) for 30 minutes at a flow rate of 3 ml/min. The radioactive products eluted from the column 
were continuously monitored by the radioactivity detector.
3 .2.2 .1 .2  A ntibody  inhibition study o f  arachidonic ac id  m etabolism
Inhibition study o f the formation o f metabolite peak I and peak III in PENCB-induced 
microsomes o f rat liver was carried out using polyclonal anti-P450 lA l and anti-P450 IV A l anti­
serum.
0.1 mg Emulgen 911 and 1 mg cholate were added per 1 mg o f liver microsomal protein in 
order to solubilize the microsomes. The reaction vessels then mixed and incubated at 4°C for 10 
minutes. These concentrations o f detergent were used in order to obtain maximum solubilization 
and hence antibody access with a minimum loss of catalytic activity.
An appropriate amount o f the respective antibodies was then added to the incubation 
vessels, mixed and incubated for 10 minutes at 25°C. The samples were then placed on ice and 
the remaining components for the assay added. The reaction was then conducted at 37°C in a 
shaking water bath as described in section 2.2.2.4.1 and the formation rates o f peak I and peak IB 
were quantitated as described in section 2.2.2.4.2 by reverse-phase HPLC.
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3.2.2.2 GA5 C H R O M A T O G R A P H Y -M A S S S P E C T R O M E T R Y  (G C -M S)  
ANALYSIS
Fractions corresponding to the radioactive metabolite peaks eluted from the normal-phase 
FŒ^ LC column were collected, pooled, dried under nitrogen and the residues reconstituted in 200 
|il o f hexane (containing 0.01% (w/v) BHT) and stored at-20®G before MS analysis.
3.2.2.2.1 D erivatiza tion  o f  arachidonic a c id  metabolites
Ethereal diazomethane was prepared by adopting the following procedures (Porter et al., 
1979). To a round-bottom flask containing 5 ml o f 40% KOH and 20 ml o f ethyl ether, 400 mg 
of N-methyl-N-nitroso-p-toluenesulfonamide was added. The mixture was stirred in the dark for 
2 hours at 0°C. The ether layer was removed and then dried with KOH pellets for half an hour. 
The upper faint yellow ether liquid was pipetted into a tight capped container and stored at 0°C 
before use.
The samples were taken to dryness under a stream of nitrogen and the residues taken up 
in 70 pi o f methanol. 700 pi o f freshly prepared ethereal diazomethane was added and the 
solutions were kept at room temperature for 10 minutes. Excessive reagent and solvents were 
removed under nitrogen, and the methylated samples were resuspended in 70 pi of BSTFA -h 1% 
(v/v) TMCS (Pierce, U. K.) and heated at 70°C for 60 minutes for silylation.
3 .2 .2 .2 .2  H ydrolysis , hydrogenation  an d  resily la tion
Aliquots of derivatised samples in BSTFA (30 pi) were added to 300 pi o f water in 1 ml 
vials. Each mixture was vortex mixed for 7 minutes for hydrolysis and then extracted twice with 
diethyl ether (500 pi and 300 pi) and the combined ether extracts taken to dryness under nitrogen. 
The residue was dissolved in 250 pi o f methanol and the solution purged with nitrogen before 
adding a trace amount of Adam's catalyst (hydrated PtOi). Hydrogen was bubbled through the 
solution for 4 minutes and further purged with nitrogen. 45 pi of BSTFA + 1%  (v/v) TMCS 
were added and the resulting solution heated at 70°C for 30 minutes.
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3.2.2.2.3 G C -M S ana lys is :  Instru m enta tion
Derivatised samples were run on a GC-MS system consisting o f a Hewlett Packard 5890 
Gas Chromatograph directly coupled to a TSQ-70 (Finnigan-MAT) mass spectrometer. The gas 
chromatography was carried out on a 25m x 0.25 mm i.d. DB5 (WCOT) fused silica capillary 
column (Jones Chromatography) using a splitless injection technique with a helium carrier gas 
head pressure o f 15 psi. The GC oven temperature was held at 150°C for 1 minute then 
programmed at 25°C/min to 240°C, and held at 240°C for 22 minutes. The injection port and 
GC-MS interface were maintained at 250°C. Electron impact spectra were obtained with an 
ionization energy of 70 eV.
A mixture o f Ci6 to C24 fatty acid methyl esters were run on the GC-MS. Retention times 
(Rt) were measured from the time at which the column oven reached 240°C (4.6 minutes). Log Rt 
values were plotted against the C-value and a calibration curve obtained which was linear between 
C20 and C24. The C-value for the unknowns were calculated from this graph (data not shown).
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3.3 RESULTS
3.3.1 PU R IFIC ATIO N OF ARACHIDO NIC ACID M ETABO LITES
Results presented in Chapter 2 demonstrated that pretreatments o f rats with PENCB, a toxic 
MC-type P450 inducer, results in significant induction o f two major metabolite peaks, which 
were designated peaks I and III, o f retention times 28.6 and 31.0 minutes respectively. In the 
present study, fractions corresponding to peak (I+II) and peak III were collected and pooled 
respectively, and dried under nitrogen at room temperature. The combined eluents were run on the 
reverse phase HPLC column to confirm the retention times before further purification by normal 
phase HPLC. Figure 3.1 shows the re-run o f peaks I and III eluents on the reverse -phase 
HPLC.
FIG U R E 3.1 R EV ER SE-PH A SE HPLC CH RO M A TO G RA M S OF PE A K  (I+II) 
AND PEA K  III FROM  PENCB-TREATED RATS (c.f. FIG. 2.1 H)
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Fractions corresponding to peak (I+II) from 28.6 minute to 29.8 minute and peak III 
from 30 minute to 31.8 minute respectively were collected, dried under nitrogen and 
reconstituted in a small volume of reverse-phase starting solvent and re-run on reverse- 
phase HPLC to confirm that the correct peak o f interests had been isolated. The major 
fractions o f these peaks were again collected and dried under nitrogen, and further 
purified by normal-phase HPLC.
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Fractions corresponding to peak (I+II) and peak III o f 3-MC/RAT (c.f. Fig.2.1G) and 
CONT/RAT (c.f. Fig.2.1 A) and peak (I+II) o f CLOF/RAT (c.f. Fig.2.1 E) were also collected, 
pooled and dried under N2 . These peaks were also further purified by normal-phase HPLC.
Figure 3.2 (A, B, C and D) shows the normal-phase HPLC chromatograms o f peak (I+II) 
from PENCB/RAT (c.f. Fig. 2.1H), 3-MC/RAT (c.f. Fig. 2.1G), CLOF/RAT (c.f. Fig.2.1E) 
and CONT/RAT (c.f. Fig 2.1 A) respectively. As can be seen from Fig 3.2 A, normal-phase 
HPLC of peak (I+II) from PENCB/RAT gives rise to a major peak with a retention time of 6.4 
minutes, (designated peak A), the other small peak with a retention time o f 8.0 minutes is hardly 
detectable, (peak B). Figure 3.2 B shows the normal-phase separation of peak (I+II) from 3- 
MC/RAT (see Chapter 2, Fig.2.1 G), the first component had a identical retention time as peak A  
in Fig. 3.2 A and thus designated A', and the second peak named as B ’. The relative ratio of 
peak A' to peak B' is approximately 70:30. Normal-phase HPLC of the clofibrate-induced peak 
(I+n) gives rise to two baseline-separated peaks (Figure 3.2 C), with very similar retention times 
as peak A and A  and peak B and B' respectively, and thus named as peak A" and peak B". Peak 
B" represents approximately 90% of the total radioactivity. Figure 3.2 D shows the normal-phase 
chromatogram of P(I+II) of CONT/RAT. The two peaks are labeled as indicated (A'" and B'").
Peak III is less polar than peak (I+IÏ) as shown in the reverse-phase chromatograms 
(Fig.2.IH), and eluted from the normal-phase column (silica column) well before peak A  (with a 
retention time of 3.4 minutes) when using normal-phase gradient I and gave no further separation 
(data not shown). However, when using a reduced polarity solvent gradient (normal-phase 
gradient II), peak III could be further separated into two peaks as shown in Figure 3.3 (A and B). 
These two chromatograms were basically very similar to each other and, both had two partially 
separated peaks with similar retention times. Figure 3.3 A was obtained by normal-phase HPLC 
separation o f peak in from PENCB/RAT, the two peaks labeled as peaks C and D as indicated. 
The corresponding peaks in Figure 3.3 B (peak III from 3-MC/RAT, Fig.2.1 G) are thereby 
labeled as peaks C  and D'. The ratios of C to D and C  to D' are 3:1 and 5:1 respectively. 
Unsuccessful attempts have been made to further separate these two peaks.
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FIGURE 3.2 NORMAL-PHASE HPLC SEPARATION OF
ARACHIDONIC ACID METABOLITE PEAK (I+II)
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Arachidonic acid metabolite were initially separated by reverse phase HPLC and fractions from 
No. 143 (28.6 minute) to 149 (29.8 minute) containing peak I and peak II from the 
PENCB/RAT, MC/RAT, CLOF/RAT and CONT/RAT were collected and pooled respectively. 
The combined eluents were dried under nitrogen at room temperature and then reconstituted in 
hexane (containing 0.01% BHT as antioxidant) and analysed by normal-phase HPLC using 
normal phase gradient I as described under section 3.2.2.1.1. The amounts o f radioactivity 
injected onto the normal-phase HPLC column were approximately 5 reverse-phase HPLC eluent 
collections.
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FIGURE 3.3 NORMAL-PHASE HPLC SEPARATION OF
ARACHIDONIC ACID METABOLITE PEAK III
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Arachidonic acid metabolites were initially separated by reverse phase HPLC and 
fractions from No. 150 (30.0 minute) to 159 (31.8 minute) o f PENCB/RAT and 
MC/RAT, (which contain peak IQ), were collected, pooled, dried under nitrogen at 
room temperature and reconstituted in a small volume of hexane (containing 0 .0 1 % 
(w/v) BHT) and separated on the normal-phase HPLC column, using normal phase 
gradient Q as described in section 3.2.2.1.1. (A) The amount o f  radioactivity 
loaded in column was approximately two reverse-phase HPLC eluent collections. 
(B) The amount o f radioactivity loaded in column was approximately three reverse- 
phase HPLC eluent collections.
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These normal-phase metabolite peaks were collected, pooled and dried under a stream of 
nitrogen at room temperature. The residues were all taken up in 200 p.1 o f hexane (containing 
0.01% (w/v) BHT) and stored at-20°C before MS analysis.
3.3.2 GC-M S A NALY SIS
The mass spectra o f the methyl esters o f the trimethylsilyl derivatives o f the isolated 
metabolites derived from normal-phase HPLC separation are shown in Figures 3.4 to 3.8. 
Metabolite peaks A, A', A" and A'", after derivatization, gives very similar mass traces (data not 
shown) and have been confirmed to be derivatives o f 19-hydroxy arachidonic acid.
GS/M S analysis o f  metabolite P eak A
Figure 3.4 shows the FI mass spectrum of the derivatized peak A (Fig. 3.2), which is in 
good agreement with that published by Oliw et al (1981) for the derivative o f the co-l- 
hydroxylated product o f AA (19-hydroxy metabolite). The derivative chromatographed with a 
retention time equivalent to a C-value o f 22.1 when compared to a standard mixture o f C i6 to C24 
fatty acid methyl esters. The characteristic fragment ions (and their structural assignments) were 
noted at m/z 117 (-CH(0 +Me3Si)CH3). The other ions are noted at m/z: 406 (M+), 391 (M+- 
CH3), 159 (-CH2CH2CH2CH(0 +Me3Si)CH3), 131 (159 - 28), 73 (Me3Si)).
GC/M S analysis o f  metabolite peak  B ”
Figure 3.5 shows the FI mass spectrum of the derivative o f peak B" (Fig. 3.2), (C-value 
of 22.8) and is in good agreement with the data reported by Capdevila et al (1985) and Sharma et 
al (1989) for the Me3Si ether methyl ester derivative of the co-hydroxylated product o f AA (20- 
hydroxy metabolite). The derivatives o f peaks B’ and B'" gave very similar FI mass spectrum 
(data not shown) and therefore were also identified as 20-HFTF.
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FIGURE 3.4 GAS CHROMATOGRAPHY-MASS SPECTROMETRY
OF ARACHIDONIC ACID METABOLITE PEAK A *
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Arachidonic acid metabolite Peak A was isolated as described in Figure 3.2. The electron impact 
mass spectrum of the unsaturated metabolite peak A as a MegSi ether methyl ester derivative. The 
mass spectrum was obtained by GC/MS analysis as described under section 3.2.2.2. The C-value 
of the derivative was 22.1. (B) The proposed metabolite structure.
*: All o f the mass spectra presented in this chapter are reproduced from the original data by the 
use o f Macintosh MacDraw II software with the exclusion o f those fragments o f less than 2%.
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FIGURE 3.5 GAS CHROMATOGRAPHY-MASS SPECTROMETRY
OF ARACHIDONIC ACID METABOLITE PEAK B
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Arachidonic acid metabolite Peak B was isolated as described in Figure 3.2. The 
electron impact mass spectrum o f the unsatuarted metabolite peak B" as a MegSi ether 
methyl ester derivative. The mass spectrum was obtained by GC/MS analysis as 
described under section 3.2.2.2. The C-value o f the derivative was 22.8. (B) The 
proposed metabolite structure.
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GCIMS analysis o f  metabolite Peak D
The El mass spectrum o f the derivatized sample o f peak D is shown in Figure 3.6 A, which 
was obtained from a GC peak with a retention time equivalent to a C-value o f 21.3, which was 
shifted to 22.2 after hydrogenation, when compared to a standard mixture o f Ci6 to C24 fatty acid 
methyl esters. In Figure 3.6 A, the highest mass ion signal is noted at m/z 406, which is in 
agreement with the molecular mass o f  a Meg Si ether methyl ester derivative o f  a 
monohydroxylated arachidonic acid. Figure 3.6 B shows the mass spectrum of this sample after 
hydrogenation, but the expected M+ was not present. The fragmentation pattern shown in 
Figures 3.6 (A and B) indicated that the hydroxyl group is attached to the carbon 16 position of 
arachidonic acid. The un saturated mass spectrum (Figure 3. 6 A) shows the expected characteristic 
fragment at m/z 349 (M+-57, loss o f -CH2CH2CH2CH3), but another expected fragment at m/z 
159 is unfortunately absent. However, after hydrogenation, the fragment ion at m/z 159 (- 
CH(0 +Me3Si)CH2CH2CH2CHg) becomes the base peak, and another characteristic fragment 
was increased by 8 to 357 m/z (M+-57, loss o f -CH2CH2CH2 C H 3). The other identified 
fragments are noted at m/z 391 (M+-15, loss o f a -CH3), 317 (M+-89, loss o f -O+MegSi) in the 
unsaturated mass spectrum, and 399 (M+-15), 384 (M+-30, loss of two -CH3) in the saturated 
mass spectrum. No other meaningful ions are identified. It should be noted a fragment o f 117 
noted in this spectrum which I had deduced was diagnostic o f the 19-hydroxy metabolite. Hence 
it is possible that this fragment is not diagnostic of the 19-hydroxy (which is unlikely) or that the 
source of this fragment still remains to be defined, and is different from that in the 19-hydroxy 
metabolite. In any case, it is highly unlikely that the 16-hydroxy metabolite is contaminated with 
the 19-hydroxy metabolite under mass spectral analysis conditions, as these are well separated in 
the GC component of the GC/MS analysis. However, we can not fully exclude the possibility that 
for some unknown reasons, there is still some residual contamination o f this peak by the 19- 
hydroxy metabolite. It must be noted that the spectrum o f the saturated derivative of peak D gave a 
mass spectrum consistent with that published recently (Falck et a l ,  1990).
Thus taken collectively, the above data tentatively identified that Peak D is 16-HETE.
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FIGURE 3.6 GAS CHROMATOGRAPHY-MASS SPECTROMETRY
OF ARACHIDONIC ACID METABOLITE PEAK D
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The electron impact mass spectrum o f the MegSi ether methyl ester derivative o f peak D  
(FIGU. 3.3) before (A) and after (B) hydrogenation. The mass spectrum was obtained 
by GC/MS analysis as described under section 3.2.2.2. The C-values for the 
unsaturated and saturated derivative were 21.3 and 22.2 respectively. (C) The proposed 
metabolite structure.
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GCIMS analysis o f  metabolite P eak C (first G C-eluting component)
Derivatised sample of peak C (Fig. 3.3) was shown to contain two components which have 
been separated by gas-chromatography (data not shown) with retention times equivalent to C- 
values o f 21.7 and 22.0 respectively, which shift to 22.4 and 22.7 after hydrogenation. The El 
mass spectrum obtained for the first eluting unsaturated component is shown in Figure 3.7 A. The 
two highest mass fi-agments were noted at m/z 479, and 405, neither o f which is an expected 
molecular ion for a monohydroxylated metabolite. The weak signal at m/z 405 appears to result 
from a HETE M+ with a loss o f a “H” atom; the other at m/z 479 (406 + 73) is probably due to 
attachment o f an extra MesSi (73) group to the carboxyl group. These fragment information in 
conjunction with the C-value is not inconsistent with this component being a HETE. In addition, 
two characteristic fragments o f particular structural information are noted at m/z 145 (- 
C H (0 +M e3 Si)-(C H 2 )2-C H 3 ) and 363 (M+-43, loss o f  -CH2 CH 2 C H 3 ). Other identified  
fragments include: 391 (M+-15), 375 (M+-31, loss o f -OCH3), 334 (M+-72, probably loss o f - 
OCHCH2CH2CH3 with migration of Me^Si to the carboxyl group), 159 ,131 ,117  and 73.
Figure 3.7 B shows the El mass spectrum of the saturated derivative o f the first GC-eluting 
component o f peak C. Fragment at m/z 145 (as above) is the predominant ion signal, whereas the 
other characteristic fragment (m/z 363) is increased by 8  to m/z 371 after hydrogenation. The 
saturated mass spectrum shows other ions at m/z 159,102 (-CH(0 +Me3Si)) and 73.
Taken collectively, the structural information shown in Figure 3.7 indicates that the hydroxyl 
group is attached to carbon 17, and is therefore a 17-HETE.
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FIGURE 3.7 GAS CHROMATOGRAPHY-MASS SPECTROMETRY
OF THE FIRST GC-ELUTING COMPONENT OF PEAK C
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The electron impact mass spectrum of the first GC-eluting component o f peak C (Figure 3.3) as the 
MegSi ether methyl ester derivative o f peak 0  before (A) and after (B) hydrogenation. The mass 
spectrum was obtained by GC/MS analysis as described under section 3.2.2.2. The C-values for 
the unsaturated and saturated derivative were 21.7 and 22.4 respectively. (C) The proposed 
metabolite structure.
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GCIMS analxsis o f  metabolite P ea k  C (Second GC-eluting com ponent)
The El mass spectrum for the unsaturated and saturated derivatives of the second GC-eluting 
component o f peak C with C-values of 22.0 and 22.7 before and after hydrogenation respectively 
are shown in Figures 3.8 A and B. These spectra show remarkable similarity to the recently 
published mass spectra for the Meg Si ether methyl ester derivative o f 18-hydroxyeicosatetraenoic 
acid (Oliw, 1989). The unsaturated mass spectrum (Fig. 3.8 A) shows the mass fragments at m/z: 
406 (M+), 391 (M +-15), 377 (M+-29, loss o f -CH2 C H 3 ), 375 (M +-31), 348 (M +-48, 
unidentified, possibly due to loss of -0 CH(0 "''Me3Si)CH2CH3 , with migration o f the MegSi to the 
carboxyl), 317 (M+-89, loss ofO+M egSi), 316 (m/z 317 -1), 287 (m/z 377-90), 159, 145, 131 (- 
CH(0 +Mc3Si)CH2CH3), characteristic fragment and 73. The saturated mass spectrum (Figure 3.8 
B) shows fragments in the high mass range at m/z 385 (m/z 377 + 8 ), 367 (M+-47, unidentified) 
356 (M+-58, unidentified). Low mass fragments were observed at m/z: 159, 131 (base peak) and 
73.
These fragmentation patterns shown in Figure 3.8 almost certainly confirm the structure of 
this second GC-eluting component as 18-hydroxyeicosatetraenoic acid (18-HETE) and is in good 
agreement with that published by Oliw (1989).
Derivatised samples of Peak C  (Figure 3.3 B) have also been shown to contain two 
components by GC separation with identical C-values before and after hydrogenation as those for 
peak C. The mass spectra are very similar (data not shown), and it is therefore concluded that 
peak C  contains the two components (17-HETE and 18-HETE) as described for peak C.
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FIGURE 3.8 GAS CHROMATOGRAPHY-MASS SPECTROMETRY
OF THE SECOND GC-ELUTING COMPONENT OF PEAK C
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The electron impact mass spectrum of the second GC-eluting component o f  peak C 
(Figure 3.3) as the MegSi ether methyl ester derivative o f peak C before (A) and after 
(B) hydrogenation. The mass spectrum was obtained by GC/MS analysis as described 
under section 3.2.2.2. The C-values for the unsaturated and saturated derivative were 
22.0 and 22.7 respectively. (C) the proposed metabolite structure.
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3.3.3 ANTIBODY INHIBITION STUDY OF ARACHIDONIC ACID METABOLISM
Antibody inhibition study o f arachidonic acid metabolism is shown in Figure 3.9. The 
present study was carried out using polyclonal anti-P-450 lA l and anti-P-450 IV A l anti-serum 
(the antibody was raised in sheep by immunization with purified rat P450 LAl protein from 3-MC- 
induced rat liver microsomes by Dr. C. loannides, or purified P450 IV A l protein from clofibrate- 
induced rat liver microsomes in our laboratory). The polyclonal anti-P-450 LAl anti-serum 
recognizes both cytochrome P-450 lA l and IA2 isoenzymes. As shown in Figure 3.9, in spite of 
the significant non-specific inhibitory effects by the pre-immune serum, differences were still 
observed between 20 and 60mg antiserum/nmol P450. Higher amount o f antiserum per nmole P- 
450 in the incubation media resulted in no observed difference between the immune and pre- 
immune control (from 80 to 200 mg anti-serum/nmol P450). The results shown in Figure 3.9 
demonstrated that the formation of arachidonic acid metabolite peak I and peak III were both 
inhibited by anti-P450 LAl antibody, suggesting that P450s lA  contribute to the formation o f both 
peak I and peak III. However, it should be emphasized that, because o f the cross-reactivity of the 
used antibody between P450 lA l and IA2, the present study could not discriminate the 
contribution of P450 lA l and LA2 to the formation of metabolite peak I and peak III. This question 
can only be addressed by using monoclonal antibody or purified P450 LAl and IA2 proteins. No 
difference was observed in the inhibitory effects on peak I and peak III formation between anti- 
P450 LVAl and pre-immune anti-serum in the present study (data not shown).
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FIGURE 3.9 INHIBITION OF THE FORMATIONS OF METABOLITE 
PEAK I AND PEAK III BY POLYCLONAL ANTI-P450 lA l  
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The antibody inhibition study was carried out as described in section 3.2.2.1.2. The metabolites 
were separated on reverse-phase HPLC as described in section 2.2.2.4.2. The 100% absolute 
values o f peak I and peak III formation rates are: PI =187.6±14.3 pmoles/min/nmol P450; PIE = 
161.0±12.2 pmoles/min/nmole P450. The values are the means o f two determinations . *, p < 
0.05.
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3.4 DISCUSSION
In the present study, several monohydroxylated arachidonic acid metabolites (20-HETE, 19- 
HETE, 18-HETE, 17-HETE and 16-HETE) have been successfully generated and identified by 
HPLC and GC-MS techniques from the incubation systems o f various xenobiotic induced rat liver 
microsomes and have been shown to be cytochrome P450 dependent. The oxygenation o f  
arachidonic acid by the cytochrome P450-mediated monooxygenase system at the double bonds 
and the terminal and the 0)-l carbons has long been established, however the hydroxylation of
arachidonic acid by cytochrome P450s has rarely been reported at the C ig, C 17 and C 16 
positions. These three novel HETEs are believed to be reported the first time for liver microsomal 
preparation, but it should be noted that 18-HETE has recently been reported to be generated from 
monkey seminal vesicle microsomes (Oliw, 1989). Many o f the cytochrome P450 dependent 
metabolites o f arachidonic acid are of current research interest because o f the significant biological 
effects of these metabolites. The present study adds 18-HETE, 17-HETE and 16-HETE to this list 
and determination of their biological activity clearly remains an area of further study.
Arachidonic acid seems to be the single most interesting polyunsaturated fatty acid due to 
its oxidative metabolism to families of biological active agents, such as prostaglandins, 
thromboxanes and leukotrienes. This fatty acid substrate can be oxidized via three distinct 
m etabolism  pathways, v iz  cyclooxygenase, lipoxygenase and cytochrom e P450  
monooxygenases. The former two pathways have well been elucidated in the past years, the latter 
P450 monooxygenase pathway is of current interest, encouraged by both the discovery o f the 
important biological effects o f many o f the oxidative metabolites derived from this pathway and 
the recognition of the strict regioselective hydroxylation of this fatty acid substrate by cytochrome 
P450 isoenzym es, which in turn provides a useful model for the investigation o f the 
haemoprotein-mediated regioselectivity o f oxygenation.
The regio- and stereoselectivity of P450-mediated substrate oxygenation has long been 
recognized, such as in the stereoselective metabolism o f warfarin (Kaminsky et al., 1980), 
amphetamine (Cho and Wright, 1978) and regioselective epoxygenation o f various polycyclic
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aromatic hydrocarbons (Jerina et al, 1982). The spectral binding studies by Backes and Canady 
(1982) demonstrated sufficient accessibility o f small solvent molecules to cause perturbations in 
the heme spectmm for cytochrome P450 in microsomal preparations from PB-induced rats but not 
in the microsomes from untreated rats. These studies provided the earliest evidence that 
differences in the active site architecture existed among various P450 isoenzymes. Another close 
example o f the regioselective hydroxylation o f arachidonic acid hydroxylation is P450-mediated 
prostaglandin hydroxylation. Similar site-specific hydroxylation o f prostaglandin Ei and E2 has 
also been demonstrated at C17 (Kupfer et a/., 1988), Gig (Holm et a/., 1985) and C19 (Kupfer et 
fl/., 1988) positions by 3-MC-induced P450 isoenzymes.
Recent reports of the vasoconstrictor effect and stimulation of Na+/K+-ATPase by 20-HETE 
and 19-HETE respectively (Schwartzman et al., 1989; Escanlante et a/., 1988) have suggested 
that cytochrome P450-mediated fatty acid hydroxylation at the terminal and adjacent sp  ^carbons 
is nott)nly a catabolic process but may be of important physiological significance. The results 
presented in the this Chapter and Chapter 2 clearly indicate that PENCB and 3-MC pretreatment 
results in the induction o f cytochrome P450 isoenzyme(s) mainly responsible for the co-l- 
hydroxylation of arachidonic acid, (particularly PENCB pretreatment), and 18-, 17- and 16- 
hydroxylation o f arachidonic acid . It is still unknown whether the induction o f these metabolite 
formations has anything to do with the toxicity of these xenobiotics. Obviously, the analysis of 
the biological activities of these newly identified metabolites is of potential interest.
Again when my work was on-going, Falck et al (1990) reported the regioselective 
hydroxylation o f arachidonic acid to 19-HETE, 18-HETE, 17-HETE and 16-HETE by |3- 
naphthoflavone-induced rat liver microsomal preparation. Antibody inhibitory study o f  
arachidonic acid hydroxylation shows that both peak 1 (19-HETE) and peak 111 (mixture o f 18-, 
17- and 16-HETEs) are inhibitable by polyclonal cytochrome P450 LAl antiserum, indicating that 
both 19-, 18-, 17- and 16-hydroxylations are catalysed by P450 lA l or probably P450 1A2 as 
well, since the presently used anti-P450 lA l antibody can also recognise 1A2 protein. This 
property of P450 1A1(2) has also been confirmed by using the reconstituted purified P450
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isoenzymes systems (Falck era/., 1990). It therefore can be concluded that 19-hydroxylation of 
arachidonic acid is mainly regulated by cytochrome P450 lA l and IA2 isoenzymes, although 
other P450 isoenzyme may more or less contribute to this reaction.
In conclusion, the regioselective hydroxylation o f arachidonic acid is strictly controlled by 
cytochrome P450 isoenzymes in a protein specific fashion. The present study has successfully 
generated and identified three novel arachidonic acid metabolites, the 18-HETE, 17-HETE and 
16-HETE.
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************ CHAPTER 4 ************
DIFFERENTIAL INDUCTION OF CYTOCHROME 
P-450 AND CYTOCHROME P-450 DEPENDENT 
ARACHIDONIC ACID METABOLISM BY 3,4,5,3’,4'- 
PENTACHLOROBIPHENYL IN THE RAT AND GUINEA 
PIG
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4.1 INTR O D U C TIO N
3,4,5,3',4'-Pentachlorobiphenyl (PENCB), one of the most toxic PCB isomers identified so 
far, possesses a coplanar structure o f two phenyl rings and, when given to animals, induces a 
pattern o f  drug-metabolizing enzym es resembling that seen after treatment with 3- 
methylcholanthrene (3-MC) (Goldstein et al., 1977; Yoshimura et al., 1978). This pattern is 
characterized by induction o f the cytochrome P-450 lA l and IA2 family, by greatly enhanced 7- 
ethoxyresorufin O-deethylase (EROD) and aryl hydrocarbon hydroxylase (AHH) activities, and 
by a shift in the absorption maximum o f the CO-binding difference spectrum to 448 nm 
(Yoshimura er a/., 1979; Ozawa er a/., 1979a; Ozawa er a/., 1979b).
However, like its dioxin counterpart, TCDD, the biological mechanism mediating its toxicity 
is still obscure. Although the Ah receptor-mediated toxicity of TCDD and coplanar PCBs is 
generally accepted in certain species such as the rat and the mouse, this hypothesis is frequently 
challenged by contradictory evidence in other species (Gasiewicz and Rucci, 1984; Rozman et al., 
1985; Henry and Gasiewicz, 1986; Griem and Rozman, 1987; Pohjanvirta et al., 1987; 
Pohjanvirta et al., 1988). For example, in the guinea pig, comparable Ah receptor levels and 
binding affinities have been noted (Gasiewicz and Rucci, 1984; Roberts e ta l. ,  1989), but higher 
resistance to induction of the cytochrome P-450 lA  sub-family has cast some doubt on the role of 
induction o f this sub-family in toxicity (Holcomb et al., 1988). In addition, no detectable 
differences have been observed in the specific binding sites (Ah-receptor) and the induction of 
EROD activity, total liver microsomal cytochrome P-450 content or the specific P450 lA l content 
after TCDD pretreatment in Han/Wistar and Long-Evans rats, which differ w idely in their 
susceptibility to the lethal effects of TCDD (Pohjanvirta er a/., 1988).
Although the precise reason(s) for these differential susceptibilities are far from clear, it is 
possible that the constitutive and PCB-inducible complement o f cytochrome P450s in the two 
species may play a role in toxicity. For example, it is well known that the cytochrome P450 gene 
family (Nebert et al., 1987) consists o f many isoenzymes and the treatment o f different species 
with xenobiotic inducers results in the inductive expression o f certain isoenzym es and the
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concomitant suppression o f others (Adams et a l ,  1985; Yeowell et a l ,  1989). Thus the alteration 
o f constitutive cytochrome P450s represents a substantial change in either cytochrome P450- 
dependent endogenous substrate metabolism (Gibson and Bains, 1985) or the ability to degrade 
xenobiotics (Adams e t aL, 1985), either o f  which in turn may cause toxicity to the animal. For 
example, it has been recognised in recent years that arachidonic acid is an excellent substrate for 
the cytochrome P450s, the biotransformation o f this fatty acid being highly regioselective and 
critically dependent on the prevailing cytochrome P450 isoenzyme complement (Capdevila et a l ,  
1985; Oliw et al., 1982). These hydroxy and epoxy arachidonic acid metabolites have significant 
biological activity (Falck gr a/., 1983; Schwartzman et al., 1990) and may contribute to the 
toxicity o f PCBs either directly or by indirect perturbation of critical cellular processes.
Accordingly, it is the purpose of the present study to determine the influence o f a toxic PCB 
isomer (PENCB) on the cytochrome P450 induction profile in the rat and guinea pig and the 
biotransformation o f arachidonic acid.
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4.2 M ATERIALS AND M ETHODS
4.2.1 M A TERIALS
4 .2 .1 .1  C H E M I C A L S
3,4,5,3'j4'-Pentachlorobiphenyl (99% pure) was purchased from the Greyhound 
Chromatography and Allied Chemical Co. (Birkenhead, Merseyside, U.K.). Arachidonic acid, 
horseradish peroxidase-labelled donkey anti-sheep antibody and NADPH were obtained from the 
Sigma Company (Poole, U. K.). 7-Ethoxyresorufin, 7-pentoxyresorufin and resorufin were 
bought from BCL, Boehringer (East Sussex, U. K ). [ 1 -^^C]- Arachidonic acid was purchased 
from the Radiochemical Centre (Amersham, U. K.). A ll other chemicals were obtained from 
commercial sources and were of the highest purity available.
4.2.1.2 A N IM A L S  A N D  A N IM A L  P R E T R E A T M E N T S
Male wistar albino rats (100-120 g body weight. University o f Surrey Breeders, U. K.) were 
pretreated with a single dose {i.p.) o f PENCB dissolved in com oil at a series o f dose levels of 
0.0, 0.5, 1.0, 3.0, 5.0, 10.0 and 15.0 mg/kg. Male Dunkin Hartley guinea pigs (130-190 g body 
weight. University o f Surrey Breeders, U. K.) were given a single dose o f  PENCB at the 
following dose levels: 0.000, 0.025, 0.050, 0.100, 0.300, 0.500 and 1.000 mg/kg. The animals 
were kept at 25°C on a 12 hour light/12 hour dark cycle with water and food provided ad libitum.
4.2.2 M ETH O DS
The determinations o f microsomal cytochrome P450, protein concentrations and the 
metabolism of arachidonic acid were carried out exactly the same as described in sections 2 .2 .2 .2 ,
2.2.2.3 and 2.2.2.4 respectively. Additional methods include the followings.
^ .2 2 .1  IS O L A T IO N  OF LIVER M IC R O SO M E S
The animals were killed 5 days after treatment by decapitation. The livers were quickly 
removed and washed in 0.9% (w/v) ice-cold NaCl solution, blotted dry and weighed. The livers 
were scissor-minced in ice-cold 0.25 M sucrose and 25% (w/v) homogenates were then prepared. 
A ll other performances were carried out at 4°C. After spinning at 10,(XK)xg for 20 minutes, the 
subsequent supernatant was further centrifuged at 1 0 0 ,0 0 0 xg for 60 minutes, the resulting
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microsomal pellets resuspended in the original volume o f 50 mM Tris HCl buffer, pH 7.5, 
containing 20% (v/v) glycerol, and stored at -70^C before use without significant loss o f enzyme 
activity.
4.2.2.2 7 ~ E T H 0 X Y R E S 0 R U F IN  O -D E E T H Y L A SE  (E R O D ) A S S A Y  
7-Ethoxyresorufin O-deethylase activity was measured spectrofluoiimetrically according to
the method of Burke et al (1974) by monitoring the rate o f formation o f the fluorescent resorufin 
product.
The assay system contained 2 ml o f 0.1 M Tris-HCl buffer (pH 7.8), 5 mM substrate (7- 
ethoxyresorufin) in DMSO and appropriate amounts o f  microsomal protein. The assay was 
performed in the thermostatically controlled cuvette chamber o f a Perkin-Elmer MPF-3 
fluoiimeter, set at an excitation wavelength o f 510 nm and an emission wavelength o f 586 nm. 
After preincubation at 37°C for about 2 minutes and the establishment o f a steady baseline, the 
reaction was initiated with 25 [Û o f 20 mM NADPH in 1% (w/v) NaHCOg and the production of 
resorufin with time was monitored as an increase in fluorescence at 586 nm. The fluorimeter 
response was calibrated with an authentic resorufin standard.
4.2 .2 .3  W E S T E R N  B L O T  A N A L Y S IS
Western blot analysis involves the techniques o f the sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-Page) separation o f the solubilised microsomal proteins 
by the method of Laemmli (1970), and the electrophoretic transfer o f the separated proteins onto 
nitrocellulose sheets which are then immunostained with the corresponding antibody. The method 
employed was a modification of the procedures o f Towbin et al (1979) and Burnette (1981).
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4.2.2.3.1 Sodium  dodecy l po lyacry lam ide  g e l  e lectrophoresis
Reagents: Acrylamide (30% w/v acrylamide);
Bisacrylagel (2% w/v NJ^-methylene-bis-acrylamide);
Separating gel buffer: 1.5 M Tris-HCl, pH 8.8, containing 0.4% 
(w/v)SDS;
Stacking gel buffer: 0.5 M Tris-HCl, pH 6.8, containing 0.4%
(w/v) SDS;
Electrophoretic buffer: 2.5 mM Tris-HCl, pH 8.3, containing 
192 mM glycine and 1 % (w/v)SDS;
Sample solubilisation buffer: 62.5 mM Tris-HCl, pH 6.8,
containing 2.3% (w/v) SDS,15% (v/v) glycerol, 5% (v/v) 
2-mercaptoethanol and 0.001% (w/v) bromophenol blue;
Ammonium persulphate 10% (w/v);
N, N-tetramethylethylethylenediamine (TEMED);
Prestained molecular weight markers (MW-SDS-blue) consisting of:
Protein Approximate MW
(daltons)
Macroglobulin 180,000
P-Galactosidase 116,000 .
Fructose-6-phosphate kinase 84,000
Pyruvate kinase 58,000
Fumarase 48,000
Lactate dehydrogenase 36,500
Triosephosphate isomerase 26,600
Liver microsomal proteins were diluted with sample buffer to give a solution o f 1 mg 
protein per ml. The solubilised proteins were then boiled for approximately 1 minute to render 
them monomeric. Electrophoresis was performed at room temperature using a vertical slab gel 
assembly, in which the gel was contained in a glass and perspex cassette o f internal dimensions 
120 mm X 160 mm x 1.5 mm. The glass plates were washed in sequence with detergent, tap 
water, distilled water and then acetone prior to use.
The cassettes were clamped in a vertical position and sealed with 2% (w/v) agar. The lower 
separating gel was prepared by m ixing acrylamide, bis-acrylamide separating gel buffer and 
distilled water to give a 10% (w/v) aciylamide/0.27% (w/v) bis-acrylamide gel containing 0.1% 
(w/v) SDS. The polymerisation process was initiated by the addition o f freshly prepared 
ammonium persulphate(10% w/v) and finally TEMED. This solution was then poured into the 
cassette to a height o f approximately 120 mm. Distiled water was gently layered above the gel 
mixture to ensure a smooth interface.
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After completion o f the polymerisation process, the water layer was removed and replaced by 
the stacking gel which is ideally o f a height o f 25 to 30 mm to ensure a tight stacking o f the 
proteins before entering the separating gel. The stacking (upper) gel was prepared by mixing 
acrylamide, bis-acrylamide, stacking gel buffer and distilled water to give a 3 % (w/v) 
acrylamide/0.08% (w/v) bis-acrylamide gel containing 0.1% (w/v) SDS. Polymerisation was 
initiated as before and the wells were formed by the introduction o f a perspex comb.
After polymerisation, the bottom edge spacer and sample comb were removed and the gel 
slab was stationed in the electrophoresis tank. Electrophoresis buffer was poured into the anode 
and cathode reservoirs and any air bubbles trapped in the sample wells and/or underneath the gel 
were removed with a syringe and fine tubing.
The solubilised microsomal proteins were loaded on an equivalent protein basis using a 
Hamilton syringe. Samples were run under a 20 mA constant current and increased to 40 mA once 
the bromophenol indicator entered the separating gel. The samples were run until the indicator dye 
was within 0.5 cm of the bottom of the gel.
The lower separating gel was cut out and either stained overnight in propan-2 -ol/acetic acid/ 
water (25 : 10 : 65, v/v/v) containing 0.05% (w/v) coomassie brilliant blue R-250 or transferred to 
a sheet o f nitrocellulose as described below. The de staining was achieved by successive washes 
with destaining solution (propan-2 -ol/acetic acid/water = 1:1:8 , by volume).
4 .2 .2 .3 .2  E le c tro p h o re tic  tra n sfer
On completion of gel electrophoresis, the separating gel was cut out and immersed in transfer 
buffer (20 mM Tris-HCl buffer, pH 8.3, 150 mM glycine, 20% (v/v) methanol) for 30 to 40  
minutes to allow any shrinkage to occur prior to transfer which avoided diffusion o f the protein 
band during the transfer process.
The transfer was achieved by the use o f a plastic sandwich apparatus. The pre-shrunk gel 
was placed on two sheets o f Whatman filter paper (3 mm) immersed in transfer buffer. A  sheet of 
nitrocellulose paper was then placed on the top o f the gel and then followed by two more sheets of 
filter paper. The whole assembly was then sandwiched between two Scotch Bride pads supported
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by a rigid plastic grid. It is important to ensure that no air bubbles are trapped between the filter 
and the gel since this may lead to low efficiency o f transfer and band distortion occurring in such 
areas. This assembly was immobilised in the electrophoresis transfer apparatus (filled with 
transfer buffer). The transfer was carried out at a 60 volts constant voltage for 3 hours. 
Subsequent staining o f the polyacrylamide gel with coomassie brilliant blue R-250 demonstrated 
that all detectable protein had been transferred under these conditions.
4.2.2.3.3 Im m u n o ch em ica l  s ta in in g
After electrophoretic transfer, the nitrocellulose sheet was blotted in phosphate-buffered 
saline containing 1% (w/v) bovine serum albumin and 0.2% (v/v) Triton X -100 (PB SET) 
overnight at 4°C. The nitrocellulose sheet was then washed twice with 50 ml o f fresh PBSBT for 
15 minutes followed by 60 minutes incubation with fresh PBSBT containing the primary antibody 
(anti-P-450 lA l — 1:4,000 dilution, anti-P-450 IV A l — 1:10,000 dilution). The sheet was then 
washed three times for 15 minutes with fresh PBSBT. The second antibody (donkey anti-sheep 
for anti-P-450 LAI and P-450 IV A l) (working dilution o f 1:1,000 as indicated by the producer) 
was labelled with the enzyme horseradish peroxidase. The nitrocellulose sheet was incubated with 
PBSBT containing this second antibody for 90 minutes followed by two 15 minute washes with 
fresh PBSBT alone and finally one 10 minute wash with PBS before being developed in 0.1 M 
Tris-HCl buffer (pH 7.5) containing 0.5 mg*mL  ^diaminobenzidine chloride and 1:5000 hydrogen 
peroxide (H2O2). The reaction was terminated by replacing the substrate buffer with distilled 
water.
4 .2  2.4  EN Z Y M E -L IN K E D  IM M U N O A B SO R B E N T  A S S A Y  (E LISA ) F O R  
CYTOCHROME P450 INDUCTION
The technique o f ELISA was performed as described by Voiler et al (1978) as modified by 
Sharma er f l / (1988).
The microsomal proteins were solubilised with Emulgen 911 and cholate (0.2 mg Emulgen 
911 and 2 mg cholate per 1 mg microsomal proteins) with stirring on ice for 20 minutes. The 
solubilised proteins were then properly diluted to required concentration with coating buffer (0 .1
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M NaHC0 3 /Na2C0 3 , pH 9.6), and 200 |il/well of the diluted proteins were loaded onto microtitre 
plates. The plates were left at overnight 4°C in a humid box to absorb protein onto the plates.
The coated plates were washed with phosphate buffered saline (pH 7.4), containing 0.1% 
gelatin and 0.05% Tween 20 (PBSGT) using a microtitre washer. The primary antibody (anti- 
P450) was diluted to the required working concentration with PBSGT and 200 |il o f the diluted 
antibody was added to each well and incubated at 37°C for 2 hour before another wash with 
PBSGT. The second antibody (with horse radish peroxidase label) was diluted as required with 
PBSGT and 200 jil was added to each well and incubated at 37°C for another 2 hours.
The substrate, orthophenylenediamine, 30 mg , was dissolved in 75 ml o f 0.025 M citric 
acid, 0.05 M Na2HP0 4  buffer, pH 5.6, containing 30 |il (30% v/v) o f hydrogen peroxide. After 
another PBSGT wash, 150 |i l o f substrate was loaded per well and the plates were further 
incubated at 37°C for 15 to 30 minutes to let the colour reaction develop and then 50 |il o f 2.5 M  
H2SO4 was added to terminate the reaction. The absorbance was read at 492 nm.
The required working dilution o f solubilised protein was determined by running an 
appropriate reaction/protein content curve. Usually, two different protein contents were chosen 
within the linear range and each run in duplicate with corresponding anti-P450 antibody blank as 
controls. The absorbance value was corrected for by the corresponding control value and the 
specific content o f P450 (nmol/mg) was calculated from the pure P450 calibration curve. If the 
pure P450 protein was available, these were run on the same plate as the samples.
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4.3 R ESU LTS
4.3.1 IN D U C T IO N  OF C YT O C H R O M E  P-450  A N D  M O N O O X Y G E N A SE
ACTIVITIES
Figure 4.1 shows the induction o f cytochrome P-450 in the rat and the guinea pig by a series 
o f dose levels o f PENCB. The maximum induction o f P-450 in the rat and the guinea pig were 
obtained at approximately 5 mg/kg and 0.1 mg/kg respectively, which were induced up to 338% 
and 200% o f the corresponding control values. Higher dose levels o f PENCB did not show any 
further induction in the cytochrome P-450 content, indicating a saturation phenomenon. Results 
presented in Figure 4.1 demonstrated that cytochrome P-450 was readily inducible in the guinea 
pig, even though the fold induction versus the corresponding control was less in the guinea pig 
than in the rat.
Figure 4.2 shows the CO-difference binding spectra o f the dithionite-reduced microsomes 
from rat and guinea pig livers and their corresponding PENCB-induced counterparts. Whereas the 
PENCB-induced rat liver microsomes, after reduction by dithionite and binding with CO, showed 
a characteristic shift o f the absorption maximum from 450 nm to 448 nm, the PENCB-induced 
guinea pig liver microsomes did not show any shift o f the absorption maximum of the dithionite- 
reduced CO-adduct, which is suggestive that P450 isoenzymes other than the P450IA family was 
responsible for the induction in this latter species.
The 0-deethylation of 7-ethoxyresorufin is preferentially catalysed by cytochrome P-448 
(or lA  family) (Burke et al, 1974). PENCB-induced rat liver microsomes demonstrated a large 
increase in EROD activity, induced for up to 60 fold o f the control value (Figure 4.3 A). By 
contrast, the guinea pig was less susceptible to induction o f EROD activity. As shown in Figure
4.3 B, even though the EROD activity was significantly induced in the guinea pig, the fold o f the 
increase in the EROD activity was significantly lower in the guinea pig than in the rat.
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FIG U R E 4.1. THE IN D U CTIO N  OF C Y TO CH RO M E P-450 BY 3,4,5 ,3',4 ' 
PENTACH LO R O BIPH ENYL IN THE RAT AND THE GUINEA PIG  
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The total cytochrome P-450 content o f control and PENCB induced rat 
and guinea pig liver microsomes were quantitated as described under 
section 2.2.2.4. Results are expressed as the mean ±  SD o f 3 animals.
*, p < 0.05; p <0 . 0 1 ;  * * * , p <  0.001.
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FIG U R E 4.2. SPEC TR O PH O TO M ETR IC  SC A N N IN G  OF M IC RO SO M A L  
C Y T O C H R O M E  P -4 5 0  F R O M  C O N T R O L  A N D  3 , 4 ,5 ,3 ' , 4 ‘- 
PEN TA CH LO R O BIPH EN Y L INDUCED RAT AND G UINEA PIG LIVERS
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The spectral features o f control and PENCB induced rat and guinea pig 
liver microsomes were scanned using a UV Kontron spectrophotometer as 
described under section 2.2.2.2. The absorption maximum was detected 
by using the peak detection mode. The numbers in brackets represent the 
protein concentrations of the corresponding microsomal solutions.
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FIG U R E 4.3 : THE EFFECTS OF 3 ,4 ,5 ,3 ’,4'-PE N T A C H L G R G B IPH E N Y L  
PRETREATM ENT GN HEPATIC CYTOCHROM E P-450- DEPENDENT  
M O NG XY G ENA SE ACTIVITY IN THE RAT AND GUINEA PIG
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7-Ethoxyresorufin O-deethylase (EROD) activity was determined from 
the 100,000 g microsomal pellets as described under section 4.2.2.2 at 
37°C. Each sample was determined in duplicate. Results are expressed 
as mean ±  SD of 3 animals.
*, p < 0.05; **, p < 0.01; ***, p < 0.001.
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4.3.2 SD S -P A G E  A N D  IM M U N O B L O T  A N A L Y S IS
Results presented in the last section demonstrated that although the total cytochrome P-450 
content in the guinea pig was significantly induced by PENCB at the given dose levels as 
compared to control (Figure 4.1 B), differences were observed between rat and guinea pig in the 
spectral analysis (Figure 4.2) and the catalytic activity (EROD) (Figure 4.3). Western blot analysis 
o f control and PENCB induced rat and guinea pig liver microsomes with antibodies to 
cytochrome P-450 lA l and IV A l are shown in Figures 4.4 and 4.5 respectively. As positive 
controls, 3-MC and clofibrate induced rat liver microsomes, which are specific cytochrome P-450 
LAl and IVA l inducers respectively, are also included on each blot. As shown in Figure 4.4, anti- 
P450 lA l antibody recognised two partially separated bands from 3-MC induced rat liver 
microsomes (track 2), according to Thomas et al (1984), the top band was identified as P450 LAl 
and the bottom band as P450 IA2. The presently used anti-P450 lA l antibody could only 
recognise one single band from control and clofibrate induced rat liver microsomes, which was 
identified as P450 LA2 as compared with track 2. The P450 LAl band was not identifiable from 
either control or clofibrate induced rat liver microsomes even though at much higher amounts of 
proteins loaded (20 |ig  proteins as compared to 2.5 p,g proteins in tracks 2 and 3). PENCB 
treatment significantly induced both cytochromes P450 LAl and LA2 jfiom the rat (track 3). Control 
guinea pig liver microsomes showed only one identifiable band with a relatively low molecular 
weight as compared to the rat liver cytochrome P450 lA l and LA2 proteins. PENCB-induced 
guinea pig liver microsomes shown two clearly separated bands (track 4). It should be noted that 
guinea pig cytochrome P450 LAl has a lower molecular weight and moves faster in the SDS- 
PAGE than its IA2 protein (Thomas et al., 1984), accordingly the single band in track 6  (control 
guinea pig) probably represents cytochrome P450 lA l. By comparison, PENCB treatment results 
mainly in the induction o f P450 LA2 protein in the guinea pig. It should be noted that the 
induction of cytochrome P450 LA2 or LAl was much lower in the guinea pig than in the rat (2.5 
Hg proteins in track 3 versus 20 pg proteins in tracks 4 and 6 ).
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Western blot analysis with anti-P-450 IVAl antibody showed a significant inhibition of P- 
450 IV A l content by PENCB in the rat as shown in Figure 4.5, in which anti-P-450 IVAl failed 
to recognise any band from PENCB induced rat liver microsomes. By contrast, PENCB induced 
guinea pig liver microsomes show increased interaction with this antibody as compared with 
corresponding controls, indicating an induction o f this isoenzyme in the guinea pig by this 
inducer.
FIGURE 4.4 W ESTERN BLOT ANALYSIS OF CONTROL AND PENCB  
INDUCED RAT AND GUINEA PIG LIVER M ICRO SO M ES W ITH ANTI- 
P450 lA I  PO LYCLO NAL ANTIBODY
20 pg solubilised microsomal proteins were loaded in tracks 1,4,5 and 6 ; 2.5 pg 
solubilised microsomal proteins were loaded in tracks 2 and 3.
Track numbers: 1, control rat; 2, 3-MC rat; 3,PENCB rat; 4, PENCB guinea pig; 
5, clofibrate rat; 6 , control guinea pig.
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FIGURE 4.5 W ESTERN BLOT ANALYSIS OF CONTROL AND PENCB  
INDUCED RAT AND GUINEA PIG LIVER M ICRO SO M ES W ITH ANTI- 
P450 IV A l A NTIBO DY
1 4
10 pg solubilised microsomal proteins were loaded in each track.
Track numbers: 1, control rat; 2, 3-MC rat; 3, PENCB rat; 4 -  PENCB guinea pig; 
5, clofibrate rat; 6 ,control guinea pig.
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4.3.3 E N Z Y M E -L IN K E D  IM M U N O A B S O R B E N T  A S S A Y  (E LISA ) FO R  
C Y T O C H R O M E  F 450 IN D U C T IO N
Results from a quantitative ELISA analysis o f the induction profile (Figure 4.6) are in a 
good agreement with the western blot data above. No statistical differences were observed for the 
specific contents o f both P450 lA l or IV A l between control rats and control guinea pigs. P450 
lA l was induced up to 56 fold in the rat, but only 2.5 fold in the guinea pig after PENCB 
pretreatment. P450 IV A l apoprotein content was slightly reduced in the rat after PENCB 
pretreatment, but was not statistically significant. However, P450 IV A l was induced up to 1.6 
fold in the guinea pig with the same inducer.
4.3.4 TOXICITY OF PENCB IN  THE R A T  A N D  GUINEA PIG  A F T E R  A
SINGLE ip .  INJECTION
In the present study, rats and guinea pigs were divided into groups, with 3 animals in each 
group. The animals were all given a single i.p. dose o f  PENCB dissolved in corn oil in two 
predetermined dose series as described under Section 4.2.1.2 and observed for 5 days before 
killing. The body weight gain was monitored daily. Figure 4.7 shows the total body weight 
change in 5 days o f experiment. Control rats and guinea pigs gained approximately 40 and 75 
grams in their body weight respectively in 5 days. In the experimental groups, a dose-dependent 
decrease o f body weight gain was observed in both rats and guinea pigs. The guinea pigs seem 
much more susceptible to this toxic effect although at much lower doses as compared to the rats. 
At doses above 0.3 mg/kg, the guinea pig demonstrated severe body weight loss (negative body 
weight gain). Other clinical symptoms were not monitored in the present experiment except 
obvious signs of weakness in the experimental groups, particularly in the higher dose groups of  
guinea pigs. No animals died in this 5 day experiment.
106
FIG U R E 4.6. EN ZYM E-LIN K ED  IM M U NO SO R BENT ASSA Y (ELISA)
OF CONTRO L AND PENCB-INDUCED RAT AND GUINEA PIG LIVER  
M ICRO SO M ES W ITH  PO LYCLO NAL A NTI-P450 l A l  AND IV A l ANTIBO DIES.
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Results are expressed as percentage o f corresponding control values. ELISA  
determinations were carried out with antibodies to P450 LAl (A) or P450 IVA l (B).
*: p < 0.05; ***: p < 0.001. 100% of absolute values o f P450 IV A l for rats and guinea 
pig are: rats, 35.65±4.53 pmoles/mg; guinea pigs, 40.78+5.23 pmoles/mg. The 100% 
absolute values o f P450 lA l for rats and guinea pigs are not available because o f lack o f  
pure cytochrome P450 lA l protein. The results can only be expressed as absorbance 
units per jig microsomal proteins.
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FIG URE 4.7 BODY W EIGHT GAINS AFTER A SING LE DOSE  
OF PENCB IN THE RAT AND THE GUINEA PIG
ECS
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The animals were treated with a single dose o f PENCB as outlined in section 
4.2.1.2. The values are expressed as the mean ±SD of three animals o f the body 
weight gains in 5 days o f treatments.
*, p < 0.05; p < 0.01; ***, p < 0.001.
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4.3.5 C H A R A C TE R IZA TIO N  OF A R A C H ID O N IC  A C ID  M E T A B O L ISM
Figures 4.8 and 4.9 show the reverse phase HPLC elution profiles o f the radioactive products 
generated during the NADPH-dependent oxidation o f arachidonic acid by control and PENCB- 
pretreated rat and guinea pig microsomal preparations. Identical amounts o f the various incubation 
extracts were injected onto the HPLC column, thus allowing semi-quantitative comparisons to be 
made. Pretreatment o f the rat with PENCB (5 mg/kg) resulted in dramatic changes in the 
arachidonic acid metabolite profile catalysed by the microsomal fractions (Figure 4.8). Whereas 
the formation o f peak I and peak m  dramatically increased on PENCB pretreatment, the formation 
o f other arachidonic acid metabolites were concomitantly suppressed, particularly the epoxide 
metabolites (EETs). Peak I and Peak II have been identified as 19-hydroxyeicosatetraenoic acid 
(19-HETE) and 20-hydroxyeicosatetraenoic acid (20-HETE) respectively (see Chapter 3). As 
demonstrated in Figure 4.9B and Table 4.1, the formation of 20-HETE was increased two-fold in 
the guinea pig on PENCB pretreatment, whereas the formation o f 19-HETE was hardly affected 
in this species.
Figures 4.8 and 4.9 indicate that, in addition to significant induction o f peaks I and II, 
PENCB-induced rat and guinea pig liver microsomes both significantly induced the formation of 
peak III. Moreover, unlike PENCB-induced rat liver microsomes, PENCB-induced guinea pig 
microsomes did not demonstrate any inhibition o f the formation o f  epoxides or other HETEs 
(Figure 4.9 A & B and Table 4.1). Peak III from PENCB-induced rat liver microsomal 
incubations has previously been shown to consist o f three components, namely the 18-HETE, 17- 
HETE and 16-HETE metabolites (see Chapter 3). The equivalent peak III derived from PENCB- 
induced guinea pig liver microsomal incubations has not been further identified to date, however it 
is a much thinner and sharper peak shape than that from PENCB induced rat, which is suggestive 
that one particular component o f the three HETEs (18-HETE, 17-HETE and 16-HETE) may 
represent the majority of this peak.
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FIG URE 4.8: R EV ER SE-PH ASE SEPARA TIO N OF ARA C H ID O N IC  ACID  
M ETABO LITES GENERATED BY  CONTROL AND PEN C B- IND U CED  RAT  
LIVER M ICRO SO M ES IN  THE PRESENCE OF NADPH
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Arachidonic acid (0.25 |iC i/|im ol) (0.5 mM) was incubated with 2 mg o f microsomal 
protein for 15 minutes in the presence o f NADPH and 0%. The reaction was terminated
with 100 p.1 HCl and the metabolites extracted three times with 4 ml ethyl acetate. The
combined extracts were dried under N2 and finally dissolved in 250 |il o f ethanol and 100
p.1 injected onto the ODS Gig column and separated as described under section 2.2.2.4. 
Abbreviations used are AA: arachidonic acid; EET: epoxyeicosatrienoic acid; HETE: 
hydroxyeicosatetraenoic acid.
110
FIG URE 4.9: R EVER SE-PH ASE SEPA RA TIO N OF A R A C H IDO NIC  ACID  
M ETABO LITES G ENERATED BY CONTROL AND PEN C B-IND UC ED GUINEA  
PIG LIVER M ICRO SO M ES IN THE PRESENCE OF NADPH  
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Arachidonic acid (0.25 }iCi/|imol) (0.5 mM) was incubated with 2 mg o f microsomal 
protein for 15 minutes in the presence o f NADPH and O2 . The reaction was terminated
with 100 fil HCl and the metabolites extracted three times with 4 ml ethyl acetate. The
combined extracts were dried under N2 and finally dissolved in 250 fil of ethanol and 100
j i l  injected onto the ODS Cig column and separated as described under section 2.2.2.4. 
Abbreviations used are A A: arachidonic acid; EET: epoxyeicosatrienoic acid; HETE: 
hydroxyeicosatetraenoic acid; DHETE: dihydroxyeicosatetraenoic acid.
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TABLE 4.1. Q UA NTITATIO N OF ARACH IDO NIC ACID M ETA BO LISM  
C A TA LY SED  BY C O N TRO L AND 3 ,4 ,5 ,3 \4 -P E N T A C H L O R O B IP H E N Y L  
(PENCB) IND UCED  RAT AND GUINEA PIG LIVER M IC RO SO M ES.
METABOLIC
PRODUCTS
CONTROL
RAT
PENCB
RAT
CONTROL 
GUINEA PIG
PENCB 
GUINEA PIG
PEAK I 
(19-HETE)
73+8 329±17*** 64±7 8115
PEAK II 
(20-HETE)
101+11 12±1*** 96111 242116**
PEAK III 
(18,17,16-HETEs)
62±17 318±8*** 120127 45815***
EPOXIDE 414±9 119110*'''' 263128 324149
TOTAL 1565±227 1170+18** 1445+204 2485132* * *
The quantitation o f arachidonic acid metabolism was determined in duplicate by collecting the 
corresponding peak fractions and counting by scintillation spectrometry. A ll results are 
expressed as mean ±  SD of three animals as pmol product formed/min/mg o f protein at 37°C. 
*** P <  0.001; ** P <  0.01.
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4.4 DISCUSSION
Results presented in this chapter indicate the differential induction of cytochrome P-450 by 
PENCB in the rat and the guinea pig. PENCB is a potent MC-type inducer, dramatically induces 
the cytochrome P-450 lA  family, with a characteristic Soret peak at 448 nm of CO-bound reduced 
hemoprotein (Ozawa et al, 1979a; Ozawa et al, 1979b), and significantly induces 7- 
ethoxyresorufin O-deethylase activity (Brustrom and Anderson, 1988) and aryl hydrocarbon 
hydroxylase activity (Nagata et al, 1985). The present study has confirmed this characteristic 
potency in the rat where P-448 and EROD activity were induced up to 4 and 60 fold respectively 
compared to the corresponding controls.
As compared to the rat, the guinea pig is a much more susceptible species to the toxicity o f  
PCBs (Griem and Rozman, 1987; Poland and Knutson, 1982), the body weight loss in the guinea 
pig was much more severe than the rat even at much lower dose levels as demonstrated in Figure 
4.7. Cytochrome P-450, in spite of being induced to 2 fold o f the control value, did not show a 
shift of the Soret peak from 450 nm to 448 nm as was expected, which strongly indicated that P- 
450 isoenzymes other than the lA  sub-family might be induced, or PENCB-induced guinea pig P- 
450 might be structurally different from the lA sub-family of the rat.
Further evidence of the differential induction between the two species can be seen from the 
EROD activities. As shown in Figure 4.3, the EROD activity was increased nearly 60 fold in the 
rat, but only less than 5 fold in the guinea pig (Fig 4.3 B) in terms o f pmoles/min/ nmol o f P-450. 
The induction o f EROD activity in the guinea pig may be largely contributed by the induction of 
cytochrome P450 IA2 as demonstrated by western blot analysis (Figure 4.4), cytochrome P450 
LAl was hardly induced by PENCB treatment in the present study. Obviously, the difference 
between the dose levels used in the present study could not be accounted for the difference in the 
EROD activity since further higher doses in both rat and guinea pig did not result in higher P-450 
induction, but resulted in more severe body weight loss in the guinea pig. The results from the 
present study have confirmed this dissociation o f cytochrome P-448 induction with PCB (Rifkind 
and Muschick, 1983; Rifkind et al 1985) or TCDD (Rozman et al, 1985; Henry e t al, 1986)
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toxicity which was reported previously. Low inducibility of hepatic microsomal EROD activity, 
by TCDD, in the guinea pig has also been reported previously (Holcomb and Safe, 1988), 
however the reasons for this low inducibility are still unknown. It is possible that ethoxyresorufin 
might be a poor substrate for the induced P-450 isoenzymes in the guinea pig or that the 
induced cytochrome P-450 orthologue may have a different antigenicity from that o f lA l or IA2 in 
the rat. This dissociation o f cytochrome P450 lA  induction from the lethal effects o f TCDD has 
also been observed between two different strains o f rats (Pohjanvirta et al., 1988). In order to 
further substantiate this dissociation, I have employed the immunoblot technique using polyclonal 
antibodies against cytochrome P-450 lA l and IV A l. As shown in Figure 4.4, PENCE treatment 
markedly induced both cytochrome P450 lA l (top band) and IA2 (lower band) isoenzymes (track 
3) in the rat only. However, cytochrome P450 lA l protein was hardly induced by PENCB 
treatment in the guinea pig (lower band of track 4, Fig. 4.4), instead cytochrome P450 IA2 was 
markedly induced in the guinea pig. Furthermore, PENCB treatment significantly inhibited the 
expression o f P450 IVA l in the rat, but induced this hemoprotein in the guinea pig (Figure 4.5), a 
conclusion which was quantitatively confirmed by the ELISA data in the guinea pig but not in the 
rat (Figure 4.6). This may be related to the possible limits of sensitivity of the ELISA assay in the 
rat. The induction of P450 IVAl in the guinea pig may readily account for the observed increased 
co-hydroxylation o f arachidonic acid by PENCB induced guinea pig liver microsomes (Table 4.1), 
when the substrate specificity of this isoenzyme is taken into account (Sharma et al., 1989). I still 
cannot identify the molecular nature of the induced guinea pig cytochrome P-450 but results from 
the immunoblot analysis further support the possibility that cytochrome P-450 isoenzyme(s) with 
different antigenicity from the P-450 LA sub-family is responsible for induction in the guinea pig.
The regioselective hydroxylation of arachidonic acid catalysed by cytochrome P-450 has 
been well established, and different isoenzymes o f cytochrome P450 catalyse arachidonic acid 
metabolism at different positions (Capdevila et al., 1985). For example, hypolipidaemic drug- 
induced cytochrome P-450 iV A l specifically catalyses the co-hydroxylation o f fatty acids, 
including arachidonic acid in the rat (Capdevila et al., 1985; Sharma et al., 1989), human liver
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cytochrome P-450aa catalyses the epoxygenation o f the four double bonds (Schwartzman et ah, 
1988) and P-NF-induced rat liver microsomal preparations specifically catalyse the co-l- 
hydroxylation o f arachidonic acid (Oliw et al., 1982). Therefore, in the present study, I used 
arachidonic acid as a selective substrate to screen the metabolite profile catalysed by the induced 
guinea pig microsomes and, hopefully, from which to derive further information concerning the 
nature o f the induced cytochrome P-450 from the guinea pig. Again, the CO-1 hydroxylation of 
arachidonic acid was observed as the predominant reaction in the present study with PENCB- 
induced rat liver microsomes, however, this was not observed in the PENCB-induced guinea pig 
liver microsomes. Instead, co-hydroxylation was significantly increased (Figure 4.9 peak II). In 
addition to the induction o f co-1 hydroxylation in the rat or co-hydroxylation in the guinea pig, an 
additional peak III was observed in both induced rat and induced guinea pig microsomes. Peak 
III from rat was identified to contain three components, 18-HETE, 17-HETE and 16-HETE (see 
Chapter 4) . Peak III from the guinea pig (Figure 4.9) has not been further characterized in the 
present study.
In conclusion, results presented in this chapter have demonstrated that the rat and guinea pig 
differentially respond to induction o f hepatic microsomal cytochrome P450 lA  and IVA sub­
families after PENCB treatment. In particular, the arachidonic acid oxidised metabolite profile is 
substantially different between the two species, and, in view o f the important biological activities 
associated with these oxidised metabolites (Smith, 1989; Fitzpatrick and Murphy, 1989; 
Schwartzman et al., 1990), may contribute to the differential susceptibility to PENCB toxicity, a 
hypothesis which requires further examination.
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************ CHAPTER 5 ************
INFLUENCE OF 3,4,5,3',4’-PENTACHLOROBIPHENYL 
ON FATTY ACID METABOLISM IN THE RAT AND 
GUINEA PIG
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5.1 INTRODUCTION
One of the most consistent signs of biochemical changes in animals intoxicated with PCBs 
and related PAHs is the disorder of lipid metabolism. Administration o f PCBs to laboratory 
animals usually results in elevated serum levels o f triglycerides, cholesterol, phospholipids and 
free fatty acids with concomitant hepatic fatty infiltration and severe depletion o f  body adipose 
reserves. Similar clinical observations have also been found in human poisoning cases caused by 
accidental consumption of rice oil contaminated with PCBs (Nakagawa et al, 1986). However, 
there are still no precise mechanisms which could explain the effects o f these chemicals on lipid 
metabolism disorders.
There exists contradictory evidence in the literature concerning the effects of PAHs on lipid 
metabolism. For example, Albro et al (1978) demonstrated that serum free fatty acid levels were 
increased by TCDD treatment, whereas Christian e ta l  (1986) reported that TCDD decreased serum 
free fatty acid levels. Decreased P-oxidation o f fatty acids has been observed in rats treated with 
TCDD as evidenced from the decrease o f serum ketone body levels (Sweatlock and Gasiewicz, 
1985; Christian et al, 1986), while Rozman and Greim (1986) demonstrated that TCDD caused 
increase of [1-^"^C]-palmitic acid p-oxidation (increased ^^C0 2  exhalation). The reasons for these 
discrepancies are not clear. It is also difficult to make a comparison between these data because 
different end point determinations were used. The effects o f TCDD on the elevation o f serum 
triglyceride have been suggested to result from the inhibitory effects o f TCDD on adipose tissue 
lipoprotein lipase (LPL) activity (Brewster and Matsumura, 1984; 1988; Brewster et al., 1988), 
which is considered to be responsible for the removal of triglyceride from serum.
It has been suggested that PCB and related PAH-dependent wasting syndrome is most 
likely to be associated with death in laboratory animals (Gorski and Rozman, 1987), but further 
evidence suggested that the wasting syndrome was not the direct cause o f death. For example, 
loss of body weight after PCB or related PAH treatment mainly resulted from the severe decrease 
of food consumption, and TPN (total parenteral nutrition) fed, TCDD-treated rats (Gasiewicz et 
a l ,  1980) and guinea pigs (Huang Lu er al., 1986) successfully prevented the loss o f body weight
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but not the eventual lethality, which strongly suggested that additional physiological and/or 
biochemical alterations occurred which also contribute to body weight loss, other signs of toxicity 
and subsequent lethality. Intermediary metabolic alterations have been demonstrated in rats treated 
with TCDD. Muzi gf al (1987) demonstrated that rats treated with TGDD appeared to be more 
resistant to toxicity when given a high carbohydrate diet, but more susceptible on a high fat diet, 
high protein diets did not affect the toxicity o f TCDD. High carbohydrate diet could delay the 
onset o f death caused by TCDD, but high fat diets just had the opposite effect (Muzi et a l ,  1989).
Although data from the literature suggested that TCDD-treated rats had difficulties in 
dealing with lipids, no precise biochemical processes have been identified to be responsible for 
these intermediary metabolic alterations. 3,4,5,3',4'-Pentachlorobiphenyl (PENCE) is a very 
toxic PCB congener, structurally closely-related to TCDD and shares the common characteristic 
toxic effects o f TCDD. The main objective o f the present study is to investigate the effects o f  
PENCE on fatty acid metabolism, by evaluating the effects o f PENCE treatment on various fatty 
acid metabolising enzymes activities to provide a comprehensive estimation o f the effects of 
PENCE on fatty acid metabolism. In view o f the significant species difference in the toxic effects 
of PCEs and PAH compounds, the present study is also intended to provide a comparison of the 
effects of PENCE on fatty acid metabolism between the rat and the guinea pig. The latter species 
has been demonstrated to be more susceptible to PCE toxicity than the former.
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5.2 MATERIALS AND METHODS
5.2.1 M A TERIALS
5 2 .1 .1  C H E M I C A L S
Additional chemicals other than those used in previous chapters were obtained from the 
following sources.
Sigm a Chemical Com pany (Poole, Dorset, U. K.): ATP, Coenzyme A, acetyl-coenzyme 
A, palmitoyl-coenzyme A, 5,5'-dithiobis (2-nitrobenzoic acid) (DNB), carnitine, FAD, NAD+, 
NADH, DTT, sodium palmitate, sodium laurate, hyamine hydroxide, penicillin, streptomycin, 
glucose determination kits, triglyceride determination kits, 2-mercaptoethanol, Triton X-1(X).
Am ersham  Radiochem ical Center (Amersham, U. K.): [l-^^CJ-palmitic acid, [l-i^C]-lauric 
acid.
BDH Chemical Company (Dorset, U. K.): MgCl2 , MgS0 4 *7 H2 0 , KCN.
G reyhound C hrom atography and A llied C hem ical CO. (Birkenhead, M erseyside, U. 
K.): 2,4,2',4'-Tetrachlorobiphenyl.
All other chemicals and solvents were obtained from commercial sources and were o f the 
highest purity available.
5 .2 .1 .2  A N IM A L S A N D  A N IM A L PRE TR E A TM E N TS
Animals and PENCE treatments were the same as described in section 4.2.1.2. 2,4,2',4'- 
Tetrachlorobiphenyl (TCE) was prepared as a stock concentration of 43.8 mg/ml (150 |imoles/ml) 
in com oil. Rats and guinea pigs were treated with a single i.p. injection o f TCE at high and low  
dose levels of 300 mmoles/kg and 100 mmoles/kg respectively and the animals were killed 5 days 
after treatment.
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5.2.2 METHODS
5.2.2.1 FA TTY  A CY L-C O EN ZYM E A SY N TH ETASE ASSAY
The fatty acyl-CoA synthetase assay was carried out as described by Wilson et al (1982).This 
isotopic assay made use o f differential partition o f unreacted free fatty acid from the long chain 
acyl-CoA ester in heptane.
The standard reaction mixture (final incubation volume o f 0.15 ml) consisted o f 15 |iM  Tris- 
HCl, pH 8.0, 3 iimoles MgCl2 , 1 fxmole o f ATP, 100 nmoles o f coenzyme A, 150 nmoles of 2- 
mercaptoethanol, 0.3 jiimoles o f Triton X-100 and 40 |il o f a 0.5 mM solution o f radiolabelled 
fatty acid (0.5 |iCi/|imole) in 50 mM NaHCOg. The reaction was initiated by the addition of 50 }ig 
microsomal protein. The incubation was carried out at 37°C for 2 minutes and terminated with 
2.25 ml of isopropanol/heptane/2 M H2SO4 (40:10:1, v/v/v). 1.5 ml of heptane and 1 ml o f water 
were added. The mixture was vortex mixed for about 3 minutes and the two phases were 
separated by brief centrifugation at 2,000 rpm for 3 minutes. The upper organic phase was 
discarded and the lower aqueous phase re-extracted with 2 ml o f heptane containing 4 mg/ml of 
palmitic acid carrier to remove the unreacted radiolabelled fatty acids. A blank control was always 
carried out by stopping the reaction at zero time o f incubation. Finally, the combined aqueous 
phases were counted by liquid scintillation in 10 ml o f Unisolve E scintillant. The results were all 
corrected for subtracting the blank control value.
The optimum incubation time was pre-determined from the time course incubation study 
using 50 jig control microsomal protein. It was found that the reaction was biphasic and the first 
linear range was obtained between zero and 3 minutes (data not shown).
S.1 ,22  D E T E R M IN A T IO N  OF C A R N IT IN E  A C Y L T R A N S F E R A S E  A C T IV IT Y
The determination of carnitine acyltransferase activity was based on the measurement o f free 
coenzyme A liberated from acyl-CoA during the acyltransfer from acyl-CoA to added carnitine. 
The free CoA is determined by using the sulphydryl reagent 5,5'-dithiobis (2-nitrobenzoic acid) 
(DNB) according to the methods of Bieber et al (1972) and Bock et al (1980). The formation o f
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the coloured product was monitored spectrophotometrically at 412 nm with acyl-CoA as 
substrate. Total carnitine acetyltransferase activity from the peroxisomal and mitochondrial 
fraction was measured. Carnitine palmitoyltransferase is located exclusively in mitochondria and 
was assayed using long chain palmitoyl-CoA as the acyl group derivative.
The incubation media (final volume o f 1 ml) contained 0.1 ml o f diluted liver homogenate 
(0.3 to 0.5 mg proteins) and a final concentration o f 0.1 mM substrate (acetyl-CoA or palmitoyl- 
CoA), 99 mM Tris-HCl, pH 8.0, 0.25 mM DNB, 2.13 mM EDTA and 0.2% (v/v) Triton X-100. 
The solution was mixed and centrifuged for 4 minutes and transferred to cuvettes. The reaction 
was initiated by the addition o f 10 pi o f 1 M carnitine and monitored at 412 nm for 5 minutes at 
25°C in UV-Kontron spectrophotometer. A blank without carnitine was run for each sample. 
Specific activity calculation used the molar extinction coefficient o f the reaction product at 412 nm 
o f 13,600 M'^cm"  ^ (Bieber et al., 1972) and corrected for blank values. The final results were 
expressed as nmole CoA formed/min/mg protein.
5 .2  2.3 F A T T Y  AC ID  P O T A SSIU M  C YAN ID E IN SE N SIT IV E  p - O X I D A T I O N
The P-oxidation o f fatty acid has been detected in both mitochondria and peroxisomes. The 
peroxisomal p-oxidation reaction mainly used long chain fatty acids as substrates. The main 
difference between the peroxisomal and mitochondrial p-oxidation of fatty acid occurs at the first 
step in the spiral. In the mitochondria, the electrons from the fatty acid oxidase are transferred via 
the cytochrome respiratory chain to oxygen (O2) and the final product is water; whereas in the 
peroxisomes, electrons are directly transferred to O2 to form H2O2 . The oxidation o f fatty acyl- 
CoA results in the reduction of FAD and NAD+. In the presence o f cyanide (KCN), NADH  
accumulates in the mitochondria because o f the blockage of the cytochrome respiratory chain and 
as the result o f the impermeability o f the mitochondrial inner membrane to the added NAD+. 
Therefore, the mitochondrial p-oxidation is rapidly inhibited, and the increase o f absorbance at 
340 nm (due to NADH formation) only represents the rate of peroxisomal p-oxidation.
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A reaction medium containing 75 |iM coenzyme A, 180 |iM FAD, 555 |iM  NAD+, 141 mM 
nicotinamide, 4.2 p.M DTT, 3 }iM KCN, fatty acid free BSA 0.255 mg/ml in 60 mM Tris-HCl 
buffer, pH 8.3, was freshly prepared and stored on ice. A  1 ml aliquot o f the above reaction 
medium and 0.48 ml of 60 mM Tris-HCl buffer, pH 8.3, were equilibrated at 37°C for 5 minutes. 
The whole tissue homogenate (containing approximately 30 mg/ml o f protein) was diluted 1:1 
with 60 mM Tris-HCl buffer (pH 8.3) containing 1% (w/v) Triton X-100, equilibrated at 37°C for 
2 minutes and 20 jil o f sample was then added to the reaction medium. This mixture was 
centrifuged at 1,000 rpm for 3 minutes using a J6B Beckman centrifuge and transferred to a 
spectrophotometric cuvette. The reaction was initiated with 20 |il o f 75 pM palmitoyl-CoA and 
the change in absorbance at 340 nm was monitored in a UV Kontron spectrophotometer for 10 
minutes at 37°C. The results were expressed as nmol NADH formed/min/mg protein, using the 
molar extinction coefficient for NADH at 340 nm of 6,220 M'^cm'k
5.2.2.4 O X ID A TIO N  OF [D^^CJ-PALM ITIC A C ID
Oxidation o f [l-^^C]-palmitic acid , after several cycles o f p-oxidation, results in the 
formation of acetyl-CoA and/or other short chain fatty acyl-CoA or ketone bodies. Under in vitro 
conditions, only minor amount of acetyl-CoA can be metabolized to ^^C02 via the tricarboxylic 
cycle. In the present study, two different methodologies were employed to estimate the rate o f  
palmitic acid P-oxidation by freshly-prepared liver homogenates. The first one made use o f the 
estimation of ^^ C0 2  production as an index o f p-oxidation, the second one was carried out by 
measuring the formation o f [1-^^C]-acetate.
5 .2 .2 .4 .1  Estimation o f  ^^CO2 p roduction  fro m  [1-^^C]-palm itic  a c id
The present method was carried out as described by McGarry et al (1977). Animals were 
killed by exsanguination via heart puncture and then cervical dislocation. Fresh liver homogenates 
(20%, w/v) were prepared in a modified Krebs-Henseleit bicarbonate (KHB) buffer (pH 7.4), 
containing no calcium, 0.573 grams o f MgS0 4  7 H2O, 769.23 ml o f 0.154 M KCl, 30.77 ml o f  
0.154 M NaCl, 7.5 ml o f 2.11% (w/v) KH2PO4 and 160 ml o f 1.3% (w/v) NaHCOg in one litre
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(referred to as potassium-KHB buffer). This potassium-KHB buffer was bubbled with 100% O2 
for 10 minutes, and the pH checked before use on each occasion.
The fatty acid free, BSA bound [l-^'^C]-palmitate solution (2.5 pCi/ml, 0.5 m M ) was 
prepared as follow: 1(X) pi o f 20 mM sodium palmitate (in methanol) was mixed with every 1 pCi 
[l-l^C]-palmitic acid and the solvents removed by a stream o f nitrogen. 0.4 ml freshly-prepared 
fatty acid free BSA solution (2%, w/v, in potassium-KHB buffer) was added per 1 pCi activity. 
The mixture was sonicated to disperse the fatty acid and then incubated at 37°C for an hour with 
occasional shaking until a clear solution was obtained.
The incubation was carried out in sealed 25 ml Erlenmeyer flasks with a 1 ml central glass 
well. The incubation mixture (final volume o f 2.9 ml) contained 4 mM ATP, 0.1 mM L-camitine, 
0.05 mM Coenzyme A and 1 pCi [l-^^C]-palmitate. The reaction was initiated by the addition of 
0.5 ml 20% (w/v) freshly prepared liver homogenates (10 to 12 mg protein) and incubated at 37°C 
in a shaking water bath for 6  minutes. The reaction was terminated by the addition o f 0.3 ml 60% 
(w/v) perchloric acid which was injected to the flask through a tightly-capped rubber stopper. 0.4 
ml o f IM hyamine hydroxide solution was then injected into the central well and the flask was 
further incubated at room temperature for additional one hour to trap the ^^ 0 0 2 . The content of 
the central well was removed and placed in a p-vial. The well was then rinsed with 4 aliquots of 
0.5 ml Unisolve E, and the rinsings were combined with the original hyamine hydroxide. The 
radioactivity was counted in 5 ml Unisolve E by scintillation spectrometry.
The incubation medium was removed from the flask and placed in test tube. The precipitated 
proteins were spun down by centrifugation at 20,000xg for 15 minutes. One ml aliquot o f the 
clear supernatant was transferred to a clean test tube and 1 ml o f water, 5 ml o f hexane added. 
The mixture was vortex mixed and centrifuged at 2,000 rpm for 3 minutes, the hexane upper layer 
removed and discarded, and the aqueous phase was further extracted twice with 5 ml hexane. 
Finally, 0.5 ml of the aqueous layer was counted, which represented the acid-soluble metabolites. 
Homogenate blank controls were run for every sample, and the final results corrected for by the 
blank values.
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5 .2 .2 .4 .2  Estim ation o f  [1-^^C] acetate production  f ro m  [ l-^ ^ C ]-p a lm i ta te
The assay method was derived from the reference o f Singh and Poulos (1986). Incubation of 
[l-l^GJ-palmitate with freshly-prepared liver homogenates fortified with various cofactors o f the 
P-oxidation cycle results in the formation o f acetyl-CoA and other short chain fatty acyl-CoA and 
ketones; only minor amounts o f the acetyl-CoA undergoes complete oxidation to ^^C02 via the 
tricarboxylic cycle. Chloroform/methanol (2:1, v/v) extraction (one time) removed the unreacted 
fatty acid substrate, leaving the fatty acyl-CoA in the acidified aqueous phase. After hydrolysis 
with KOH at 55°C, various fatty acyl-CoAs were converted into their corresponding fatty acid 
moieties. The long-chain fatty acid can be removed by hexane extraction under acidic conditions, 
leaving the short-chain product (mainly [1-^^C]-acetate) in the aqueous solution. These hexane 
unextractable and water soluble radioactivities therefore represent the extent of P-oxidation.
400 p i o f 100 mM palmitic acid plus 50 p i o f [l-l"^C]-palmitic acid and 2 mg 
phosphatidylcholine were mixed and the solvents evaporated under a stream of nitrogen. 5 ml of 
50 mM Tris-HCl buffer (pH 8.0) was added and sonicated for 30 minutes to disperse the fatty 
acid, yielding a 8 mM [l-^^^Cj-palmitic acid solution (specific activity o f 0.125 pCi/pmole).
The incubations were carried out in 15 ml test tubes. The reaction mixture (total volume of 
0.5 ml) consisted o f 50 mM Tris-HCl buffer (pH 8.0), MgCl2 (1 mM), ATP (2 mM), 
dithiothreitol (1 mM), NAD+ (0.4 mM), L-camitine (0.4 mM), FAD (60 pM), coenzyme A (60 
pM), penicillin (0.3 mg/ml), streptomycin (0.3 mg/ml) and 200 nmoles (total content) o f palmitic 
acid. The reaction was initiated by the addition o f 50 pg homogenate protein, diluted with 50 pM  
Tris-HCl buffer (pH 8.0). The incubation was carried out at 37°C in a shaking water bath for 60 
minutes and terminated by the addition o f 4 ml chloroform/methanol (2/1, v/v); 0.5 ml o f water 
was added to initiate separation of the two phases.
The mixture was thorough mixed and left for 10 minutes, whereupon, 0.2 ml aliquots o f  
upper aqueous phase (total volume o f 2  ml) was counted, representing the total water-soluble 
products. Another 1 ml aliquot o f the upper aqueous phase was transferred to a clean test tube, 
and 10 pi o f 10 M KOH added and the mixture incubated at 55°C for 16 hours to hydrolyse the
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fatty acyl-CoA. The incubation mixture was acidified with 20 |il of 10 M HCl and extracted twice 
with 2 ml o f hexane. The hexane unextractable radioactivity was counted to determine the actual 
amount of [l-^^C]-acetate.
The entire procedure is illustrated in the following diagram.
4 ml Chloroform/methanol (2:1) 
"X 0.5 ml water
0.2 ml upper phase counted
37°C 1 hour Vortexed
Shaking
1.0 ml upper phase hydrolysed
2 ml of hexane Hexane extract 20 ul of 10 M HCl 10 ul of 10 M KOH
y/"2 ml hexane
5^C 16 hourAcidifiedHexane extraction 
--------------
Hexane extract
The aqueous content was coimted. 
The radioactivity represents the 
amount of [1- '^^C]-acetate
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S.2.2.5 LAURIC ACID HYDROXYLATION
The metabolism of lauric acid to 11- and 12-hydroxylated products was evaluated by means 
of a HPLC technique as described by Parker and Orton (1980).
The standard incubation mixture (final volume o f 2 ml) consisted o f 0.5 M Tris-HCl buffer 
(pH 7.4), 0.1 mM unlabelled lauric acid (200 mM stock solution diluted appropriately with 0.5 M 
Tris-HCl buffer, final substrate content was 200 nmoles), 10 p.1 o f [l-l^C]-lauric acid (0.1 |iCi in 
10 p-1 methanol) and, 0.5 mg to 1 mg microsomal protein. The tubes were preincubated for 5 
minutes at room temperature before the reaction was initiated by the addition o f 40 p,l o f 40 mM 
NADPH in 1% (w/v) NaHCOg. The incubation was carried out at 37°C in a shaking water bath 
and terminated by the addition o f 0.3 ml of 3 M HCl.
The hydroxylated metabolites and unreacted substrate were extracted with 10 ml diethyl ether 
by mixing on a rotary shaker for 20 minutes. The tubes were then centrifuged at 2,000 rpm for 5 
minutes to clarify the two phases and the ether layer transferred to a test tube and evaporated to 
dryness under a stream o f nitrogen. The residue was reconstituted in 200 |il o f HPLC starting 
solvent (water/methanol/acetic acid, 45/55/0.05 by volume), of which 150 }il was injected onto a 
reverse phase CDS C%g Ultrasphere column (25 x 0.4 cm, Beckman, U. K.). The 11- and 12- 
hydroxylated products o f lauric acid were separated using the following gradient programme at a 
flow rate of 1 ml/min.
Time % Water* % Methanol
Start 45 55
25 45 55
35 0 100
40 0 100
45 45 55
* Containing 0.1% (v/v) glacial acetic acid.
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The radioactive metabolite peaks were monitored with a HPLC radioactivity detector, 
interfaced with a Commodore PET (Series 4000) data processing station. 11- and 12- 
Hydroxylauric acid were successively eluted followed by the unmetabolised lauric acid. The rate 
o f hydroxylation was calculated from the percentage conversion o f  substrate to 11 - and 12 - 
hydroxy products thus making the need for the estimation o f recovery o f  radioactive products 
unnecessary.
5 2.2.6 D E T E R M IN A T IO N  O F S E R U M  G LU C O SE  L E V E L
Blood samples were obtained via heart puncture. Serum was separated from clotted blood 
by centrifugation at 2,500 rpm and stored at 4°C before analysis (within two days).
The serum glucose concentration was assayed using glucose diagnostic kits according to the 
procedure described by Sigma (Sigma procedure No. 510), essentially derived from the method 
of Raabo and Terkildson (1960).
S.2.2.7 D E T E R M IN A T IO N  OF SE R U M  TR IG LYC E R ID E  L E V E L
The determination of serum triglyceride level was carried out as described in Sigma 
procedure No. 334-UV, which is based on the enzymatic method as described by Bucolo and 
David (1973) and carried out using the diagnostic kits supplied by Sigma.
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5.3 RESULTS
5.3.1 EFFECTS OF PENCE TREATM ENT ON FATTY ACID M ETA BO LISING  
ENZYM E ACTIVITY
The catabolic metabolism of fatty acids involves the cooperative action o f a number of 
enzymatic reactions, including fatty acid activation to fatty acyl-CoA to the tricarboxylic cycle 
which results in complete oxidation o f acetyl-CoA to CO2 . In the present study, various enzymes 
involved in the fatty acid metabolism process were determined to provide a comprehensive 
evaluation o f the effects o f toxic PCB treatment on fatty acid metabolism.
Figure 5.1 shows the effects o f PENCB treatment on the activity o f palmitoyl-CoA  
synthetase in rats and guinea pig liver microsomal fractions. As can be seen from Fig. 5.1, rats 
and guinea pigs demonstrated differential responses to the effects o f PENCB on palmitoyl-CoA 
synthetase activity. In rats, 5 days after treatment, PENCB caused a dose-dependent decrease in 
palmitoyl-CoA synthetase activity. Significantly inhibitory effects were obtained at a dose as low 
as 1.0 mg/kg. At dose of 15.0 mg/kg, the enzyme activity was inhibited up to 50% of the control 
values. However, as compared with the rat, PENCB treatment did not inhibit synthetase activity 
in the guinea pig, even in the highest dose group o f 1.0 mg/kg. On the contrary, higher PENCB 
doses caused a slight but unsignificant increase in palmitoyl-CoA synthetase activity.
The other important enzyme in fatty acid metabolism is carnitine acyl transferase, which is 
involved in the transfer o f acyl-CoA from cytosol to mitochondria. The effects o f PENCB 
treatment on carnitine acyltransferase are shown in Figure 5.2. In the present study, two different 
substrates (palmitoyl-CoA and acetyl-CoA) were employed to evaluate the carnitine acyltransferase 
activity for long and short chain acyl-CoAs respectively. As indicated in Fig. 5.2, carnitine 
acetyltransferase (CAT) appeared to be more susceptible to the inhibitory effects o f PENCB than 
the carnitine palmitoyltransferase (CPT). Both CAT and CPT demonstrated a dose-related 
decrease in activity after PENCB treatment in the rat. However, PENCB treatment had no effect 
on the activities o f either CAT or CPT in guinea pigs (Figure 5.2B).
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FIG U R E  5.1 E FF E C T S OF PEN C E T R E A T M E N T  O N PA L M IT O Y L -C oA  
SY N TH ETASE A CTIV ITY  OF RAT AND G UINEA PIG  LIVER  M ICRO SO M A L  
FR A C T IO N S
RAT LIVER M ICROSOMES
PENCB DOSE (mg/kg)
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The activity o f microsomal palmitoyl-CoA synthetase was determined using the isotopic 
method as described in section 5.2.2.1. The assay was carried out in triplicate. The results 
are all expressed mean ±  sd o f three animals. **, p < 0 .0 1 ; ***, p < 0 .0 0 1 .
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FIGURE 5.2A EFFECTS OF PENCB TREATMENT ON ACYL CARNITINE
TRANSFERASE ACTIVITIES IN RAT LIVER HOMOGENATES
0.5  1 3 5 10
PENCB DOSES (mg/kg)
u  0 0 .5  1 3 5
PENCB DOSE (mg/kg)
Carnitine acyltransferase activities were determined spectrophotometrically in rat liver 
homogenates as described in section 5.2.2.2. The assay was carried out in duplicate. The 
results are all expressed as mean ±  sd o f three animals. *, p < 0.05; p < 0.01.
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FIGURE 5.2B EFFECTS OF PENCB TREATMENT ON ACYL CARNITINE
TRANSFERASE ACTIVITIES IN GUINEA PIG LIVER HOMOGENATES
0 .025  0 .05  0.1 0.3
PENCB DOSE (mg/kg)
0 .025  0 .05  0.1 0.3
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Carnitine acyltransferase activities were determined spectrophotometrically in 
guinea pig liver homogenates as described in section 5.2.2.2. The assay was 
carried out in duplicate. The results are all expressed as mean ±  sd of three animals.
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5.3.2 EFFECTS OF PENCB TREATMENT ON HEPATIC FATTY ACID 15-
OXIDATION
The effects o f PENCB treatment on hepatic peroxisomal acyl-CoA oxidase activities in 
the rat and guinea pig are shown in Figure 5.3. This enzyme is the rate limiting step in the 
peroxisomal P-oxidation pathway and hence is a marker enzyme for overall peroxisomal P- 
oxidation activity. PENCB treatment caused different responses in the activity o f KCN- 
insensitive palmitoyl-CoA oxidase (PCO) in the rat and guinea pig. In the rat, PENCB treatment 
resulted in a dose-dependent decrease in PCO activity. At doses above 5 mg/kg, PCO activity was 
decreased to only 30% of the control values, a significant reduction in peroxisomal P-oxidation 
activity. In contrast, PENCB treatment did not cause any reduction in PCO activity in the guinea 
pig. On the contrary, PENCB significantly increase this enzyme activity 5 days after treatment in 
a dose-dependent manner. At a dose of 1.0 mg/kg, PCO was increased up to 160% of the control 
value. This is a rare example o f an increase in peroxisomal p-oxidation activity in the guinea pig 
caused by xenobiotic treatment as this species has been demonstrated to be relatively refractory to 
peroxisome proliferators (Holloway et al., 1982; Elcombe and Mitchell, 1986).
The effect o f PENCB treatment on hepatic p-oxidation activities has also been evaluated in 
the present study in total liver homogenates by two different methodologies, which measured the 
total hepatic p-oxidation activities (both peroxisomal and mitochondria p-oxidations). The effect of 
PENCB to decrease hepatic P-oxidation has been confirmed in total liver homogenates in rats 
employing the determination o f the production o f both f^C02 and [l-^^C]-acetate in the present 
study. Table 5.1 demonstrates the effects o f PENCB treatment in the production o f "^^ C0 2  
evolved from the incubation of [l-^^C]-palmitic acid with freshly-prepared rat liver homogenates. 
The present study was carried out in two separate experiments o f low and high doses o f PENCB; 
the low dose experiment (0 .5 ,1 .0  and 3.0 mg/kg), and high dose experiment (5.0, 10.0 and 15.0 
mg/kg), each with separate controls. There was no difference in either ^'^C02 production or 
formation o f acid-soluble metabolites in the low dose ranges between control and PENCB treated 
groups (data not shown). In Table 5.1, results are all expressed as cpm/100 mg/6  min. The
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FIGURE 5.3 EFFECTS OF PENCB TREATMENT ON KCN-INSENSITIVE
PALMITOYL-CoA OXIDASE ACTIVITY IN RAT AND GUINEA PIG LIVER
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The activity of KCN-insensitive palmitoyl-CoA oxidase was determined spectrophotometrically 
as described in section 5.2.2.3 from rat and guinea pig liver homogenates. The assay was 
carried out in duplicate. All o f the results are expressed as mean ±  sd (nmoles NADH  
formed/min/mg o f protein at 37°C) of three animals. *, p < 0.05; **; p < 0.01; ***, p < 0.001.
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scintillation spectrometry conditions were kept as close as possible for both control and 
treatment samples, thus made the counting efficiency to be comparable between individual 
determinations. PENCB treatment at a dose above 5.0 mg/kg caused significant reduction in both 
the production of ^^COi and the acid-soluble metabolites.
Figure 5.4 shows the effects o f PENCB treatment on [l-l^C]-palmitic acid metabolism  
using a different methodology, in which formation o f [l-^^CJ-acetate was evaluated as an index of 
hepatic (3-oxidation activities. It should be noted that under m vitro conditions, p-oxidation of 
fatty acids results mainly in the formation of acetyl-CoA, with only minor amounts o f acetyl-CoA 
further metabolized to CO2 (Singh and Poulos, 1986). According to these latter authors, the 
overwhelming majority of the radioactivity recovered after KOH hydrolysis and hexane extraction 
is [l-l^C]-acetate. Figure 5.4 clearly demonstrates a dose-related inhibition o f fatty acid oxidation 
by PENCB treatment in rat liver. Maximum inhibition was obtained at a dose o f 5.0 mg/kg, 
corresponding to 44% of the control activity. Higher doses did not show any further inhibition 
effects. There was a parallel decrease in the formation of total acid-soluble radioactivities (Figure 
5.5), in a good agreement with the decrease in [l-^^C]-acetate production.
In contrast to the above data in the rat, there was no difference in the effect o f PENCB 
treatment on fatty acid p-oxidation activity in the guinea pig, using either evaluation 
methodologies employed in the present study (data not shown). This was not unexpected because 
neither o f the PCS, PCO, CAT and CPT enzymes had been inhibited by PENCB treatment as 
presented earlier.
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Table 5.1 Metabolism of [l-f^Cl-palm itic acid by freshly-prepared rat 
liver homogenates.^
PENCB Treatment 
(Dose, mg/kg)
^"^C02 Production 
(cpm/1 0 0  mg/6  min)
Acid-soluble radioactivity 
(cpm/1 0 0  mg/6  min)
0 4,474+642 93,34316,542
5 3,396+285* 72,05213,509*
10 3,382±66* 63,585113,229*
15 3,533±223* 60,58317,283*
a: Three rats in each group. The assay was carried out in duplicate as described in section 
5.2.2.4.I. The results presented are the mean ±  sd o f three rats. *, p<0.05.
FIG U R E 5 .4  EFFEC T OF PENCB TR EATM EN T ON [ l-1 4 c ] -P A L M I T I C  
ACID P-OXIDATION IN FRESH LY-PREPARED RAT LIVER H O M O G ENATES
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The assay was performed in triplicate as described in section 5.2.2.4.2. The results are all 
expressed as mean ± sd (nmoles [l-^"^C]-acetate formed/houi/mg o f protein) o f three animals.
*, p < 0.05; ***, p < 0.001.
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F IG U R E  5 .5  P R O D U C T IO N  O F A C ID -S O L U B L E  R A D IO A C T IV E  
M ETA BO LITES D UR ING  THE P-O XIDATIO N OF [l-l^C J-PA L M IT IC  ACID  
CATALYSED BY PENCB TREATED RAT LIVER H O M OG ENATES
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The assay was carried out in triplicate as described in section 5.2.2.4.2. The 
radioactivity recovered in the aqueous phase after chloroform/methanol extraction 
represents the acid-soluble metabolites. The results are all expressed as mean ±  sd 
(dpm/hour/50 jig of protein) of three animals. ***, p < 0 .0 0 1 .
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5.3.3 EFFECT OF PENCE TREATMENT ON SERUM GLUCOSE AND
TRIGLYCERIDE LEVELS  
Serum glucose levels in the rat and guinea pig after PENCB treatment are shown in Figure 
5.6. Significant reduction o f glucose level was observed in the two highest dose groups (10.0 
mg/kg and 15.0 mg/kg) (p < 0.05, two tailed student t-test) as compared with control. No 
significant changes were obtained at doses lower than 5.0 mg/kg in the present study. In the 
guinea pig, the blood glucose level was also significantly decreased 5 days after dosing. At a dose 
of 1.0  mg/kg, pronounced reduction o f the blood glucose level was observed, to nearly half of the 
control value. As compared to the rat, the guinea pig appeared to be more susceptible to 
hypoglycaemia on exposure to PENCB.
Figure 5.7 shows the effect of PENCB treatment on blood triglyceride levels. A slight 
increase in triglyceride level in the rat was observed at the higher dose levels, but statistical 
analysis shown no differences between control and treated groups. It should be noted that in the 
group of 15.0 mg/kg, two o f the three rats exhibited a considerable elevation o f blood triglyceride 
level (341.11+17.65 mg/100 ml and 313.99±7.14 mg/100 ml vs the control average value of 
160.56+37.54 mg/100 ml), while a third rat in this group shown no change (157.03±9.19 
mg/100 ml). Individual increases in triglyceride level but not the average value o f the group was 
also observed in the 5.0 and 10.0 mg/kg dose groups. In the guinea pig, there was an elevation 
in blood triglyceride levels after PENCB treatment, in a dose-dependent manner (Fig. 5.7 B). A 
three fold increase in the blood triglyceride level was observed in the highest dose group (1 
mg/kg).
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FIGURE 5.6 EFFECT OF PENCB TREATMENT ON SERUM GLUCOSE
CONCENTRATION IN THE RAT AND GUINEA PIG
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The glucose concentrations were determined from serum fractions o f rat and guinea pigs 5 
days after PENCB treatment as described in section 5.2.2.6. The results are all expressed as 
mean ±  sd of three animals. *, p <0.05; **, p < 0.01.
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FIGURE 5.7 EFFECT OF PENCE TREATMENT ON SERUM TRIGLYCERIDE
CONCENTRATION IN THE RAT AND GUINEA PIG
H g  200
V / i
v / i
0.5  1 3 5 10
PENCB DOSE (mg/kg)
B
GUINEA PIG
%
0 0 .025  0 .05  0.1 0.3  0.5
PENCB DOSE (mg/kg)
The triglyceride (TO) concentrations were determined from the serum fractions o f rats and 
guinea pigs 5 days after PENCB treatment as described in section 5 2 2 .1 .  The results are all 
expressed as mean ±  sd of three animals. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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5.3.4 C O N G E N E R -SPE C IF IC  IN D U C T IO N  OF R A T  H E P A T IC  L A U R A T E  I I -  
AN D  12-HYDROXYLASE ACTIVITIES
Induction o f cytochrome P450 IVAl by PCB (Aroclor 1254) treatment has previously been 
reported in rats (Borlakoglu et al., 1989). Aroclor 1254 is a technical grade mixture o f PCBs, 
which contains many different congeners and isomers. A s reviewed in the Introduction, PCBs 
may be classified into different groups according to their ability to induce different cytochrome 
P450 families. The present study was carried out to evaluate the inducibility o f two different types 
(MC and PB types) of PCB congeners as cytochrome P450TVAl inducers.
TCB (2,4,2’,4'-tetrachlorobiphenyl) and PENCB (3,4,5,3',4'-pentachlorobiphenyl) are 
representatives o f PB-type and MC-type PCB congeners respectively, and both significantly 
induced the total hepatic cytochrome P450 content, but differentially influenced laurate 11- and 
12-hydroxylase activities in the rat (Table 5.2). At a dose o f 87.6 mg/kg, TCB significantly 
induced the 11- and 12- hydroxylase activities to 153% and 182% o f the corresponding control 
•values in terms o f nmole product formed/min/mg of protein. By contrast, PENCB treatment 
resulted in significant inhibition of both 11- and 12-hydroxylase activities o f lauric acid to 35% 
and 29% of the corresponding control values. Results presented in Table 5.2 clearly indicate that 
cytochrome P450 IV A l inducibility by PCBs is strictly congener specific in the rat. While PB- 
type congener can significantly induce laurate 12-hydroxylase activity, the MC-type congener 
inhibited this enzyme activity.
14 0
Table 5.2 PCB congener-specific induction of lauric acid 11-
and 12-hydroxylase activities in the rat
P45Q specific content Lauric acid hydroxylase activity
___________________(nmol/mg) 11-QH-ase________  12-OH-ase
Control 0.78±0.10 LI 8+0.22 2.5710.69
TCB (87.6 mg/kg) 1.2710.05** 1.8110.34* 4.6910.23*
PENCB (5 mg/kg) 2.5910.15*** 0.4210.22** 0.7410.37*
Results are all expressed as mean 1  sd (nmol/min/mg) of three animals. The assay was carried 
out in duplicate at 37°C. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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5.3.5 DOSE-DEPENDENCE INDUCTION OF LAURATE 12-HYDROXYLASE
ACTIVITY IN THE GUINEA PIG BY PENCB TREATMENT
Results presented in Chapter 4 clearly indicated that PENCE treatment resulted in 
differential responses in the induction o f cytochrome P450s in the rat and guinea pig. PENCB 
suppressed P450 IV A l expression in rats but induced P450 IV A l expression in guinea pigs as 
evaluated by Western blot, ELISA and arachidonic acid metabolism techniques. Furthermore, 
results presented in last section (5.3.4) demonstrated that PCB-induced cytochrome P450 IVA l 
expression in the rats is congener-specific, in that only TCB (PB-type congener) but not PENCB 
(MC-type congener) induced cytochrome P450 IVA l. The present study was carried out to further 
evaluate the induction o f cytochrome P450 IV A l in the guinea pig by TCB and PENCB 
treatments.
Figure 5.8 shows effects o f PENCB on the 11- and 12-hydroxylase activities. PENCE 
treatment resulted in a dose-dependent increase in 12-hydroxylase activity in guinea pig liver 
microsomal fractions. The maximum induction o f laurate 12-hydroxylase activity was obtained at 
1 .0  mg/kg, the highest dose used in the present study, which was induced up to 2  fold o f  the 
control value. The 11-hydroxylase activity was also significantly induced by PENCE at dose 
above 0.05 mg/kg. The maximum induction o f this enzyme activity was observed at dose o f 0.1 
mg/kg, which was induced up to 1.79 fold, and higher doses did not cause any further induction 
of the 11-hydroxylase activity.
As compared to the rat, TCB treatment o f guinea pigs had no effect in either the induction 
of hepatic total cytochrome P450 contents or the lauric acid 11- and 12-hydroxylase activities in 
either low or high doses (Table 5.3). At a dose o f 300 |im ol/kg (or 87.6 mg/kg), TCB could 
significantly induce the total cytochrome P450 concentrations and the catalytic activity toward 
lauric acid hydroxylation in rats (Table 5.2). The guinea pig, on the other hand in spite o f its 
established high susceptibility to the toxicity o f PCBs, had no response to TCB treatment.
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Table 5.3 Effects of TCB treatment on the lauric acid 11
and 12-hydroxylase activities in the guinea pig
P450 specific content Laurie acid hydroxylase activity
(nmol/mg) 11-OH-ase 12-OH-ase
CONTROL (5) 0.9410.08 2.1610.42 3.5810.68
100 |im oles/kg (3) 0.8710.18 2.3210.68 2.8910.51
300 |Li moles/kg (3) 0.9610.09_________  2.1010.53 3.6710.07
Guinea pigs were treated once with low (100 pmol/kg) or high (300 pmol/kg) doses of 
TCB and killed 5 days after dosing. The 11- and 12-lauric acid hydroxylase activities 
were determined as described in section 5.2.2.5 from the liver microsomal fractions, and 
expressed as nmol/min/mg. Statistically, no difference was observed in either the total 
cytochrome P450 content or lauric acid 11- and 12-hydroxylase activities between 
control and treated groups. The numbers in brackets represent the numbers o f animals in 
each group.
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FIGURE 5.8 DOSE-DEPENDENT INDUCTION OF LAURATE 12-HYDROXYLASE
ACTIVITY BY PENCE TREATMENT IN GUINEA PIGS
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Guinea pigs were treated with a single i.p. injection of FENCE at different dose levels 
and killed 5 days after treatment. The activities o f lauric acid 11- and 12-hydroxylases 
were determined from the liver microsomal fractions as described in section 5.2.2.5.
*, p < 0.05; p <0.01; ***, p < 0.001.
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5.4 DISCUSSION
PCBs and related PAH compounds have long been recognized to perturb lipid metabolism 
in a number o f animal species, including rats, mice, rabbits and man. The main clinical signs of 
lipid metabolism disorders are depletion o f body adipose tissue, increased serum triglyceride 
(Brewster et a i ,  1988), cholesterol, phospholipid and free fatty acid (Kato et aL, 1982; 
Pohjanvirta et ah, 1989) levels and widespread hepatic fatty infiltration (Kohli et al., 1979; 
Biocca et al., 1981). The mechanisms underlying these biological alterations have been 
investigated for many years, however little has been elucidated so far. Data from the literature 
concerning the effects o f TCDD on fatty acid metabolism have been very confusing as reviewed in 
section 1.3.2.14. The effects o f TCDD on the elevation o f plasma triglyceride levels have been 
attributed to the effects o f TCDD on the inhibition o f lysosomal acid lipase which resulted in 
decreased lipid utilisation (Albro et al., 1978), and recently Brewster et al (1988) demonstrated 
that TCDD-dependent elevation o f serum triglyceride levels resulted from the inhibition o f TCDD 
on adipose lipoprotein lipase activity, which is responsible for the clearance o f trigylcerides from 
the serum. There is consistent evidence suggesting that TCDD-treated rats have an impaired 
ability to utilize fat (Sweatlock and Gasiewicz, 1985; Christian et al., 1986; Muzi et al., 1987;
1989), indicating an alteration in energy metabolism (Muzi et al., 1989).
Results from the present study clearly indicate that PENCB treatment caused a general 
depression o f fatty acid metabolism in the rat but not in the guinea pig. PENCB caused a dose- 
dependent decrease o f fatty acid activating enzyme (palmitoyl-CoA synthetase) activity in rat 
microsomes. Free fatty acid , no matter whether it is released from triglycerides or absorbed from 
diet, before entering the metabolism process (except in the case o f MFO-dependent 
hydroxylation), must be activated to a form o f coenzyme A ester. This fatty acyl-CoA can then 
either be esterified to form triglycerides or transported into mitochondria or peroxisomes for 13- 
oxidation, dependent on the energy metabolism status o f the animals. Inhibition o f this activating 
enzyme activity could eventually result in both a decrease in (3-oxidation and elevation o f free fatty
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acid level. These effects have both been observed in TCDD-treated rats (Christian et al., 1986;
Pohjanvirta et al., 1989).
Mitochondria and peroxisome possess carnitine acyltransferase activities, which are 
involved in the transfer o f the acyl groups across the membranes. These enzyme activities were 
determined in the present study. My results again demonstrated that PENCB caused a significant 
decrease o f both carnitine acetyltransferase (CAT) and carnitine palmitoyltransferase (CPT) 
activities in the rat but not in the guinea pig. PENCB caused no such inhibition in the guinea pig.
These species differences in the effects o f PENCB on fatty acid metabolism have also been 
observed for several other enzyme activities. In the rat, fatty acid p-oxidation in both peroxisomes 
and mitochondria were significantly suppressed by PENCB treatment. PENCB caused severe 
inhibition o f peroxisomal p-oxidation in rats, and this inhibition was dose-dependent in the low  
dose range (from 0.5 mg/kg to 5.0 mg/kg). Above 5.0 mg/kg, PCO activity was only 30% of the 
control values, whereas in guinea pigs, PENCB caused a slight but significant induction o f the 
PCO activity (160% of the control value). This inductive effect o f PENCB on peroxisomal p- 
oxidation is probably the result o f increased cytochrome P450 IV A l dependent fatty acid co- 
hydroxylation. The induction of cytochrome P450 IV A l in the guinea pig was first demonstrated 
in Chapter 4 and further confirmed in the present Chapter. Induction o f cytochrome P450 IV A l 
results in increased fatty acid co-hydroxylation which leads to the accumulation o f dicarboxylic 
fatty acids and peroxisome proliferation (Sharma et al., 1988). Interestingly, TCB, a PCB 
congener which could induce the total hepatic cytochrome P450 content and the catalytic activity 
toward lauric acid hydroxylation, had no effects on the guinea pig. The reasons for this species 
discrepancy are still unknown.
TCDD-dependent perturbation o f intermediary metabolism pathways has been suggested as 
the cause of eventual lethality o f TCDD in rats (Muzi et a l ,  1987; 1989; Gorski et a/., 1988a; 
1988b). Results presented in this chapter provide a striking comparison o f PENCB on fatty acid 
metabolism between the rat and the guinea pig. The guinea pig is a highly susceptible species to 
the toxicity o f PCBs and TCDD. If PENCB inhibition o f fatty acid p-oxidation directly
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contributes to PENCB lethality in the rat, the cause o f lethality in the guinea pig still remains 
speculative and may suggest different mechanisms o f PENCB toxicity in these two species.
In the present study, the effect o f PENCB on serum glucose and triglyceride levels was 
very obvious in the guinea pig. The effect o f PENCB on serum glucose level at least partially 
resulted from the severe decrease in food intake in the guinea pig. The reason for this substantial 
increase in serum triglyceride levels is still unknown. Obviously, this hypertriglyceridemia effect 
o f PENCB is incompatible with its peroxisome proliferating effects as demonstrated by the 
induction o f cytochrome P450 IV A l and increased peroxisomal p-oxidation, even though the 
induction o f cytochrome P450 IVAl and peroxisomal p-oxidation is relatively small as compared 
with such effects of ciprofibrate in rats (Sharma et a l ,  1988).
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DISCUSSION
In my studies, pretreatment o f rats with different xenobiotic inducers o f cytochrome P450s 
resulted in substantial alteration o f P450-mediated arachidonic acid oxidative metabolism, 
particularly with inducers o f cytochrome P450 lA  and IVA sub-families. Clofibrate pretreatment 
gave a 6 .6 -fold induction o f 20-HETE (Table 2.3), while 19-HETE was unaffected; other 
metabolites were barely identifiable. 3-MC and PENCB pretreatments resulted in significant 
inductions of the 19-HETE (3 and 4.5 fold respectively) and a mixture o f 18-, 17- and 16-HETEs 
(4.7 and 5.1 fold respectively). Falck et al (1990) have performed similar experiments in P- 
naphthoflavone treated rats with a very similar profile o f AA metabolites to the 3-MC induced A A 
metabolite profile in my study, in which while 19-, 18-, 17- and 16-HETEs were significantly 
induced, 20-HETE formation was unaffected (Table 2.3). PENCB significantly suppressed 20- 
HETE formation (8 -fold). This suppressive effect could result from two possible mechanisms. 
Firstly, in vivo treatment with PCBs leaves residues which act as in vitro inhibitor o f cytochrome 
P450. Secondly, PCBs act at the gene/mRNA level in switching off cytochrome P450 synthesis. 
The first possibility is probably not true as this has not been previously reported elsewhere in the 
literature. More importantly, previous studies have convincingly demonstrated that PCBs 
decreased the steady state levels of cytochrome P450 mRNA (Yeowell et al., 1987; 1989). 
Previous comparative studies demonstrated that ciprofibrate-induced alteration o f co- and co-1 
hydroxylation o f fatty acids appeared to be most pronounced for arachidonic acid and other 
polyunsaturated fatty acids, e.g. oleic, linoleic and linolenic acids, did not show similar alterations 
in metabolite profiles, suggesting strict conformational constraints in the substrate specificity of 
the cytochrome P450 active site (Capdevila etal., 1985; Sharma et al., 1989). This conformational 
constraint of cytochrome P450 active sites has also been confirmed and extended to different P450 
isoenzymes in my study (chapter 2), in which the clotrimazole induced P450 IIIAl (and probably 
IIIA2) and DEI did not support any identifiable arachidonic acid oxidation. The precise molecular 
basis o f this substrate specificity of cytochrome P450 as well as the site-specific hydroxylation of 
fatty acid by cytochromes P450 is largely unclear at present.
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The above mentioned alterations in arachidonic acid metabolism following xenobiotic 
exposure may have a pronounced effect on cellular homeostasis, as evidenced by the potent 
biological activities of the oxidized metabolites o f arachidonic acid (Table 1.5).
Species differences in the toxicity o f PCBs is a well-established phenomenon. The guinea 
pig is one o f the most susceptible species to the toxicity o f PCBs and related PAHs (Poland and 
Knutson, 1982; Safe, 1984). In order to explore this species sensitivity further, comparative 
experiments have been carried out in my study to investigate the effect o f one o f the most toxic 
PCB congeners (PENCB) on fatty acid metabolism in rats and guinea pigs. As described in 
chapter 5 , perturbation of lipid metabolism appears to be one of the key biochemical alterations on 
exposure to PCBs and related PAHs. Chapter 4 gave a detailed description o f this species 
difference in cytochrome P450 induction and cytochrome P450-mediated arachidonic acid 
metabolism by PENCB treatment. In spite o f 2-fold induction o f the total hepatic cytochrome 
P450 content, spectral and immunoblot analysis indicated that the induction o f cytochrome P450 
lA  sub-family was very low in the guinea pig (Figure 4.4). The slight but significant induction of 
EROD activity may largely result from the induction o f P450IA 2 in PENCB-treated guinea pigs. 
The cytochrome P450 IA2 was nondetectable in untreated guinea pig liver microsomes as 
evidenced from the immunoblot analysis by PENCB treatment (Figure 4.4). It should be noted 
that the guinea pig cytochrome P450 lA l has a lower molecular weight than the IA2 (Thomas et 
a l ,  1985). However, in spite o f this low induction o f cytochrome P450 IA1(2), arachidonic acid 
metabolism demonstrated a 4-fold induction o f metabolite peak III (which was identified as a 
mixture o f 18-, 17- and 16-HETE in PENCB-induced rats) in PENCB-induced guinea pig liver 
microsomal incubations. By comparison, peak I (identified as 19-HETE), which was the 
predominant reaction product in PENCB-induced rat liver microsomal incubations, was hardly 
affected in the guinea pig by PENCB treatment. As described in chapter 4, metabolite peak III 
formed by PENCB-induced guinea pig liver microsomes shown a thinner and sharper peak shape, 
possibly indicative o f one o f the three metabolites being predominant. Unfortunately, further 
HPLC separation and GC-MS analysis were not carried out in the present study mainly due to the
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insufficiency o f material. Nevertheless, results from my studies strongly indicate that PENCB 
treatment resulted in differential induction o f cytochrome P450 between rats and guinea pigs, 
mainly in the difference o f the P450-dependent formation o f 20- and 19-HETEs. Moreover, 
PENCB pretreatment resulted in significant induction of metabolite peak IE in both rats and guinea 
pigs, particularly in the guinea pig. It is still premature to define any correlation between the 
formation o f these AA metabolites and PENCB toxicity, and this question can only be addressed 
after structural identification of metabolite(s) in peak m  of guinea pig and comprehensive analysis 
of the biological activity of these metabolites. Obviously, the further exploration o f the biological 
activities o f 18-, 17- and 16-HETEs is o f potential significance.
Cytochrome P450-mediated fatty acid hydroxylations has been known for a long time. It 
was suggested that co- and co-1 hydroxylations were catalysed by different monooxygenases in the 
oxidation o f prostaglandins (Kupfer e t a l ,  1979; Kupfer 1982) and laurate (Okita gf a/., 1979). 
My results also suggest that co- and co-1 hydroxylations o f arachidonic acid are catalysed by 
different cytochrome P450 monooxygenases, in which clofibrate significantly induced co- 
hydroxylation with no effect on co-1 hydroxylation. PENCB significantly induced co-1 but 
suppressed co-hydroxylation, and 3-MC significantly induced co-1 hydroxylation with no effect on 
co-hydroxylation. It remains to be determined whether hydroxylations at the thermodynamically 
less favourable C i6 through C19 carbons are catalysed by different cytochrome P450 enzymes. 
Metabolism o f AA by purified cytochrome P450 lA l resulted in the major reaction product of 19- 
HETE (46% o f total) and a mixture of 16-, 17- and 18-HETEs (46% of total, in a molar ratio o f  
2:2:1 respectively), whereas metabolism by purified P450 IA2 resulted in oxygenation at C16, 
C i7, C18 and C19 in a molar ratio o f 7:3:2:3 respectively, o f which 19-HETE represents only 9% 
and the mixture of 16-, 17- and 18-HETEs 35% of the total metabolite formation (Falck et al.,
1990). Tables 6.1 and 6.2 shows the regioselectivity o f purified cytochrome P450 isoenzymes for 
the metabolism of arachidonic acid (Falck et al., 1990). Similar site-specific hydroxylations o f  
prostaglandins Ei and E% at C n  (Kupfer et al., 1988), Cig (Holm et a l ,  1985) and C19 (Kupfer et 
al., 1988) have been demonstrated by 3-MC-induced cytœhrome P450 isoenzymes. In addition, a
P450 like enzyme preparation isolated from monkey seminal vesicles has been demonstrated to
predominantly catalyse predominant 18(R)-hydroxyeicosatetraenoic acid formation (Oliw, 1989).
Taken collectively, the information presented so far indicates that hydroxylation at these 
thermodynamically less favourable carbons (Cie through C19) could be catalysed by a single 
isoenzyme with different site-specific preference and/or more than one enzyme could catalyse 
these site specific hydroxylation reactions.
Differential induction o f cytochrome P450 by PENCB treatment has also been observed in 
the P450 IVA sub-family between the rat and guinea pig as evidenced from the co-hydroxylase 
activities towards arachidonate and laurate (Chapters 4 and 5). In my study, the IV A l protein 
appeared to be suppressed by PENCB treatment in the rat, but induced in the guinea pig. As 
judged from the immunoblot analysis with anti-P450 FVAl antibody, the two bands recognized in 
the guinea pig appeared to be different from those o f the rat in terms o f SDS-PAGE mobility, 
particularly the upper band which characterized by a higher molecular weight than the 
corresponding rat upper band. The molecular identity o f this upper band in PENCB-induced 
guinea pig liver microsomes has not been identified in my study.
The induction of the cytochrome P450 IV A l sub-family is a characteristic response o f  
peroxisome proliferator exposure (Sharma et al., 1988), which has also been attributed to the 
genesis o f peroxisome proliferation (Sharma et al., 1988). It has also been widely demonstrated 
that the guinea pig is one o f the relatively refractory species to peroxisome proliferation (Holloway 
et al., 1982; Elcombe and Mitchell, 1986). The present study demonstrated a two-fold induction 
of cytochrome P450 IV A l and its associated catalytic activities (co-hydroxylases o f arachidonic 
acid and lauric acid) after PENCB administration to this species. In addition, a 160% induction of 
peroxisomal p-oxidation has also been observed in guinea pigs dosed with 1.0 mg/kg PENCB in 
my study. According to the mechanistic scheme proposed by Sharma et al (1988) for peroxisome 
proliferators, the induction o f cytochrome P450 IVA l and peroxisomal P-oxidation observed in 
my study in the guinea pig after PENCB treatment may be causally related. It should be noted that 
the induction o f cytochrome P450 IV A l and peroxisomal P-oxidation after administration o f
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TABLE 6.1 R EG IO SELEC TIVITY  OF OF ARACH IDO NIC ACID M ETABO LISM  
W ITH  PURIFIED CYTO CH RO M E P-450 ENZYM ES ^
Product E C U lA l IA2
19-OH-AA 0.06 (9) 0.28(40) 0 .03(9 )
20-GH-AA 0.02 (3) 0.05 (7) <0 .0 1
PEAKEI 0.05 (7) 0.28(40) 0 .12(35)
HETEs 0.13(19) 0.05 (7) 0.12 (35)
14,15-EET 0.18 (27) 0.02 (3) 0 .02(5)
11,12-EET 0.12(18) <0 .01 0.04(12)
8,9-EET 0.09 (14) <0 .0 1 0.01 (3)
5,6-EET 0.02 (3) <0 .01 <0 .01
TOTAL 0.67 0.70 0.34
a: The rates o f product formation are expressed in nmol o f product/mir
Values are the mean of three determinations with SE < 15%. The numbers
are the percentage of the total. (Derived from Falck ef fl/., 1990)
T A B L E  6 .2  F O R M A T IO N OF C 16 TO C 20 M O N O H Y I
PRO DUCTS BY PURIFIED CYTO CH RO M E P-450 ENZYM ES a
ALCOHOL E C U lA l IA2
16-OH-AA 0.03 (23) 0.03(8) 0.07(47)
17-OH-AA 0 .0 1 (8 ) 0.07(19) 0 .03(20)
18-OH-AA 0 .0 1 (8 ) 0.07(19) 0.03(20)
19-OH-AA 0.06(46) 0.17(46) 0.03(20)
20-OH-AA 0.02(15) 0.03(8) <0 .01
% of total 19 87 44
Rate 0.13 0.37 0.15
a: The rates o f product formation are expressed as nmol o f product/min/nmol P-450. 
Values are all expressed as mean of three determinations. The numbers in brackets are 
the percentage o f the total alcohol formation. (Derived from Falck et al., 1990)
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peroxisome proliferators results in a decrease o f plasma triglyceride and cholesterol levels. 
However, substantial elevation o f serum triglyceride levels has been demonstrated in guinea pigs 
after PENCB treatment (chapter 5). The reasons for PENCB-caused elevation o f serum 
triglyceride level in the guinea pig remain unclear. Obviously, this effect o f PENCB in the guinea 
pig is incompatible with its effect on the induction o f cytochrome P450 IV A l and peroxisomal p- 
oxidation, or these effects may be regulated via different mechanisms between different species.
As compared to the guinea pig, PENCB treatment resulted in significant suppression of 
cytochrome P450 IV A l and its associated catalytic activities. In addition, the peroxisomal fatty 
acid p-oxidation has also been severely suppressed by PENCB treatment in the rat. The reasons 
underlying this species difference in the effects o f PENCB treatment on the induction o f  
cytochrome P450 IV A l and fatty acid metabolizing enzyme activities are still unknown. In 
particular, it would appear that the majority o f changes in fatty acid metabolism produced by 
PENCB occur in the rat (a relatively less responsive species to PENCB toxicity) and not the 
guinea pig (a more susceptible species). The reasons for this apparent contradiction are not clear 
at present but may be related to:
(i) fatty acid metabolism changes are not important for toxicity;
(ii) the mechanisms o f toxicity may be different between the rat and the guinea pig.
Which of these two possibilities are true, still remains to be determined.
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SUG G ESTIO N S FOR FU TU RE EXPER IM ENTS
The present study has focused on the purification and structural identification o f three newly 
identified arachidonic acid metabolites formed by liver microsomal preparations derived from rats 
pretreated with either PENCB or 3-MC. In order to additionally explore the role o f cytochrome 
P450 induction in PCB toxicity, further examination o f the potential biological effects o f these 
newly identified metabolites seems to be o f potential significance. However, it should be realized 
that the systemic study o f biological effects of these metabolites are rather difficult because of the 
complexity o f the biological system. Therefore, the choice o f the biochemical parameters to be 
examined appears to be o f critical importance. In recent years, the role o f calcium-mediated 
chemical toxicity has received much attention, and there are reports that TCDD exposure alters 
calcium homeostasis (Al-Bayati et al., 1988; Canga et al., 1988) and calcium-mediated TCDD 
toxicity (McConkey et al., 1988). Accordingly, the influence of these arachidonic acid metabolites 
on calcium homeostasis merits further investigation.
The formation o f these newly identified metabolites in PENCB-induced rats was also 
observed in PENCB-induced guinea pigs in my study as a predominant reaction product, and the 
structures o f these latter metabolite(s) in the guinea pig should be identified and the potential 
role(s) of these metabolites in species susceptibility further examined.
In addition, my studies have demonstrated that PENCB pretreatment in guinea pig 
significantly induced the expression o f two rat cytochrome P450 IV A l antibody-recognisable 
protein bands, with the upper, higher molecular weight band exhibiting a different SDS-PAGE 
mobility than its rat counterpart. To understand species differences in the regulation o f  
cytochrome P450 IV A l gene expression by PCB congeners, these P450 isoenzymes should be 
purified and their substrate specificities characterized.
Chapter 5 demonstrated that the induction o f cytochrome P450 IV A l, peroxisomal fatty 
acid p-oxidation and elevation of serum triglyceride levels by PENCB treatment in the guinea pig 
is inconsistent with the well-established mechanistic proposal for the action o f  peroxisome
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proliferators in the rat. More experiments are still needed to clarify the validity of this mechanistic
inter-relationship in the guinea pig.
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